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Abstract
This project investigates the use of ultrahigh resolution mass spectrometry along with
fragmentation techniques such as electron capture dissociation (ECD) and
collisionally activated dissociation (CAD) to study deamidation of ancient bone, by
using potential deamidation markers present in bovine collagen standards. With the
application of these techniques, several marker peptides present in the digested
protein standard of bovine collagen were successfully assigned. The sequences of
these peptides correlated well with the reported sequences for bovine collagen in the
literature.
FT-ICR-MS was used to monitor deamidation of collagen by following a shift of
+0.948 Da in the spectrum, resulting in a mass difference of 19 mDa from the 13C of
the non-deamidated form and the 12C of the deamidated form, which can be difficult
to assign due to overlap with the 13C isotopic distribution in peptides. The rate
constants for the deamidation reaction were calculated, and the extent of deamidation
before sample handling was determined. The methodology developed was then
applied to collagen extracted from real bone samples, both modern and ancient,
proving to be a useful method for monitoring asparagine deamidation before sample
preparation. Differentiation of the isomers products of deamidation (aspartic and
isoaspartic acid) were successfully assigned (where possible) using the diagnostic
ions originated from their ECD spectra.
xix
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21. 1. Archaeological Importance of Deamidation
Deamidation of asparagine (Asn) and glutamine (Gln) in proteins and peptides has
been the focus of extensive biomedical research for the last 20 years.1 Research
carried out by groups such as Robinson’s and Smith’s has significantly contributed
towards understanding the role of deamidation in aging proteins.1-9 For example the
accumulation of Asn and Gln deamidation was showed to be the major modification
in proteins such as crystallins.6-8, 10-12 This modification has been reported to
increase with age.2 As a result, studies involving Asn and Gln deamidation are
closely related to the process of aging. However, the study of deamidation of
proteins originating from ancient materials has recently increased interest in the field.
Recent reports have shown the importance of deamidation for assessing the age of
ancient materials.13-16 Particularly, in studies by Collins and co-workers that have
pointed out that deamidation is remarkably increased in collagen from archaeological
mammal bones. These studies emphasise the use of Gln and Asn deamidation as a
potential technique for assessing the age of the materials.17 Collagen has been
extensively used for radio carbon dating18 but there is no evidence of deamidation of
collagen being used for age assessment in archaeological bone. The observation of
Collins and co-workers, from the archaeological point of view, introduces a new
possibility to determine the relative age of ancient materials. Thus, the importance of
developing a method to monitor Asn deamidation in collagen is highlighted in this
thesis.
To monitor deamidation of Asn in collagen is a challenge. This is mainly because
deamidation of Asn could be artificially introduced into the system by sample
handling. A different case is for Gln deamidation which has been predicted to be 10-
3fold slower than Asn deamidation.19 For this reason the study presented in this thesis
only focuses on Asn deamidation and not Gln deamidation. The present work will
provide a solution to the issue of introducing artificial deamidation in the sample and
will be discussed in depth in the following chapters. The background for the work
presented in this thesis will be described in the following sections.
SCHEME 1.1: Isomerisation of aspartic acid (α-aspartic acid) and deamidation of Asn to isoaspartic 
acid (β-aspartic acid) and aspartic acid via a succinimide intermediate. Adapted from Cournoyer JJ,
Pittman JL, Ivleva VB, Fallows E, Waskell L, Costello CE, O'Connor PB. 2005. Deamidation:
Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation.
Protein Science 14:452-463.
1.2. Introduction to Peptide and Protein Deamidation
Deamidation of Asn and isomerisation of aspartic acid (Asp) residues in proteins are
common, spontaneous, non-enzymatic post-translational modifications (PTMs), and
result in a mixture of isomers of Asp and isoaspartic acid (IsoAsp) or, in the case of
Gln deamidation glutamic acid (α-Glu) and isoglutamic acid (γ-Glu), as shown in 
Schemes 1.1 and 1.2 respectively.1 Asn deamidation is faster due to the formation of
a stable 5-membered ring intermediate, by contrast the reaction in Gln goes through a
4less stable 6-membered ring intermediate as shown in Scheme 1.2. The modification
is also associated with many diseases, particularly those which involve problems
with protein folding. Due to the difficulty of distinguishing Asp and IsoaAsp,
insufficient work has been done to understand their formation or impact on diseases
at a molecular level. The first reaction (Asn deamidation) results in a +0.984 Da
mass shift making it relatively straightforward to detect. The second one, Asp
isomerisation results in a mixture of Asp and IsoAsp (see Scheme 1.1) that can be
differentiated by mass spectrometry using several strategies. Since the
differentiation of both isomers using Fourier transform ion cyclotron resonance mass
spectrometry (FT-ICR-MS) is part of the scope of the thesis; the strategies used for
their analysis will be discussed further in the chapter.
SCHEME 1.2: Gln/Glu can undergo a similar reaction to Asn/Asp but the intermediate is a 6-
membered succinimide which is hydrolyzed to a mixture of glutamic and γ-Glu.  
51. 2.1. Mechanism of Deamidation in Peptides and Proteins
The most accepted mechanism describes that the reaction occurs spontaneously
under physiological conditions through a succinimide intermediate whose rate is
affected by both: its amino acid sequence and three-dimensional structure.20-22 A
nucleophilic attack of the peptide nitrogen occurs on the γ-carbonyl of the Asn losing 
ammonia to form the succinimide intermediate, as previously shown in Scheme 1.1.
The reaction is highly affected by the neighbouring amino acids around the Asn
residue. Consequently, the rate of the reaction will be dependent upon the bulkiness
of the side chain.23 Hydrolysis of the succinimide intermediate results in a mixture
of products including L-IsoAsp, D-IsoAsp, L-Asp, and D-Asp. From this mixture,
IsoAsp and Asp can be differentiated using mass spectrometry (MS), but MS can
rarely differentiate stereoisomers.24, 25
The most direct mechanism of deamidation involves the nucleophilic attack of the
carbonyl group, which is a unimolecular reaction or a first order reaction.
Consequently, the extent of deamidation in the system can be calculated by
measuring the intensity ratios between the non-deamidated and the deamidated
species at different points of the reaction. Non-deamidated and deamidated species
behave similarly under ESI conditions,26 thus allowing a relationship to be
established between the peak intensities of each species. Deamidation at time zero
can be determined by using the first order equation and extrapolating back to time
zero.
A = A0e-kt (1.1)
where A = concentration of species A (N(t), intensity of the non-deamidated
monoisotopic peak), A0 = initial concentration of species A (N(0)+D(0), where D is the
6intensity of the monoisotopic peak of the deamidated species), k = rate constant, t =
time. The exponential coefficient in equation 1.1 represents the rate constant for the
deamidation reaction.
1. 2. 2. Mass Spectrometric Methods for Studying Deamidation
The most common methods used for studying deamidation using mass spectrometry
are isotopic deconvolution15, 19, 23, 27 and mass defect.28, 29 The first method uses the
+0.984 Da shift in the mass spectrum related to the change from NH2 to –OH, which
is highlighted by the atypical combination of isotopic patterns of the two species, as
shown in Figure 1.1.A.
By assuming that the intensities of the non-deamidated species (N) and the
deamidated species (D) are additive, the pattern can be deconvolved to its two
separate forms, as seen in Figure 1.B and 1.C. To achieve deconvolution, the
theoretical isotopic pattern of the two separate forms N and D needs to be fitted with
the overall experimental pattern. This method is a quick way of monitoring
deamidation and can be used to interpret data from instruments with low resolution
such as ion traps mass spectrometers. Previous data processing using this method
has been applied by Robinson and co-workers. They carried out an extensive
analysis of the rates of Asn and Gln deamidation in over 700 hundred peptides using
the data from a quadrupole mass spectrometer.19, 23, 27 Isotopic deconvolution has
also been carried out using data from MALDI-TOF15, 30-32 and FT-ICR-MS.33-35
7FIGURE 1.1: A) Isotopic distribution of the combination of non-deamidated (N) and deamidated (D)
species. B) Deconvoluted isotopic distribution of the N. C) Deconvoluted isotopic distribution of D,
showing the shift of 0.984 Da.
The mass-defect method uses the high resolving power of FT-ICR-MS to resolve the
19 mDa mass difference between the A+1 or 13C isotope of a non-deamidated
peptide and the monoisotopic peak (A) or 12C of the deamidated form, as seen in Fig
1.2, which can be obtained in broadband mode (full spectrum) at around 500,000
resolving power.28, 36 Once the peaks are resolved, the relative intensity of the two
peaks will show the extent of deamidation assuming the same ionisation and
detection conditions for both forms.26 Due to the speed in the analysis using the
8mass defect method and the access to high resolution mass spectrometry, in this case
FT-ICR-MS, the mass defect was the method of choice to carry out the experiments
presented in this thesis. For this reason the following sections will describe the
instrumentation and techniques used for the work presented here.
FIGURE 1.2: Simulation of the high resolution isotopic patterns corresponding to non-deamidated
(black) and deamidated species (red).
1.3. Mass Spectrometry
Mass spectrometry (MS) is a powerful tool used to determine the mass-to-charge
ratio of ions from a wide range of sample types. The technique has been
implemented in numerous disciplines such as pharma industry, biology, medicine,
archaeology, etc. The highlighted advantages of mass spectrometry rest on its
universal applicability; nearly all molecules show a mass spectrum. High selectivity
and sensitivity allow selection of single components amongst complex mixtures, also
allowing detection levels as low as 1 femtomole. The principal layout of the
instrument consists of four distinct regions that can be combined differently to obtain
the desired instrument for specific analysis. Example of the distribution of these
regions is shown in Fig. 1.3 in the FT-ICR-MS arrangement. In this case the
ionisation source is electrospray ionisation (ESI); fragmentation methods such as
9collisionally activated dissociation (CAD), electron transfer dissociation (ETD), and
electron capture dissociation (ECD) can be used; and analyser-ion detection occurs in
the ion cyclotron resonance cell (ICR cell).
FIGURE 1.3: Schematic representation of the 12 T Bruker SolariX system. Adapted with permission
from Bruker Daltonik GmbH.
1.3.1. Ionisation sources
Mass spectrometers separate and detect ionised molecules using electric and in some
cases magnetic fields. For the mass spectrometer to measure mass-to-charge ratio,
the sample must be ionised. This is needed because most molecules are electrically
neutral. The ionisation step can be achieved by adding or removing one or more
charged particles, which will generate positive or negative charges. Different
methods are used to achieve ionisation of molecules; they are classified into two
groups: “classical” and “soft” ionisation methods. The “classical” methods refers
primarily to electron ionisation (EI), which is the primary ionisation/fragmentation
method used for structural analysis of low molecular weight compounds (<500 Da).
In EI, the analyte precursors are ionised and fragmented by interaction with a beam
of energetic electrons (70 eV).37, 38 These are emitted from an incandescent filament
and travel through the ion chamber to an anode (electron trap) on the opposite side as
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shown in Fig. 1.4. A stream of vaporized sample molecules interacts with the beam
of electrons to produce different products (precursor ions, metastable intermediates,
and fragments). These are pulsed out of the source and accelerated into the mass
analyser device. EI produces radical rearrangements to generate significant
fragmentation. EI requires the analyte to be vaporized before ionisation; as a
consequence it is typically limited to stable molecules with molecular weights below
500 Da.
FIGURE 1.4: Electron ionisation source.
The main disadvantage in the analysis of an EI spectrum is emphasized when no
information about the precursor ion is available. All the vaporized molecules in the
sample will be ionised contributing to the mass spectrum, which take the spectrum to
a high level of complexity, making the interpretation very challenging. Also the
extensive fragmentation of the precursor ion often complicates the spectrum. The
need for new ionisation techniques to address these issues and to extend ionisation to
non-volatile molecules such as proteins, peptides, and other macromolecules drove
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the creation of other ionisation methods. Amongst these are fast atom bombardment
(FAB),39 matrix-assisted laser desorption/ionisation (MALDI),40 and electrospray
ionisation (ESI).41
Fast Atom Bombardment (FAB)
This ionisation technique uses a high energy beam (~ 8 keV) of neutral atoms (Cs,
Xe, or Ar)39 to vaporize the analyte immersed in a matrix such as glycerol, which is
commonly used for this purpose.
FIGURE 1.5: Process of ionisation in FAB.
In the bombardment process, high energy atoms or ions desorb positive ions,
negative ions, and neutrals from the surface of the matrix as seen in Fig. 1.5. These
charged species are then transferred to the mass analyser by applying an electric
field. Later on, other ionisation techniques were implemented to compensate for the
low signal-to-noise ratio and to facilitate sample delivery in the MS.
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Matrix-assisted Laser Desorption/Ionisation (MALDI)
In laser desorption/ionisation (LDI) the analyte molecules absorb radiation from a
laser at the working wavelength. If the analyte is not able to absorb radiation, a
matrix is used to assist the ionisation process, which is the technique known as
matrix-assisted laser desorption/ionisation (MALDI). Matrices that readily absorbs
the laser radiation are aromatic molecules such as 2,5-dihydroxy benzoic acid
(DHB)42 and alpha cyano hydroxycinnamic acid.43 (See Fig 1.6 for structures).
FIGURE 1.6: Chemical structure for alpha cyano hydroxycinnamic acid and 2,5-dihydroxy benzoic
acid (DHB).
In most cases the analyte is mixed with the matrix and dried down on a surface. The
exact mechanism of the MALDI ionisation process is not totally understood, but
there are several theories.44 The most accepted theory is that protons are transferred
from the matrix molecules to the analyte molecules, either during or after the
desorption process. In this process the analyte becomes charged, as seen in Fig 1.7.
The technique was first implemented by Karas and co-workers in 1987 to ionise
proteins from a crystalline nicotinic acid matrix mixture using a neodymium-yttrium
aluminium garnet laser Nd:YAG (4th harmonic, 266 nm) as the radiation source.40
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The function of the matrix is to be an intermediate in the energy transfer between the
laser and analyte. Later on the technique was used in 1989 by Beavis and co-
workers where they observed the influence of the wavelength on laser desorption of
ions from organic solids for various amino acids and dipeptides, some absorbing at
266 nm and all nonabsorbing at 355 nm.45 The exact mechanism of this process still
remains unknown but is hypothesized to be a process where laser absorption and
excitation of the matrix boost vaporization of the sample. As a consequence, a
mixture of ionised matrix and neutral analyte is produced followed by proton transfer
that result in an ionised analyte.44
FIGURE 1.7: Representation of the MALDI ionisation process.
MALDI typically generates singly charged species as opposed to ESI which often
generates multiply charged ions (depending on the number of available ionisation
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sites). The method is used for detection and characterization of biomolecules, such
as proteins, peptides, oligosaccharides and oligonucleotides, with molecular masses
between 400 and 350,000 Da.46, 47
Electrospray Ionisation (ESI)
Electrospray ionisation has been around for a while, but it was not until 1989 when
John Fenn pioneered its use for ionisation of high mass biomolecules that were
analysed by mass spectrometry.41 His significant achievement was recognized by the
awarding of the Nobel Prize in Chemistry in 2002. ESI serves as an interface to ease
the transition of molecules from solution to the gas phase. Usually, the analyte is
dissolved in a volatile solution such as 50:50 methanol: water, but the solvent will
depend on the properties of the analyte and whether ionisation is in positive or
negative mode. If ionisation in positive mode is desired, a small amount of acid is
added to boost the ionisation of the analyte. The solution passes through an
electrospray needle that has a high potential difference with respect to the entrance of
the mass spectrometer (normally in the range of 2.5 to 4 kV). This can be done for
either charge, positive or negative, by changing the polarity of the potentials applied
to the needle. Charge accumulates at the meniscus of the solution, at the tip of the
capillary as shown in Fig. 1.8. This charge is induced by the electrical potential. A
cone is formed at the end of the capillary and highly-charged droplets are expelled
from the capillary needle.48 The process is assisted by a nebulising gas (usually
nitrogen), which flows towards the inlet of the mass spectrometer (Fig. 1.8).
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FIGURE 1.8: Electrospray ionisation process. Figure adapted from Kebarle, P. A Brief Overview of
the Present Status of the Mechanisms Involved in Electrospray Mass Spectrometry. Journal of Mass
Spectrometry. 2000, 35, 804-817.
The process of ionisation is believed to occur through two mechanisms; the ion
evaporation model49 (IEM) and the charge residual model (CRM).50 During these
processes solvent evaporates from the droplets and their size decreases down to the
point when coulombic repulsion exactly balances the surface tension and the droplet
explodes, this process is best known as “Coulumbic Explosion.” The point at which
this happens is known as the Rayleigh Limit. The IEM suggests that when the
droplet approaches certain radius desorption of the analyte ions is assisted by the
field strength at the surface of the droplet.49 The CRM model proposes that the
highly-charged droplets undergo repeated cycles of solvent evaporation and
Coulumbic explosions, leading eventually to droplets that only contain one analyte
ion as seen in Fig. 1.8.50 In general is thought that ions with a small number of
charges are preferably formed by the IEM model, and multiply-charged ions are
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formed by the CRM model.48 Multiply-charged ions are normally produced in ESI,
which takes the spectrum to a higher level of complexity.
1.3.2. Mass Analysers
There is a variety of mass analysers available on the market. They vary according to,
separation principles, mass range limit, resolving power, mass accuracy, dynamic
range, sensitivity, and price. They often use electric and/or magnetic field to sort the
ions by their mass-to-charge ratio. In a mass spectrometer, the mass analyser is
located at low pressures, which prevent collisions with background gases, to avoid
damping of ions during trajectory.
Quadrupole Mass Analyser
Quadrupole have been used since the 1950’s and are still one of the most popular
mass analysers.51 Quadrupole are commonly used because they can operate at a
relatively poor vacuum, and also due to their low cost compared to other mass
analysers.
The quadrupole mass analyser consists of four identical rods in a parallel
arrangement. Each rod is connected electrically opposite to each other and they
allow ions with specific m/z values to pass through the middle of the arrangement
until the ions reach the detector. This is achieved by applying a direct current (DC)
radio frequency (RF) to the rods.37, 38 Other ions will clash toward the rods and get
neutralized as seen in Fig. 1.9 for the red ions. This allows filtering ions with a
specific m/z by scanning through different voltages at the particular m/z range.
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FIGURE 1.9: Representation of a quadrupole mass analyser.
The mass accuracy and resolution of quadrupoles are lower compared to other mass
analysers such as time of flight and FT-ICR. Quadrupoles can be used for tandem
mass spectrometry analyses, where three quadrupoles are placed in sequence. This
arrangements of quadrupoles is known as triple quadrupole mass spectrometry.
Time of flight (TOF) Mass Analyser
TOF mass analyser is the simplest of all mass analysers in terms of theory. Ions are
given a particular kinetic energy and they are allowed to travel through a field-free
region to a detector (normally the length of the region is from 0.5 to several meters).
The time it takes for the ions to reach the detector is measured and converted to the
mass-to-charge ratio with the following equation:
Where v is the velocity of the ion, z is the charge, e is the magnitude of the electronic
charge, V is the accelerating potential and m is the mass of the ion. Usually the ion
packet is accelerated to a defined kinetic energy and then separated in the field-free
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region according to their mass-to-charge ratio, as seen in Fig. 1.10. During this
travel the pressures are kept to around 10-7 mbar to avoid collisions with background
gas. The time the ion takes to reach the detector is associated with equation 1.2 and
the mass is calculated. The main advantages of TOF instruments are reflected in the
wide range of m/z that can be measured with good sensitivity, high speed, moderate
resolving powers (5,000 to 20,000), and cost (£60 K to £400 K). The resolution of
TOF instruments is limited by the length of the tube, propagation delay in detector,
and the kinetic energy distribution of the ions. Sensitivity is also limited due to ion
stability and ion transfer efficiency.
FIGURE 1.10: Combined Linear/Reflectron MALDI-TOF mass spectrometer. Reprinted with
permission from O’Connor.
1.3.3. Fourier Transform–Ion Cyclotron Resonance Mass Spectrometry (FT-
ICR-MS)
First introduced by Marshall and coworkers, FT-ICR mass spectrometry52, 53 is used
to determine the mass of ions that are trapped in a “cell,” which is typically cubical
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or cylindrical in geometry and it is located in a magnetic field. Ions are generated
externally in a separate ion source and then injected in packets into the cell where
they are trapped within an electric and magnetic field, see Fig. 1.3. Since ions are
charged particles, they will rotate around the center of the magnetic field axis,
resulting in an orbit. This motion is known as the “cyclotron motion.” Ions are
excited to their particular cyclotron orbit by applying an RF potential to the
excitation plates that are opposite to each other in the cell (see Fig. 1.11).
FIGURE 1.11: Representation of the process of excitation and detection of the ions in the ion
cyclotron resonance (ICR) cell. Reproduced with permission of Bruker Daltonik GmbH.
The detection of the ions is performed when they pass the two detector plates located
opposite to each other. The potential (voltage) change between the detection plates
can be measured as a function of time and it is from here that the raw data (known as
a transient, time-domain data, or free induction decay (FID)) is obtained. This raw
data represents the detection of all the ions at the same time, with their different
cyclotron frequencies. As a consequence it is necessary to extract the data from the
different ion packets. This is achieved by using a Fourier transformation (FT)54
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where the time-domain signal spectrum is transformed into a frequency-domain
spectrum.
The major advantage of this technique relies on the fact that once excited, the ions
can rotate thousands of times (kHz range) for several seconds, which is measured
constantly. The exceptional characteristic of numerous rotations allows high
precision measurements that generate high-quality mass spectra with a resolving
power that often reaches 106, and it is used for experiments that require high
resolution and mass accuracy, which is the case of the experiments presented in this
thesis.
Ion Cyclotron Resonance Cell (ICR cell)
One of the key components of the FT-ICR MS is the trapped-ion cell (ICR cell, ICR
trap, or Penning trap), which is located in the homogenous region of a strong
magnetic field (see Fig. 1.3), and where all the measurements of the mass-to-charge
ratio (m/z) of an ion take place. Each measurement cycle requires ion injection,
excitation, and acquisition of the induced ion signal (transient detection).
Over many years, significant improvements have been made to the ICR cells. These
improvements are based on achieving a more uniform electromagnetic field inside
the cell. To address this issue a new type of cell called the “infinite cell” was
introduced in 1991. The approach of this cell was to eliminate the z-ejection of ions,
which is caused by the z component of the excitation electric field, without affecting
the trapping and sensitivity properties of the cell.55 This is the cell currently used by
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Bruker Daltonics Ltd. in the 12 T Bruker solariX (Fig. 1.12), which is the instrument
used for the work reported in this thesis.
FIGURE 1.12: Diagram of the “Infinite cell”. Red arrow shows the diection of the magnetic field.
Figure was reproduced with the permission of Bruker Daltonik GmbH.
Ion Motion in the ICR Cell
In general, charged particles moving in the presence of a magnetic field will
experience a force known as the Lorentz Force. The axes of the force, motion of the
positively charged particle, and magnetic field are mutually perpendicular, as
directed by right hand rule, see Fig. 1.13.
The Lorentz Force acting on a charged particle in the presence of a magnetic field
alone is given by the following equation 1.3:
Where q is the charge of the particle in coulombs (C), ν is the velocity of the charged 
particle (ms-1), B is the magnetic field strength (tesla, T). The vector cross product in
equation 1.3 means that the direction of the magnetic component of the Lorentz force
is perpendicular to the plane determined by v and B as shown in Fig. 1.13. If the
trajectory of the ion, moving in the direction of the magnetic field, is stable at
constant speed, the centripetal force (the inward force) and the centrifugal force (the
outward force) need to be the same, as shown in equation 1.4
FIGURE 1.13: Direction of the Lorentz force due to the presence of a magnetic field perpendicular to
the plane of the paper.
Equation 1.4 can be expressed in the magnitude form as:
= qvBsin (1.r
mv2
In this equation θ is the angle between
field.
To simplify equation 1.5
perpendicularly to the axis of the magnetic field, then equation 1.5 would be
= qvB (1.6)r
mv2
If the angular velocity is defined by
(1.7) = vr
Rearrangement of equatio
v qB
r m
(1.8)=
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:
5)
the axes of the ion motion and the magnetic
it can be assumed that the ion is moving only
:
n 1.6 yields:
qB
m
(1.9)=
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Equation 1.9 is called the cyclotron equation, where m is the mass of the ion (kg),
and ω (rad s-1), is the cyclotron frequency. According to equation 1.9, all ions of a
given mass-to-charge ratio have the same ICR frequency, which is independent of
their velocity. From this last equation it is clear that ions with lower m/z have higher
cyclotron frequencies than ions with higher m/z.
Ions are trapped in the cell where they oscillate along the magnetic field lines, which
is possible due to the potential applied to the trapping plates shown in Fig. 1.12. The
potential is usually ~1V of the same polarity as the ion charge. The ions will then
oscillate along the z-axis of the ICR cell. As consequence of this trapping potential
an electric field is induced in the xy-plane causing the ions to be pushed towards the
detection and excitation plates. The presence of this electric field introduces a third
motion of the ions called magnetron motion, which causes the centre of the ion
cyclotron orbit to oscillate around the ICR cell axis (see Fig. 1.14).
So far, the derivation up to equation 1.9 has assumed the presence of no electric
field. However, as explained above there is a radial electric field induced by the
trapping potentials in the ICR cell, creating a force which opposes (and, thus, has
opposite sign with respect to the Lorentz force). The force is called radial force, and
is defined by the following equation:
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FIGURE 1.14: Ion motion in the ICR cell. The axis of the magnetic field is parallel to the plane of the
paper. Reprinted from Kolhinen, V.S., et al. Commissioning of the double Penning trap system
MLLTRAP. Nuclear Instruments and Methods in Physics Research Section A: Accelerators,
Spectrometers, Detectors and Associated Equipment, 2009, 600, 391-397, with permission from
Elsevier.
Where α is a constant that depends on the geometry of the cell and a is the distance 
between the trapping plates.  Expressing equation 1.6 in terms of ω and combining 
with equation 1.10:
Rearranging equation 1.11:
Equation 1.12 is a quadratic equation, which provides two solutions.
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Where ω+ and ω- are the reduced cyclotron and magnetron frequencies, in which ωc
and ωz are the unperturbed cyclotron frequency and the axial oscillation frequency
respectively. In equation 1.14 ωz is defined by:
As seen in equation 1.15 the trapping oscillation frequency is directly proportional to
the trapping potentials, which is the reason why they are kept low ~1 V. The
magnetron and the trapping frequencies are usually a lot less than the cyclotron
frequency, and they are not commonly detected.
Ion Excitation and Detection in the ICR Cell
Once the ions are in the cell, their rotation radius becomes highly important because
it must be large enough to be measured by the detection plates but not so large that
the ions strike the plates and are lost. Furthermore, field inhomogeneities worsen as
the ion radius increases, thus the optimal radius is usually around 50 % of the cell
radius. In order to detect the ions, excitation is necessary. This is achieved by
applying a radio frequency (RF) potential to one set of opposed excitation plates.
The excited ions enter an orbit that is resonant with the applied oscillating excitation.
As the ion packet passes close to the detection plates, it induces accumulation of
charges on the plate with opposite sign to the ion packet. As a result an alternating
image current will be generated on the two detection plates. The image current is
converted into an alternating voltage, which is amplified to generate a time domain
signal (a transient). The time domain signal is then Fourier transformed into a
frequency-domain spectrum, which is calibrated in terms of m/z ratio using the
cyclotron equation (see Fig.1.15).
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FIGURE 1.15: Fourier transformation of the time domain signal into frequency domain signal.
Adapted from P. B. O’Connor, 2010
After the ions have been excited into a larger orbit, they will lose their energy and go
back down to the centre of the cell, which causes the transient to decay throughout
time. The decay in the transient will directly affect the FT-ICR resolving power,56
which is often represented by the “rule of thumb” in equation 1.16:
where R is resolution, f is the cyclotron frequency, and T is the transient length.
1.3.4. Fragmentation Methods Used for Structural Analysis of Proteins and
Peptides in Mass Spectrometry
Collisionally Activated Dissociation (CAD)
CAD is the fragmentation of ions as a result of collisions with neutral gases. In this
process, a percentage of the kinetic energy of an ion is converted to internal energy
by collision with gas molecules. CAD was discovered by Keith Jennings, although
he named the method collisionally induced dissociation (CID), a nomenclature
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confusion which persists to this day.57, 58 He realized that by increasing the gas
pressure in the flight tube of the spectrometer, precursor ions could be fragmented,
and that these product fragments carried chemical structure information with them.
The technique was rapidly implemented elsewhere by McLafferty.59
Low-energy CAD is considered a “slow-heating” fragmentation method because ions
are activated and deactivated via low energy collisions. Collision with gas molecules
results in vibrational excitation allowing the energy transmitted from the collision to
be randomly distributed throughout the molecule, in a process known as
intramolecular vibrational redistribution; as a consequence, fragment ions are
primarily formed from the lowest energy bonds or rearrangements available in the
molecule. For peptides and proteins, the amide bond usually dissociates first, via a
proton transfer rearrangement,60 thus generating b and y ions61, 62 (see scheme 1.3)
The formation of b and y ions in the gas phase is described by the “Mobile Proton”
model.63-72 This model states that fragmentation is driven by the charge-bearing
proton and its location. The fragmentation of protonated peptides would require the
presence of a proton at the cleavage site. When the amino acid is attached to the
proton, the energy is used to move the proton from the side chain to the backbone
where dissociation happens. Thus, the general fragmentation mechanism of peptides
following low energy (<100 eV collisions) CAD is believed to occur via nucleophilic
attack of the carbonyl oxygen of one amide group to a nearby carbonyl carbon of
another amide group, which has been rendered electrophilic by protonation.73
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SCHEME 1.3: Product ion fragmentation of peptides. Adapted from: Roepstorff, P. and Fohlman, J. Proposal for a Common Nomenclature for Sequence Ions in Mass
Spectra of Peptides. Biomedical Mass Spectrometry. 1984, 11, 601. 50.Johnson, R.S., Martin, S.A., Biemann, K., Stults, J.T., and Watson, J.T. CID of Peptides. Analytical
Chemistry. 1987, 59, 2621-2625. And Wysocki, V.H., Tsaprailis, G., Smith, L.L., and Breci, L.A. Mobile and Localized Protons: A Framework for Understanding Peptide
Dissociation. Journal of Mass Spectrometry. 2000, 35, 1399-1406.
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In addition to backbone cleavages, other labile bonds in peptides and proteins also
dissociate easily; this includes those involving PTMs, such as glycosylation of the
side chain amide nitrogen of Asn (N-glycosylation) and the side chain oxygens of
serine (Ser) and threonine (Thr) (O-glycosylation), as well as phosphorylation on the
side chain groups of Ser, Thr, and tyrosine (Tyr). In some cases, loss of such labile
groups represents a considerable limitation of the method since the localisation of
PTMs at a certain residues is, in some cases, required for study of the function of a
modified protein.
Electron Capture Dissociation (ECD)
Electron capture dissociation is a fragmentation technique used in tandem mass
spectrometry experiments where low energy electrons (<0.5 eV) are reacted with
multiply charged positive ions. These ions are charge reduced (for example, an
[M+nH]n+ becomes [M+nH](n-1)+●) forming a radical cation.
The mechanism by which this fragmentation takes place is the topic of extensive
discussion in the field. Scheme 1.4 shows the currently most accepted mechanism of
the fragmentation pathway corresponding to ECD. This mechanism has been
proposed independently by the groups of Simons74-77 and Turecek78 and is
consequently referred to as the Utah-Washington mechanism or UW for short. The
UW mechanism considers ECD to occur by a cascade process79 where a number of
electronic states of the incipient charge-reduced ion are sampled consecutively.
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SCHEME 1.4: General mechanism of Electron Capture Dissociation of peptides. Ground and excited electronic states of peptide ions. Reprinted from Syrstad EA, Turecek
F. 2005. Toward a general mechanism of electron capture dissociation. Journal of the American Society for Mass Spectrometry 16:208-224. Copyright © 2005, with
permission from ELSEVIER.30
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If the ground state of an ammonium radical (lysine or N-terminus) is reached, a
hydrogen atom can be transferred from the ammonium group onto a proximate amide
carbonyl. Because of the competition between H-atom loss and transfer, the latter is
favoured when occurring at an internally solvated amide carbonyl. According to the
UW mechanism the capture of the low energy electron (~ 0.2 eV) is believed to
occur at the π orbital of an amide group in the presence of a remote charge in the 
molecule, producing a charged reduced species.  Subsequently, the N-Cα bond 
cleaves producing c and z● fragment ions.
Even though ECD generally provides a better range of masses for sequencing
peptides than does CAD, it has the limitation that it does not cleave at proline (Pro)
because the N-Cα bond is inside the Pro ring which thus requires two cleavages to 
see a fragment (note, this Pro effect can be taken advantage of to simplify sequencing
of Pro rich peptides).80 ECD has proved in many applications to be highly
complementary to CAD81 and has to date been particularly effective in defining the
position and structure of labile PTMs in proteins.82-86
ECD has also a demonstrated ability to differentiate IsoAsp from Asp in synthetic
peptides.87  The primary fragmentation during this process is cleavage of the N-Cα 
bond which forms c/z● or c●/z cleavage pairs (Scheme 1.5). Because ECD cleaves
the N-Cα bond, and IsoAsp does not have an N-Cα bond, this allows the 
differentiation of the two species, due to the different fragments produced, see
scheme 1.5.
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IsoAsp residues show fragment ions corresponding to cleavages on either side of the
residue as well as the c●+58/z–57. Overall, ECD represents the fragmentation
method of choice for sequencing peptides and proteins.
SCHEME 1.5: ECD mechanism for the formation of aspartyl ((M+nH)(n-1)+● and isoaspartyl (c●+58
and z-57) diagnostic fragment ions. Reprinted with permission from Sargaeva NP, Lin C, O'Connor
PB. 2009. Identification of Aspartic and Isoaspartic Acid Residues in Amyloid beta Peptides,
Including A beta 1-42, Using Electron-Ion Reactions. Analytical Chemistry 81:9778-9786. Copyright
© 2009 American Chemical Society.
ECD requires the precursor sample ions to be immersed in a dense population of low
kinetic energy electrons, restricting its use to FTMS instruments. Some exceptions to
this were reported in a couple of studies, where ECD has been achieved on an ion
trap mass spectrometer.88, 89 Another limitation of ECD is its charge state
restrictions, for example single charge would get neutralised leaving no more charges
to be detected.
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Six years after the appearance of ECD, researchers were looking for alternative ways
of achieving ECD in instruments other than FT-ICR-MS; thus, in 2004 electron
transfer dissociation (ETD) was introduced by Joshua Coon and John Syka.90, 91
ETD is similar to ECD except that small-molecule odd-electron (OE) anions transfer
an electron to multiply charged cations to induce dissociation. ETD can be
performed in instruments such as ion traps due to their ability to trap negative and
positive ions simultaneously, to promote their interaction. The key to successful
ETD relies on the electrophilic characteristics of the anion used for electron
donation. Molecules like anthracene, fluorobenzene, etc., are selected based on their
facility to donate an electron rather than extracting a proton from the cation. This
fragmentation method has also allowed new types of isomer differentiation on
peptides.92, 93
The main disadvantage of this fragmentation technique is that it is generally
performed on an ion trap, which has a poor mass resolution and accuracy compared
to other instruments such as Orbitrap and FT-ICR-MS. The main advantage is the
low cost of this type of instrumentation.
Due to the lack of mass resolution in the ion trap, the resultant ETD fragments are
often also reacted with small gaseous molecules that promote proton transfer to
reduce their charge state. Reducing the charge state makes the separation between
the peaks of an isotopic cluster broader, which at the same time makes the spectrum
less complicated to interpret and reduces the need for high resolution.
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Infrared Multiphoton Dissociation (IRMPD)
IRMPD is a fragmentation technique similar to CAD. Ions are heated with a CO2
laser (10.6 μm) until they dissociate. The fragmentation is originated due to energy
redistribution through the molecule, where lowest energy bonds are the preferential
cleavage site. Like CAD IRMPD generates mostly b and y ions. IRMPD is
commonly performed on a FT-ICR-MS,64, 94 or ion traps.65 The mechanism of
fragmentation involves the absorption of infrared photons by ions trapped in the cell.
In this process the molecule heats up until it dissociates, resulting in the cleavage of
an amide bond. When the dissociation is performed on a FT-ICR-MS, the IR laser is
aligned with the centre of the trap, which is the place where the ion cloud is normally
located. After radiation, the fragments generated stay in the centre of the trap, where
they are efficiently excited and then detected. The evident advantage of IRMPD is
that no gas is needed, because no collision is involved, which keeps the pressure
constant during dissociation. The use of IRMPD along with ECD is advantageous
because each technique will complement the sequence coverage of the peptide in
study. This is due to the facility of performing both fragmentation techniques
simultaneously, which is not the case for CAD.
1.4. Differentiation of Isomeric Amino Acids Using Mass Spectrometry
Determination of isomeric products in biological environments using mass
spectrometry represents a considerable challenge. For more than 30 years,
researchers have tried numerous ways of performing analyses of this kind. Until
recently, this has only been routinely possible using high-energy collisionally-
activated dissociation (HE-CAD) on magnetic sector instruments.95, 96 The first
evidence of isomer differentiation in peptides using this type of instrument was
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reported in the 1980s.96-98 Since then many other attempts have been made to
distinguish isomeric forms in peptides with varying success. Some of these attempts
used fast atom bombardment, and entirely relied on signature immonium ions.97-101
Other attempts were based on abundance ratio of b/y fragments.102, 103 Additional
studies showed that b+H2O peaks were observed with the IsoAsp residue and not in
the Asp residue.102, 104
High energy CAD has assisted in the differentiation of isomers using mass
spectrometry since 1980. The fragmentation using high energy CAD results in b and
y ions, but also c, z, d, a, b, v, and w ions, due to the excess of energy that results in
secondary fragmentation, see Scheme 1.3 for structure of these ions. Thus, the
technique allows differentiating between isomeric forms such as Ile/Leu in proteins
and peptides.96, 105-107 However, commercial access to this type of fragmentation was
limited due to the high cost, complexity, and low sensitivity of the instrumentation
involved (magnetic sector instruments). More modern mass spectrometers were
developed in such a way that only low-energy CAD was achievable (< 100 eV).105,
108 This range of energies is commonly used in mass spectrometers such as triple
quadrupoles and ion traps. Typical gases used for collisions are argon, helium, and
nitrogen.
Research carried out in the last decade has opened the door to new fragmentation
methods with the capability to reliably discriminate between isomers according to the
fragmentation patterns of peptides. The pioneering fragmentation method used to
achieve these new types of isomer differentiation on peptides was ECD.109 A
considerable number of publications have been published since then using this
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technique in proteomic studies. Its early application in isomer differentiation was
explored by Zubarev and co-workers,110 when the energy of the electrons in the
external cathode electron gun of a Fourier Transform Ion Cyclotron Resonance Mass
Spectrometer was increased from 0.2 eV (conventional ECD experiments) to 3-13
eV (hot ECD or HECD) producing secondary fragmentation that allowed structural
discrimination between isomeric forms of Isoleucine/Leucine (Ile/Leu).110, 111
Recently Cooper and co-workers utilized the application of hot ECD in the field of
medicine, to differentiate lIe from Leu and identified a new hemoglobin variant in
blood samples.112
Other isomers such as Asp and IsoAsp play a significant role in the development of
diseases like Alzheimer’s, amyloydosis, etc.113 Currently, numerous papers are
published annually in biological journals regarding Asp/IsoAsp formation in
proteins and one systematic study has been published regarding the ratios of the rates
of formation of these two products over time.114, 115 This study was a considerable
effort which involved high resolution HPLC separation of peptides containing the
two Asp isomers, as well as synthesis of each individual peptide in both isoforms to
determine their peak elution times. O’Connor and co-workers reported the
differentiation of Asp from IsoAsp in peptides87, 92 and proteins116 using conventional
ECD experiments. The methodology was further applied to differentiation of Asp
and IsoAsp in β-peptides 117, 118 and also in the differentiation of α-glutamic (α-glu) 
and ɣ-Glu.119 Zubarev in 2009 also demonstrated the valuable application of ECD in
proteome-scale identification of Asp isomerisation and Asn deamidation.120, 121 The
application of ECD has also been extended to other isomers such as glu and ɣ-glu,119
ε-peptides,122 and stereoisomers.24, 25
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An extensive body of research in mass spectrometry of isomers using ECD has
focused on the structural assignment of oligosaccharides.85, 123 Although the analysis
of oligosaccharides, such as glycoprotein glycans, is an example of isomeric
differentiation using mass spectrometry, a full approach of this topic is beyond the
scope of this thesis. Joseph Zaia has compiled extensive summaries of this area.124,
125
ETD provided an alternative technique to dissociate multiply charged peptides and
proteins into the homologous c and z● type ion series fragments using reactions of
multiply charged peptide/protein cations with negatively charged radical anions.90, 91
The ability to produce similar fragmentation to ECD with a relatively low cost
instrument was a significant step forward in proteomic studies, particularly in the
characterization of PTMs. ETD has also been applied to differentiation of isomers of
Asp using the same diagnostic peaks as those observed with ECD.92, 93
“Hot” ECD was introduced by Zubarev, in 2002.110, 111 In these studies it was found
that the rate of dissociative capture was also significant using hot electrons (3-13
eV). In terms of energy, this reaction was well separated from the conventional ECD
reaction typically carried out at around 0.2 eV, where significantly less fragmentation
is observed. Besides the N-Cα bond cleavage, HECD also promotes other
fragmentation pathways, cleaving more bonds than ECD and producing abundant
secondary fragmentation. The secondary fragments are typically even-electron ions
originated from excited z●, as well as b and y ions, due to the excess of vibrational
energy imparted by the higher energy electrons. These secondary ions are extremely
useful and have been used to differentiate isomers such as Leu from Ile in
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peptides.111, 112 A comprehensive approach of the role of ECD in proteomics has
been reviewed by Cooper and co-workers126, and can also be found in a review
chapter by Zubarev and co-workers.127
1.4.1. High-energy CAD and hot ECD applied in the differentiation of Ile from
Leu
Several high-energy dissociation techniques have been developed that potentially
allow Leu/Ile differentiation. Amongst these are high-energy CAD,96, 97, 128 hot
electron capture dissociation (HECD),110-112 VUV-photodissociation,129 and, most
recently, studies have reported the use of MALDI in-source decay followed by
collisional cooling, that allows the differentiation of these isomers.130, 131
Johnson showed that secondary fragmentation was achieved as a consequence of the
high-energy collision (HE-CAD) with gas molecules.96 The presence of a
characteristic peak at 54 Da higher than that corresponding to an ion of type y, was
present in the spectra of high energy CAD of peptides, using magnetic sector
instruments.96 This new secondary fragment type was assigned by Biemann105 with
the notation w. It was not frequently observed and it mainly occurred when the N-
terminal amino acid of the zn+1 ion was of the type that cannot undergo cleavage of
the Cβ-Cɣ bond, such as aromatic amino acids and when the next amino acid is one
that readily cleaves at the Cβ-Cɣ bond, such as Leu or Glu. The isoforms could be
differentiated based on the principle that Leu can only form one type of w and d ion
by losing propyl from the side chain, while Ile does not. See Scheme 1.6.
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SCHEME 1.6: Proposed fragmentation for the elucidation of Leu and IsoLeu using high-energy
CAD. Adapted from Biemann, K. and S.A. Martin. Mass spectrometric determination of the
aminoacid sequence of peptides and proteins. Mass Spectrometry Reviews. 1987, 6, 1-75.
An earlier study reported by Aubagnac in 1985 using FAB high energy CAD showed
that Leu/Ile could be differentiated using the MS/MS spectra of the m/z 86
immonium ions corresponding to the Leu and Ile residues. The limitation of this
approach was for peptides containing only one form of either lle or Leu, because, in
the FAB spectra of peptides containing both, the ion at m/z 86 is usually a mixture of
isomeric immonium ions formed from both residues.97
Later approaches to address this issue were proposed by Biemann’s group in 1988.
They used the nominal loss of an olefin from the side chain of the C-terminal amino
acid of an an ion, the (an-42)+ ion in the case of Leu and the (am-28)+ ion in the case
of Ile. These ions, well known as d-series ions, were present in the MS/MS spectrum
of protonated molecules [MH]+ of Substance P. This approach was limited to cases
where both the a-series fragment and the diagnostic d-series were sufficiently intense
to be recognized.106
In 2002, Zubarev and co-workers reported the use of more energetic electrons in
electron capture dissociation (HECD) that allowed them to induce secondary
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fragmentation of amino acid side chains of a● and z● ions, thereby producing d and w
ions. The loss of ●CH(CH3)2 (-43 Da) or ●CH2CH3 (-29 Da) from a● and z● ions
containing N- terminal Leu or lIe, respectively enables the two amino acids to be
distinguished, Scheme 1.7.110, 111
Macht and co-workers128 reported the presence of w-fragment ions as well as d-
fragment ions corresponding to Leu and Ile in a MALDI-TOF/TOF with HE-CAD.
Since Leu can only form one type of w and d ions, by losing propyl from the side
chain, Leu was differentiated unambiguously from Ile. More recently in 2009,
Zhang and co-workers also observed the presence of w ions corresponding to Leu by
using photodissociation with 157 nm light in a commercial tandem TOF-MS.129 In
the spectra obtained for the peptide VNVDEVGGEALGR, the presence of x3 and y3
indicated the presence of either Ile/Leu; alternatively, the presence of w3 certainly
indicated the presence of Leu.
In 2009 Cooper and co-workers reported a new variant of hemoglobin that was very
difficult to precisely identify using previous ESI-MS procedures such as CAD triple
quadrupole (tripleQ), where only 95 % of the variants encountered could be
assigned. In their study, the use of HECD in a FT-ICR allowed them to successfully
distinguish between Leu and Ile residues in human hemoglobinopathies without the
need of performing DNA analysis.112 This remarkable study shows that HECD
represents a useful tool in the analysis of a considerable number of hemoglobin
variants that involve amino acid exchanges governed by single mutations in the
nucleotide codon to either Leu or Ile.
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SCHEME 1.7:. Secondary fragmentation of a z ion to produce the w ion from a peptide containing (a)
a Leu residue and (b) an Ile residue. Reprinted with permission from Kjeldsen F, Haselmann KF,
Sorensen ES, Zubarev RA. 2003. Distinguishing of Ile/Leu amino acid residues in the PP3 protein by
(hot) electron capture dissociation in Fourier transform ion cyclotron resonance mass spectrometry.
Analytical Chemistry 75:1267-1274. Copyright © 2003 American Chemical Society.
In 2010, Soltwisch and Dreisewerd showed how making use of in-source decay
fragmentation (ISD) in MALDI-TOF is also a valuable tool for differentiating the
two isomers.130 Here the species were generated in a fast charge-remote dissociation
process which is similar to electron capture (ECD) and electron transfer dissociation
(ETD). However, because it is initiated by the transfer of neutral hydrogen rather
than a charged particle, it can be used to analyze singly protonated as well as
negatively charged ions. This process produces a small percentage of diagnostic
fragment d and w ions, but they show a consistency and reliability for assignment of
either Leu or Ile.131
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Another amino acid, which differs in mass by only 0.03638 Da, from Leu/Ile is
hydroxyproline (Hyp). This amino acid is produced by the hydroxylation of Pro
during the post-translational modification of proteins by propyl hydroxylase. Hyp is
found only rarely in most proteins, but in collagen it constitutes about 10% of all
amino acids.132 In 1990 Biemann and co-workers reported the differentiation
amongst Leu/Ile and Hyp, the masses of which differ by 36 mDa, using high-energy
CAD. They observed that differentiation was only possible if an N-terminal basic
moiety was present in the peptide. This is due to the ability of this basic moiety to
provide ions that retain their charge at the N-terminus.107 This was the only way of
distinguishing between these amino acids until the development of modern high
resolution mass spectrometers, such as the FT-ICR.
1.4.2. Use of high-energy CAD, ECD, and ETD to differentiate Asp from IsoAsp
in proteins and peptides
Deamidation is, perhaps, the most common post-translational modification in
proteins and results in a mixture of isomers of Asp and IsoAsp. It is associated with
many diseases, particularly those which involve problems with protein folding. Due
to the difficulty of distinguishing Asp and IsoAsp in proteins, insufficient research
has been performed regarding their formation or impact on diseases at a molecular
level, although there is extensive correlation and there is much speculation.113
Early methods were developed in order to differentiate the isomers products of
deamidation. In 1988 Lloyd and co-workers used fragment ion abundance ratios to
differentiate Asp from isoAsp residues in the MS/MS spectra of peptides using a
double focusing magnetic sector mass spectrometer.100 Their studies were based on
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the experimental observations of Okada and Kawase in 1977, where the intensities of
certain fragments corresponding to α-Glu and ɣ-Glu, (see Scheme 1.2 for structures), 
were a function of the type of linkage present in the protein.133 The most relevant
observation was the facile loss of CO from the b type fragment ion in the α-glu case 
and the absence of any CO loss from the b type fragment ion formed in the ɣ-glu 
case. The conclusions to these observations were based on the stability of the
carbocation formed in the two cases: a less stable primary carbocation in the ɣ-glu 
case and a secondary cation in the case of α-glu.  The same principle was applied by 
Lloyd and co-workers in Asp/IsoAsp differentiation. They observed the loss of CO
from bn+1 to form an+1 while the same loss was much less abundant for the isoAsp
versions (bn+1/an+1(Asp) > bn+1/an+1(isoAsp)); these results are also explained by the
same carbocation stability theory. The structure proposed by Lloyd for the a1 ion in
the MS/MS spectrum of the peptide DIRKF-NH2, which was missing in the spectrum
of the isoAsp form, was actually the immonium ion for an Asp residue (m/z = 88).
Immonium ions are fragments containing single side chains or backbone chain
formed by a combination of a type and y type cleavage.
Later, Papayannopoulos and Carr134, 135 reported the use of MS to differentiate
between Asp and IsoAsp. The differentiation was achieved by the presence of the
fragment corresponding to the isoAsp [bn-l + H2O]+ in the spectrum, where n is the
position of the Asp/IsoAsp; this fragment was not found in the spectrum
corresponding to Asp form of the same peptide. The same fragment was also used to
differentiate the isoAsp from Asp forms of a deamidated proteolytic peptide, from
hirudin, an anticoagulant peptide.136 The formation of the fragment [bn-l + H2O]+
could be explained using the mechanism proposed by Papayannopoulos,134 where
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nucleophilic attack of the carboxyl OH group of β-Asp at the adjacent carbonyl can 
be assumed to form an oxazolidone intermediate, as seen on Scheme 1.8. This
intermediate should easily decompose to the observed [bn-l + H2O]+ ion, along with
CO and a C-terminal aldimine-type moiety that represent a pair of highly stable
neutral species. Since the isoAsp side chain resembles the C–terminus, generation of
[bn-l + H2O]+ for isoAsp residues is suggested to resemble the fragmentation channel
shown to occur in the low-energy MS/MS spectra of peptides where a C–terminal
hydroxyl rearrangement generates [bn-l + H2O]+ fragment ions. Schindler and co-
workers managed to prove the mechanism proposed by Papayannopoulos with
respect to the hydroxyl transfer. This was achieved by using 18O labelling of the
peptide and then performing MS/MS. The MS/MS of the ion [bn-l + H2O]+ showed a
1:1 ratio of 16O:18O, which proves that there is a migration of –OH from the side
chain to the diagnostic fragment.136
In 2000, Lehmann and co-workers indirectly determined the presence of isoaspartyl
residues in peptides. This was achieved based on the relative abundance of fragment
ions.137 In general, the product ion spectra of peptides with isoAsp sites exhibit
different characteristics than their Asp-containing analogues. A significant
difference was observed in the spectra of peptides containing Asp and IsoAsp. As a
general trend, the presence of isoAsp enhanced y-ion formation and reduced b-ion
formation at the cleavage site.
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SCHEME 1.8: Mechanism proposed for the attack of –OH from the IsoAsp/Asp side chain to the
carbonyl backbone Adapted from Papayannopoulos, I.A. and K. Biemann. Fast atom bombardment
and tandem mass-spectrometry of synthetic peptides and by-products. Peptide Research. 1992, 5, 83-
90.
This tendency is observed due to a competition between forming the oxazolone
containing the N–terminus (b ion) and direct cleavage to form a terminal amine
containing the C–terminus (y ion). In the case of peptides containing Asp, the
oxazolone is formed as a five-membered ring due to nucleophilic attack at an Asp
side chain, while in a peptide containing isoAsp the result is a less favorable six-
membered ring, resulting in reduced b-ion abundance. Immonium ion intensities
were also investigated as candidates to differentiate the isoforms.138 On average the
immonium ion corresponding to Asp was 5.5 times higher than the one for the
isoAsp form.
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In 2000, a study by Gonzalez and co-workers showed that the [bn-1+H2O]+ fragment
ion and its complement, the [yl-n-46]+ fragment ion, can be used to differentiate
IsoAsp from Asp residues in sets of synthetic peptides, including D7 and D23 of ß-
Amyloid peptide analogues.102 The data showed that the [bn+H2O]+ ion intensity was
higher if a basic amino acid or the N-terminus was on the N-terminal side of the
isoAsp residue. Thus the resulting fragment ions were highly controlled by the
position of the basic amino acid. Otherwise, the rearrangements to generate the
diagnostic ions were not feasible, due to the lack of intermolecular interaction
between the side chain of the basic amino acid and the isoAsp residues. In addition
to this limitation, it was also noted that the diagnostic ion, [bn+H2O+ from the tryptic
peptides, was frequently undetected or at low abundance. This is because the ESI-
MS/MS of tryptic peptides are dominant for C-terminal ions (mainly “y” ions), while
the N-terminal ions usually appear with much lower intensity. In these cases
immonium ions were used to differentiate the isomers. The IsoAsp spectrum also
showed a signal at 70 Da, which was not detected for the Asp isoform. A
mechanism for the formation of this immonium ion was proposed via a
rearrangement of a primary carbocation (unstable structure). The loss of water and a
further rearrangement yields a more stable acylium ion (C3H4NO+), detected at m/z
70.02928 (see Scheme 1.9). Regardless, these immonium ions could not be used to
predict the presence of an isoAsp residue because Pro also yields an intense
immunium ion (C4H8N+) at m/z 70.06567.
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SCHEME 1.9: Proposed structures for the formation of the IsoAsp/Asp immonium ions. Adapted
from Gonzalez, L.J., T. Shimizu, Y. Satomi, L. Betancourt, V. Besada, G. Padron, R. Orlando, T.
Shirasawa, Y. Shimonishi, and T. Takao. Differentiating alpha- and beta-aspartic acids by
electrospray ionization and low-energy tandem mass spectrometry. Rapid Communications in Mass
Spectrometry. 2000, 14, 2092-2102.
Another way of identifying the isomers in proteins and peptides was proposed by
O’Connor and co-workers.87, 116, 139 The first report showed the development of a
methodology to reliably identify the isomers in synthetic peptides by using ECD as
the fragmentation method.87 Besides the conventional ECD N–Cα bond cleavage
leading to complementary c and z● fragments, the authors also detected a diagnostic
cleavage giving cn● + 58.0054 (C2H2O2) and zn-56. 9976 (C2HO2) (see Fig. 1.16 and
1.17), where n is the position of the isoaspartyl residue. Figures 1.16 and 1.17 show
that IsoAsp generated peaks corresponding to c●+ 58 and z-57 that were observed for
BUSM2 (RAAGADβGDβGAGADβAR) and not for BUSM1
(RAAAGADαGDαGAGADαAR). The c●+ 58 and z-57 diagnostic fragments are
usually less abundant than the adjacent conventional cn and zn species. The same
fragments were observed with Electron Transfer Dissociation (ETD).93, 140, 141 The
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generation of c●+ 58 and z-57 indicates the presence and position of isoAsp, and the
generation of [M+nH](n-1)+●-60 indicates the presence (but not the position) of Asp.
A more comprehensive study was performed by the same group in 2006 when they
proved that the methodology could be used to differentiate the isomers in tryptic
digested proteins.116 In 2009 Sargaeva and co-workers demonstrated the used of the
diagnostic fragments generated by ECD to identify the isomers in the whole amyloid
β 1-42 fragment, which corresponds to the most abundant component in plaque 
deposits in patients with Alzheimer’s.
FIGURE 1.16: ECD spectrum of two peptides BUSM1 and BUSM2, the shaded regions represent
the c●+58 corresponding to the presence of isoAsp. Reprinted with permission from Cournoyer JJ,
Pittman JL, Ivleva VB, Fallows E, Waskell L, Costello CE, O'Connor PB. 2005. Deamidation:
Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation.
Protein Science 14:452-463. Copyright © 2005 John Wiley and Sons.
Little has yet been done in terms of quantitation of Asp/IsoAsp isomers using ECD.
A report by Cournoyer in 2007 showed the use of a two point calibration curve to
achieve relative quantitation of the isomers, which also proved the linearity of the
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plots independent of the sequence of the small synthetic peptides. Construction of
this calibration curve was partially based on the evidence that Asn deamidation in
linear peptides produces a mixture of IsoAsp/Asp at a ratio of 3:1.20, 104, 142
FIGURE 1.17: ECD spectrum of two peptides BUSM1 and BUSM2, the shaded regions represent
the z-57 corresponding to the presence of isoAsp. Reprinted with permission from Cournoyer JJ,
Pittman JL, Ivleva VB, Fallows E, Waskell L, Costello CE, O'Connor PB. 2005. Deamidation:
Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation.
Protein Science 14:452-463. Copyright © 2005 John Wiley and Sons.
The authors used this evidence to suggest that rapid aging of a peptide with an
asparaginyl residue released from a protein by enzyme digestion should produce the
~75% isoAsp mixture that can be used for rough calibration. The results proved this
hypothesis, but the method was only applicable for quantification of IsoAsp
produced by deamidation, not for Asp isomerisation. Also, it is not yet clear if this
approach could be applied to other peptides, but it is suggested to be a good
approximation.
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Despite the fact that ETD and ECD have shown to be reliable in the differentiation of
Asp from IsoAsp in peptides and proteins, they are less commercially available than
low-energy CAD. Thus researchers are developing alternative methodologies that
can allow them to distinguish between these isomers using more common
fragmentation methods.143 Also, other studies available in the literature have
attempted to differentiate the two isomers using negative ion fragmentation,144
however the results from this study showed that the ion abundance corresponding to
α and β backbone cleavage were remarkably low and occasionally absent.  
1.4.3. Differentiation of α-Glu and ɣ-Glu residues in peptides 
Like Asn, Gln (Q) deamidates in proteins and peptides by direct hydrolysis, under
acidic conditions and proceeds via a glutarimide intermediate at neutral or alkaline
conditions.1 The reaction is much slower than Asn deamidation23 with the exception
of when Gln is located at the N-terminus, under which condition it deamidates more
rapidly than Asn to form pyroglutamic acid.145 The deamidation rates of
pentapeptides containing Asn and Gln have been theoretically calculated in previous
studies23 and the general trend shows that the half-lives of the sequence dependent
Asn peptide deamidation at neutral pH and physiological temperature range from 0.5
to 500 days, while those of Gln range from 600 to 20,000 days.
Although Asn deamidation has been extensively studied, there are a limited number
of Gln studies in the literature.19, 23, 145 The only general results that emerged from
these studies were the lower deamidation rate at the Gln site, but no indication of a
reaction pathway had been reported, until 1991, when Capasso and co-workers
reported the first evidence of the formation of a glutarimide intermediate and its
deamidation products, α- and ɣ-glutamate (Glu, E).146 However, the identification of
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the Gln deamidation sites is straightforward; similar to Asn, it can be located by a 1
Da mass shift per site.
The differentiation of the deamidation products (α-Glu and ɣ-Glu) using mass 
spectrometry has remained largely unexplored. In 1977 Okada and Kawase were the
first to find that the intensities of certain fragments corresponding to α- and ɣ-
glutamyl were a function of the type of linkage present in the protein.133 Again,
much like Asn, the most relevant observation was the facile loss of CO from the b
type fragment ion in the α-glutamyl case and the absence of CO loss from the b type 
fragment ion formed in the ɣ-glutamyl case.  The conclusions to these observations 
were based on the stability of the carbocation formed in both cases; a less stable
primary carbocation in the ɣ-glutamyl case, and a secondary cation in the case of α-
glutamyl. Later, Nagasawa and Magnan used chemical ionisation mass spectrometry
to identify the isomers.147 In their studies the separation of the isomers was achieved
by ion exchange chromatography followed by chemical ionisation. At the time this
was the only possible way of differentiating between the two isomers. Unfortunately
all these methods were limited to small peptides with less than five amino acids, and
most of them can only be applied to peptides with a glutamyl residue located at the
N-terminus when it can generate the cyclic structure for identification.
Recently, studies reported by Li and co-workers in 2010 show the differentiation of
the isomers using ECD.119 In their studies, an ECD methodology was developed to
directly differentiate the α- from the ɣ-glu residues in three human eye lens 
crystalline peptides in their potentially deamidated forms. The methodology was
entirely based on the Asp/IsoAsp differentiation method also developed by the same
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group.87 They found that the presence of z●-72 ions can be used to both identify the
existence and locate the position of the ɣ-Glu residues.   
SCHEME 1.10: a) Direct partial chain loss (w Ion formation), b) through-space radical
rearrangement, and c) mechanism for the formation of site specific zn●-59 ions in ECD of the γGlu.  
Reprinted with permission from Li XJ, Lin C, O'Connor PB. 2010. Glutamine Deamidation:
Differentiation of Glu and gamma-Glu in Peptides by Electron Capture Dissociation. Anal Chem
82:3606-3615. Copyright © 2010 American Chemical Society.
They also reported that when the peptide contains a charge carrier near its N-
terminus, the c+57 and c+59 ions may also be generated at the ɣ-Glu residue.  The 
presence of Glu residue or (α-Glu) was inferred from the observation of a series of z●
– 59 ions. Scheme 1.10 and 1.11 show the mechanisms proposed by this group for
the formation of these diagnostic ions.
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SCHEME 1.11. Proposed mechanism for the formation of site specific z●-72 ions in ECD of the
γGlu containing peptide via a) primary backbone cleavage and b) secondary fragmentation.  Reprinted 
with permission from Li XJ, Lin C, O'Connor PB. 2010. Glutamine Deamidation: Differentiation of
Glu and gamma-Glu in Peptides by Electron Capture Dissociation. Anal Chem 82:3606-3615.
Copyright © 2010 American Chemical Society.
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1.5. Aims and Objectives
The work presented in this thesis involved the use of high resolution mass
spectrometry (FT-ICR-MS) to study deamidation of Asn from bovine collagen I, and
also the differentiation of the deamidation products (IsoAsp and Asp) by using ECD.
The use of FT-ICR-MS to study deamidation of collagen is a relatively a new
approach. The interest in this particular protein originated from the research carried
out by Matthew Collins and co-workers at the University of York. They observed
that deamidation of Asn and Gln was remarkably increased in collagen from ancient
mammal bones. Since deamidation of Asn is easily induced by sample preparation,
researchers have stayed away from its use for potentially assessing the age of ancient
bone. To address this concern a methodology is needed to reliably measure the
extent of deamidation before sample preparation. The methodology is introduced in
this thesis and will be discussed in depth in Chapters 2 and 3. Since deamidation
produces IsoAsp and Asp, the differentiation of the isomers in ancient bone will be
presented in Chapter 5.
The aims of this project were to:
1. Find particular peptides within the sequence of collagen that can serve as
markers for deamidation, and that can also be reliably identified in bovine
collagen I from different sources.
2. Develop a methodology to measure the extent of deamidation before sample
preparation in bovine collagen fragments.
3. Apply the methodology to real samples, ancient bones in this case.
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4. Differentiate the isomers products of deamidation using ECD that could be
use as alternative methodology to measure the extent of deamidation of Asn.
1.6. Research Papers
The research presented in this thesis has resulted in three publications
 Perez P., Lam P., Kilgour D., Bristow A., McBride E., O’Connor P., Use of
High Resolution Mass Spectrometry for the Analysis of Polymeric Excipients in
Drug Formulations. Analytical Chemistry, 2012.
 Perez P. , O’Connor P. Deamidation of Collagen. Analytical Chemistry. 2012,
84 (6), 3017–3025.
 Perez P. , O’Connor P. Differentiation of Isomeric Amino Acid Residues in
Proteins and Peptides Using Mass Spectrometry. Mass Spectrometry Reviews.
Article first published online: 9 Feb 2012.
56
1.7. References
1. Robinson, N.E. and Robinson, A.B., Molecular Clocks: Deamidation of
Asparaginyl and Glutaminyl Residues in Peptides and Proteins. Althouse
Press: Cave Junction, OR, 2004.
2. Miesbauer, L.R., Zhou, X., Yang, Z., Sun, Y., Smith, D.L., and Smith, J.B.
Post-Translational Modifications of Water-Soluble Human Lens Crystallins
from Young Adults. Journal of Biological Chemistry. 1994, 269, 12494-502.
3. David, L.L., Lampi, K.J., Lund, A.L., and Smith, J.B. The Sequence of
Human B1-Crystallin Cdna Allows Mass Spectrometric Detection of B1
Protein Missing Portions of Its N-Terminal Extension. Journal of Biological
Chemistry. 1996, 271, 4273-4279.
4. Lampi, K.J., Ma, Z., Shih, M., Shearer, T.R., Smith, J.B., Smith, D.L., and
David, L.L. Sequence Analysis of Βa3, Βb3, and Βa4 Crystallins Completes 
the Identification of the Major Proteins in Young Human Lens. Journal of
Biological Chemistry. 1997, 272, 2268-2275.
5. Smith, J.B., Miesbauer, L.R., and Sun, Y.P. Post Translational Modification
of Crystallins Isolated from Human Lenses. Pure and Applied Chemistry.
1994, 66, 95-100.
6. Hanson, S.R.A., Smith, D.L., and Smith, J.B. Deamidation and Disulfide
Bonding in Human Lens Γ-Crystallins. Experimental Eye Research. 1998, 67,
301-312.
7. Lund, A.L., Smith, J.B., and Smith, D.L. Modifications of the Water-
Insoluble Human Lens Α-Crystallins. Experimental Eye Research. 1996, 63,
661-672.
8. Zhang, Z.L., Smith, D.L., and Smith, J.B. Human Beta-Crystallins Modified
by Backbone Cleavage, Deamidation and Oxidation Are Prone to Associate.
Experimental Eye Research. 2003, 77, 259-272.
9. Hanson, S.R.A., Hasan, A., Smith, D.L., and Smith, J.B. The Major in Vivo
Modifications of the Human Water-Insoluble Lens Crystallins Are Disulfide
Bonds, Deamidation, Methionine Oxidation and Backbone Cleavage.
Experimental Eye Research. 2000, 71, 195-207.
10. Bloemendal, H., De Jong, W., Jaenicke, R., Lubsen, N.H., Slingsby, C., and
Tardieu, A. Ageing and Vision: Structure, Stability and Function of Lens
Crystallins. Progress in Biophysics & Molecular Biology. 2004, 86, 407-485.
11. Wistow, G.J. and Piatigorsky, J. Lens Crystallins - the Evolution and
Expression of Proteins for a Highly Specialized Tissue. Annual Review of
Biochemistry. 1988, 57, 479-504.
12. Wilmarth, P.A., Tanner, S., Dasari, S., Nagalla, S.R., Riviere, M.A., Bafna,
V., Pevzner, P.A., and David, L.L. Age-Related Changes in Human
Crystallins Determined from Comparative Analysis of Post-Translational
Modifications in Young and Aged Lens: Does Deamidation Contribute to
Crystallin Insolubility? Journal of Proteome Research. 2006, 5, 2554-2566.
13. Leo, G., Andreotti, A., Marino, G., Pucci, P., Colombini M. P., and Birolo, L.
Deamidation at Asparagine and Glutamine as a Major Modification Upon
Deterioration/Aging of Proteinaceous Binders in Mural Paintings. Analytical
Chemistry. 2011, 83, 2056-2064.
14. Araki, N. and Moini, M. Age Estimation of Museum Wool Textiles from
Ovis Aries Using Deamidation Rates Utilizing Matrix-Assisted Laser
57
Desorption/Ionization Time-of-Flight Mass Spectrometry. Rapid
Communications in Mass Spectrometry. 2011, 25, 3396-3400.
15. Wilson, J., Van Doorn, N.L., and Collins, M.J. Assessing the Extent of Bone
Degradation Using Glutamine Deamidation in Collagen. Analytical
Chemistry. 2012, 84, 9041-9048.
16. Van Doorn, N.L., Wilson, J., Hollund, H., Soressi, M., and Collins, M.J. Site-
Specific Deamidation of Glutamine: A New Marker of Bone Collagen
Deterioration. Rapid Communications in Mass Spectrometry. 2012, 26, 2319-
2327.
17. Buckley, M., Walker, A., Ho, S.Y.W., Yang, Y., Smith, C., Ashton, P.,
Thomas-Oates, J., Cappellini, E., Koon, H., Penkman, K., Elsworth, B.,
Ashford, D., Solazzo, C., Andrews, P., Strahler, J., Shapiro, B., Ostrom, P.,
Gandhi, H., Miller, W., Raney, B., Zylber, M.I., Gilbert, M.T.P., Prigodich,
R.V., Ryan, M., Rijsdijk, K.F., Janoo, A., and Collins, M.J. Comment on
"Protein Sequences from Mastodon and Tyrannosaurus Rex Revealed by
Mass Spectrometry". Science. 2008, 319.
18. Brock, F., Wood, R., Higham, T.F.G., Ditchfield, P., Bayliss, A., and
Ramsey, C.B. Reliability of Nitrogen Content (%N) and Carbon:Nitrogen
Atomic Ratios (C:N) as Indicators of Collagen Preservation Suitable for
Radiocarbon Dating. Radiocarbon. 2012, 54, 879-886.
19. Robinson, N.E., Robinson, Z.W., Robinson, B.R., Robinson, A.L., Robinson,
J.A., Robinson, M.L., and Robinson, A.B. Structure-Dependent
Nonenzymatic Deamidation of Glutaminyl and Asparaginyl Pentapeptides.
Journal of Peptide Research. 2004, 63, 426-436.
20. Geiger, T. and Clarke, S. Deamidation, Isomerization, and Racemization at
Asparaginyl and Aspartyl Residues in Peptides. Journal of Biological
Chemistry. 1987, 262, 785-794.
21. Aswad, D.W., Paranandi, M.V., and Schurter, B.T. Isoaspartate in Peptides
and Proteins: Formation, Significance, and Analysis. Journal of
Pharmaceutical and Biomedical Analysis. 2000, 21, 1129-1136.
22. Radkiewicz, J.L., Zipse, H., Clarke, S., and Houk, K.N. Accelerated
Racemization of Aspartic Acid and Asparagine Residues Via Succinimide
Intermediates: An Ab Initio Theoretical Exploration of Mechanism. Journal
of the American Chemical Society. 1996, 118, 9148-9155.
23. Robinson, N.E. and Robinson, A.B. Molecular Clocks. Proceedings of the
National Academy of Sciences of the United States of America. 2001, 98, 944-
949.
24. Adams, C.M., Kjeldsen, F., Zubarev, R.A., Budnik, B.A., and Haselmann,
K.F. Electron Capture Dissociation Distinguishes a Single D-Amino Acid in
a Protein and Probes the Tertiary Structure. Journal of the American Society
for Mass Spectrometry. 2004, 15, 1087-1098.
25. Adams, C.M.Z., R. A. Distinguishing and Quantifying Peptides and Proteins
Containing D-Amino Acids by Tandem Mass Spectrometry. Analytical
Chemistry. 2005, 77, 4571-4580.
26. Stroop, S.D. A Modified Peptide Mapping Strategy for Quantifying Site-
Specific Deamidation by Electrospray Time-of-Flight Mass Spectrometry.
Rapid Communications in Mass Spectrometry. 2007, 21, 830-836.
27. Robinson, N.E., Robinson, A.B., and Merrifield, R.B. Mass Spectrometric
Evaluation of Synthetic Peptides as Primary Structure Models for Peptide and
Protein Deamidation. Journal of Peptide Research. 2001, 57, 483-493.
58
28. Schmid, D.G., Von Der Mulbe, F., Fleckenstein, B., Weinschenk, T., and
Jung, G. Broadband Detection Electrospray Ionization Fourier Transform Ion
Cyclotron Resonance Mass Spectrometry to Reveal Enzymatically and
Chemically Induced Deamidation Reactions within Peptides. Analytical
Chemistry. 2001, 73, 6008-6013.
29. Perez Hurtado, P. and O’connor, P.B. Deamidation of Collagen. Analytical
Chemistry. 2012, 84, 3017-3025.
30. Zomber, G., Reuveny, S., Garti, N., Shafferman, A., and Elhanany, E. Effects
of Spontaneous Deamidation on the Cytotoxic Activity of the Bacillus
Anthracis Protective Antigen. Journal of Biological Chemistry. 2005, 280,
39897-39906.
31. Solstad, T., Carvalho, R.N., Andersen, O.A., Waidelich, D., and Flatmark, T.
Deamidation of Labile Asparagine Residues in the Autoregulatory Sequence
of Human Phenylalanine Hydroxylase. European Journal of Biochemistry.
2003, 270, 929-938.
32. Carvalho, R.N., Solstad, T., Bjørgo, E., Barroso, J.F., and Flatmark, T.
Deamidations in Recombinant Human Phenylalanine Hydroxylase:
Identification of Labile Asparagine Residues and Functional Characterization
of Asn → Asp Mutant Forms. Journal of Biological Chemistry. 2003, 278,
15142-15152.
33. Robinson, N.E., Zabrouskov, V., Zhang, J., Lampi, K.J., and Robinson, A.B.
Measurement of Deamidation of Intact Proteins by Isotopic Envelope and
Mass Defect with Ion Cyclotron Resonance Fourier Transform Mass
Spectrometry. Rapid Communications in Mass Spectrometry. 2006, 20, 3535-
3541.
34. Robinson, N.E., Lampi, K.J., Mciver, R.T., Williams, R.H., Muster, W.C.,
Kruppa, G., and Robinson, A.B. Quantitative Measurement of Deamidation
in Lens Beta Β2-Crystallin and Peptides by Direct Electrospray Injection and 
Fragmentation in a Fourier Transform Mass Spectrometer. Molecular Vision.
2005, 11, 1211-1219.
35. Zabrouskov, V., Han, X., Welker, E., Zhai, H., Lin, C., Van Wijk, K.J.,
Scheraga, H.A., and Mclafferty, F.W. Stepwise Deamidation of Ribonuclease
a at Five Sites Determined by Top Down Mass Spectrometry†. Biochemistry.
2005, 45, 987-992.
36. Noah E. Robinson, M.L.R., Stephanie E. S. Schulze, Bert T. Lai, and Harry
B. Gray. Deamidation ofSynuclein. Protein Science. 2010, 18, 1766-1773.
37. Watson, J.T., Introduction to Mass Spectrometry. Raven Press: New York,
1985.
38. Chapman, J.R., Practical Organic Mass Spectrometry. 2nd ed.; Wiley: West
Sussex, England, 1997.
39. Tomer, K.B. The Development of Fast Atom Bombardment Combined with
Tandem Mass Spectrometry for the Determination of Biomolecules. Mass
Spectrometry Reviews. 1989, 8, 445-482.
40. Karas, M.I., Bachmann, D., Bahr, U., and Hillenkamp, F. Matrix-Assisted
Ultraviolet Laser Desorption of Non-Volatile Compounds. International
Journal of Mass Spectrometry and Ion Processes. 1987, 78, 53-68.
41. Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F., and Whitehouse, C.M.
Electrospray Ionization for Mass Spectrometry of Large Biomolecules.
Science. 1989, 246, 64-71.
59
42. Strupat, K., Karas, M., and Hillenkamp, F. 2,5-Dihydroxybenzoic Acid: A
New Matrix for Laser Desorption-Ionization Mass Spectrometry.
International Journal of Mass Spectrometry and Ion Processes. 1991, 111,
89-102.
43. Beavis, R.C. and Chait, B.T. Cinnamic Acid Derivatives as Matrices for
Ultraviolet Laser Desorption Mass Spectrometry of Proteins. Rapid Commun
Mass Spectrom. 1989, 3, 432-435.
44. Zenobi, R. and Knochenmuss, R. Ion Formation in Matrix-Assisted Laser
Desorption/Ionization Mass Spectrometry [Review]. Mass Spectrometry
Reviews. 1998, 17, 337-366.
45. Beavis, R.C., Chait, B.T., and Standing, K.G. Matrix-Assisted Laser-
Desorption Mass Spectrometry Using 355 Nm Radiation. Rapid
Communications in Mass Spectrometry. 1989, 3, 436-439.
46. Marvin, L.F., Roberts, M.A., and Fay, L.B. Matrix-Assisted Laser
Desorption/Ionization Time-of-Flight Mass Spectrometry in Clinical
Chemistry. Clinica Chimica Acta. 2003, 337, 11-21.
47. Laremore, T.N., Murugesan, S., Park, T.J., Avci, F.Y., Zagorevski, D.V., and
Linhardt, R.J. Matrix-Assisted Laser Desorption/Ionization Mass
Spectrometric Analysis of Uncomplexed Highly Sulfated Oligosaccharides
Using Ionic Liquid Matrices. Analytical Chemistry. 2006, 78, 1774-1779.
48. Kebarle, P. A Brief Overview of the Present Status of the Mechanisms
Involved in Electrospray Mass Spectrometry. Journal of Mass Spectrometry.
2000, 35, 804-817.
49. Iribarne, J.B. and Thomson, B.A. On the Evaporation of Small Ions from
Charged Droplets. Journal of Chemical Physics. 1976, 64, 2287-2294.
50. Mack, L.L., Kralik, P., Rheude, A., and Dole, M. Molecular Beams of
Macroions. Ii. Journal of Chemical Physics. 1970, 52, 4977-4986.
51. De Hoffmann, E.a.S.V., Mass Spectrometry Principles and Applications.
John Wiley and Sons, Ltd.: Chichester, 2002.
52. Comisaro, M.B. and Marshall, A.G. Fourier-Transform Ion-Cyclotron
Resonance Spectroscopy. Chemical Physics Letters. 1974, 25, 282-283.
53. Comisaro, M.B. and Marshall, A.G. Frequency-Sweep Fourier-Transform
Ion-Cyclotron Resonance Spectroscopy. Chemical Physics Letters. 1974, 26,
489-490.
54. Marshall, A.G. and Comisarow, M.B. Fourier and Hadamard Transform
Methods in Spectroscopy. Analytical Chemistry. 1975, 47, 491A.
55. Caravatti, P. and Allemann, M. The ‘Infinity Cell’: A New Trapped-Ion Cell
with Radiofrequency Covered Trapping Electrodes for Fourier Transform Ion
Cyclotron Resonance Mass Spectrometry. Organic Mass Spectrometry. 1991,
26, 514-518.
56. Amster, I.J. Fourier Transform Mass Spectrometry. Journal of Mass
Spectrometry. 1996, 31, 1325-1337.
57. Jennings, K.R. Metastable Transitions In the Mass Spectrum of Benzene.
Journal of Chemical Physics. 1965, 43, 4176-4177.
58. Jennings, K.R. Collision-Induced Decompositions of Aromatic Molecular
Ions. International Journal of Mass Spectrometry and Ion Physics. 1968, 1,
227-235.
59. Haddon, W.F. and Mclafferty, F.W. Metastable Ion Characteristics. Vii.
Collision-Induced Metastables. Journal of the American Chemical Society.
1968, 90, 4745-4746.
60
60. Tsaprailis, G., Somogyi, A., Nikolaev, E.N., and Wysocki, V.H. Refining the
Model for Selective Cleavage at Acidic Residues in Arginine-Containing
Protonated Peptides. International Journal of Mass Spectrometry. 2000, 196,
467-479.
61. Roepstorff, P. and Fohlman, J. Proposal for a Common Nomenclature for
Sequence Ions in Mass Spectra of Peptides. Biomedical Mass Spectrometry.
1984, 11, 601.
62. Johnson, R.S., Martin, S.A., Biemann, K., Stults, J.T., and Watson, J.T. Cid
of Peptides. Analytical Chemistry. 1987, 59, 2621-2625.
63. Wysocki, V.H., Tsaprailis, G., Smith, L.L., and Breci, L.A. Mobile and
Localized Protons: A Framework for Understanding Peptide Dissociation.
Journal of Mass Spectrometry. 2000, 35, 1399-1406.
64. Summerfield, S.G., Whiting, A., and Gaskell, S.J. Intra-Ionic Interactions in
Electrosprayed Peptide Ions. International Journal of Mass Spectrometry and
Ion Processes. 1997, 162, 149-161.
65. Poulter, L. and Taylor, L.C.E. A Comparison of Low and High-Energy
Collisionally Activated Decomposition Ms-Ms for Peptide Sequencing.
International Journal of Mass Spectrometry and Ion Processes. 1989, 91,
183-197.
66. Nold, M.J., Wesdemiotis, C., Yalcin, T., and Harrison, A.G. Amide Bond
Dissociation in Protonated Peptides. Structures of the N-Terminal Ionic and
Neutral Fragments. International Journal of Mass Spectrometry and Ion
Processes. 1997, 164, 137-153.
67. Harrison, A.G. and Yalcin, T. Proton Mobility in Protonated Amino Acids
and Peptides. International Journal of Mass Spectrometry. 1997, 165, 339-
347.
68. Vaisar, T. and Urban, J. Low-Energy Collision Induced Dissociation of
Protonated Peptides. Importance of an Oxazolone Formation for a Peptide
Bond Cleavage. European Mass Spectrometry. 1998, 4, 359-364.
69. Vaisar, T. and Urban, J. Gas-Phase Fragmentation of Protonated Mono-N-
Methylated Peptides. Analogy with Solution-Phase Acid-Catalyzed
Hydrolysis. Journal of Mass Spectrometry. 1998, 33, 505-524.
70. Summerfield, S.G. and Gaskell, S.J. Fragmentation Efficiencies of Peptide
Ions Following Low Energy Collisional Activation. International Journal of
Mass Spectrometry. 1997, 165, 509-521.
71. Harrison, A.G. and Tu, Y.P. Ion Chemistry of Protonated Aspartic Acid
Derivatives. Journal of Mass Spectrometry. 1998, 33, 532-542.
72. Paizs, B., Lendvay, G., Vekey, K., and Suhai, S. Formation of B2+ Ions from
Protonated Peptides: An Ab Initio Study. Rapid Communications in Mass
Spectrometry. 1999, 13, 525-533.
73. O'hair, R.a.J. Special Feature: Commentary - the Role of Nucleophile-
Electrophile Interactions in the Unimolecular and Bimolecular Gas-Phase Ion
Chemistry of Peptides and Related Systems. Journal of Mass Spectrometry.
2000, 35, 1377-1381.
74. Sobczyk, M., Anusiewicz, W., Berdys-Kochanska, J., Sawicka, A., Skurski,
P., and Simons, J. Coulomb-Assisted Dissociative Electron Attachment:
Application to a Model Peptide. Journal of Physical Chemistry A. 2005, 109,
250-258.
61
75. Anusiewicz, W., Berdys-Kochanska, J., and Simons, J. Electron Attachment
Step in Electron Capture Dissociation (ECD) and Electron Transfer
Dissociation (Etd). Journal of Physical Chemistry A. 2005, 109, 5801-5813.
76. Anusiewicz, I., Berdys-Kochanska, J., Skurski, P., and Simons, J. Simulating
Electron Transfer Attachment to a Positively Charged Model Peptide.
Journal of Physical Chemistry A. 2006, 110, 1261-1266.
77. Sobczyk, M. and Simons, J. The Role of Excited Rydberg States in Electron
Transfer Dissociation. Journal of Physical Chemistry B. 2006, 110, 7519-
7527.
78. Syrstad, E.A. and Turecek, F. Toward a General Mechanism of Electron
Capture Dissociation. Journal of the American Society for Mass
Spectrometry. 2005, 16, 208-224.
79. Sawicka, A., Skurski, P., Hudgins, R.R., and Simons, J. Model Calculations
Relevant to Disulfide Bond Cleavage Via Electron Capture Influenced by
Positively Charged Groups. Journal of Physical Chemistry B. 2003, 107,
13505-13511.
80. Leymarie, N., Berg, E.A., Mccomb, M.E., O'connor, P.B., Grogan, J.,
Oppenheim, F.G., and Costello, C.E. Tandem Mass Spectrometry for
Structural Characterization of Proline-Rich Proteins: Application to Salivary
Prp-3. Analytical Chemistry. 2002, 74, 4124-4132.
81. Zubarev, R.A., Zubarev, A.R., and Savitski, M.M. Electron Capture/Transfer
Versus Collisionally Activated/Induced Dissociations: Solo or Duet? Journal
of the American Society for Mass Spectrometry. 2008, 19, 753-761.
82. Mirgorodskaya, E., Roepstorff, P., and Zubarev, R.A. Localization of O-
Glycosylation Sites in Peptides by Electron Capture Dissociation in a Fourier
Transform Mass Spectrometer. Analytical Chemistry. 1999, 71, 4431-4436.
83. Kelleher, N.L., Zubarev, R.A., Bush, K., Furie, B., Furie, B.C., Mclafferty,
F.W., and Walsh, C.T. Localization of Labile Posttranslational Modifications
by Electron Capture Dissociation: The Case of Gamma-Carboxyglutamic
Acid. Analytical Chemistry. 1999, 71, 4250-3.
84. Stensballe, A., Jensen, O.N., Olsen, J.V., Haselmann, K.F., and Zubarev,
R.A. Electron Capture Dissociation of Singly and Multiply Phosphorylated
Peptides. Rapid Communications in Mass Spectrometry. 2000, 14, 1793-
1800.
85. Hakansson, K., Cooper, H.J., Emmett, M.R., Costello, C.E., Marshall, A.G.,
and Nilsson, C.L. Electron Capture Dissociation and Infrared Multiphoton
Dissociation Ms/Ms of an N-Glycosylated Tryptic Peptide to Yield
Complementary Sequence Information. Analytical Chemistry. 2001, 73,
4530-4536.
86. Shi, S.D.H., Hemling, M.E., Carr, S.A., Horn, D.M., Lindh, I., and
Mclafferty, F.W. Phosphopeptide/Phosphoprotein Mapping by Electron
Capture Dissociation Mass Spectrometry. Analytical Chemistry. 2001, 73, 19-
22.
87. Cournoyer, J.J., Pittman, J.L., Ivleva, V.B., Fallows, E., Waskell, L.,
Costello, C.E., and O'connor, P.B. Deamidation: Differentiation of Aspartyl
from Isoaspartyl Products in Peptides by Electron Capture Dissociation.
Protein Science. 2005, 14, 452-463.
88. Baba, T., Hashimoto, Y., Hasegawa, H., Hirabayashi, A., and Waki, I.
Electron Capture Dissociation in a Radio Frequency Ion Trap. Analytical
Chemistry. 2004, 76, 4263-6.
62
89. Silivra, O.A., Kjeldsen, F., Ivonin, I.A., and Zubarev, R.A. Electron Capture
Dissociation of Polypeptides in a Three-Dimensional Quadrupole Ion Trap:
Implementation and First Results. Journal of the American Society for Mass
Spectrometry. 2005, 16, 22-27.
90. Syka, J.E., Coon, J.J., Schroeder, M.J., Shabanowitz, J., and Hunt, D.F.
Peptide and Protein Sequence Analysis by Electron Transfer Dissociation
Mass Spectrometry. Proceedings of the National Academy of Sciences of the
United States of America. 2004, 101, 9528-33.
91. Coon, J.J., Syka, J.E.P., Schwartz, J.C., Shabanowitz, J., and Hunt, D.F.
Anion Dependence in the Partitioning between Proton and Electron Transfer
in Ion/Ion Reactions. International Journal of Mass Spectrometry. 2004, 236,
33-42.
92. O'connor, P.B., Cournoyer, J.J., Pitteri, S.J., Chrisman, P.A., and Mcluckey,
S.A. Differentiation of Aspartic and Isoaspartic Acids Using Electron
Transfer Dissociation. Journal of the American Society for Mass
Spectrometry. 2006, 17, 15-19.
93. Chan, W.Y.K., Chan, T.W.D., and O'connor, P.B. Electron Transfer
Dissociation with Supplemental Activation to Differentiate Aspartic and
Isoaspartic Residues in Doubly Charged Peptide Cations. Journal of the
American Society for Mass Spectrometry. 2010, 21, 1012-1015.
94. Little, D.P., Speir, J.P., Senko, M.W., O'connor, P.B., and Mclafferty, F.W.
Infrared Multiphoton Dissociation of Large Multiply-Charged Ions for
Biomolecule Sequencing. Analytical Chemistry. 1994, 66, 2809-2815.
95. Medzihradszky, K.F. and Burlingame, A.L. The Advantages and Versatility
of a High-Energy Collision-Induced Dissociation-Based Strategy for the
Sequence and Structural Determination of Proteins. Methods (Orlando).
1994, 6, 284-303.
96. Johnson, R.S., Martin, S.A., Biemann, K., Stults, J.T., and Watson, J.T.
Novel Fragmentation Process of Peptides by Collision-Induced
Decomposition in a Tandem Mass-Spectrometer Differentiation of Leucine
and Isoleucine. Analytical Chemistry. 1987, 59, 2621-2625.
97. Aubagnac, J.L., El Amrani, B., Devienne, F.M., and Combarieu, R.
Characterization of Leucine and Isoleucine by Use of Fab Ionization Method
in Tandem Mass Spectrometry. Organic Mass Spectrometry. 1985, 20, 428-
429.
98. Heerma, W. and Bathelt, E.R. Identification of Leucine, Isoleucine and
Norleucine in the Positive-Ion Fab Spectra of Peptides. Biomedical and
Environmental Mass Spectrometry. 1986, 13, 205-208.
99. Castet, S., Enjalbal, C., Fulcrand, P., Guichou, J.F., Martinez, J., and
Aubagnac, J.L. Characterization of Aspartic Acid and Beta-Aspartic Acid in
Peptides by Fast-Atom Bombardment Mass Spectrometry and Tandem Mass
Spectrometry. Rapid Communications in Mass Spectrometry. 1996, 10, 1934-
1938.
100. Lloyd, J.R., Cotter, M.L., Ohori, D., and Doyle, D.L. Distinction of Alpha-
Aspartyl and Beta-Aspartyl and Alpha-Glutamyl and Gamma-Glutamyl-
Transferase Peptides by Fast Atom Bombardment Tandem Mass
Spectrometry. Biomedical and Environmental Mass Spectrometry. 1988, 15,
399-402.
101. Kusmierz, J.J. and Abramson, F.P. Tracing 15n with Chemical Reaction
Interface Mass Spectrometry: A Demonstration Using 15n-Labeled Glutamine
63
and Asparagine Substrates in Cell Culture. Biological Mass Spectrometry.
1994, 23, 756-763.
102. Gonzalez, L.J., Shimizu, T., Satomi, Y., Betancourt, L., Besada, V., Padron,
G., Orlando, R., Shirasawa, T., Shimonishi, Y., and Takao, T. Differentiating
Alpha- and Beta-Aspartic Acids by Electrospray Ionization and Low-Energy
Tandem Mass Spectrometry. Rapid Communications in Mass Spectrometry.
2000, 14, 2092-2102.
103. Luu, N.C., Robinson, S., Zhao, R., Mckean, R., and Ridge, D.P. Mass
Spectrometric Differentiation of Alpha- and Beta-Aspartic Acid in a Pseudo-
Tetrapeptide Thrombosis Inhibitor and Its Isomer. European Journal of Mass
Spectrometry. 2004, 10, 279-287.
104. Chelius, D., Rehder, D.S., and Bondarenko, P.V. Identification and
Characterization of Deamidation Sites in the Conserved Regions of Human
Immunoglobulin Gamma Antibodies. Analytical Chemistry. 2005, 77, 6004-
6011.
105. Biemann, K. and Martin, S.A. Mass Spectrometric Determination of the
Aminoacid Sequence of Peptides and Proteins. Mass Spectrometry Reviews.
1987, 6, 1-75.
106. Johnson, R.S., Martin, S.A., and Biemann, K. Collision-Induced
Fragmentation of (M+H)+ Ions of Peptides-Side-Chain Specific Sequence
Ions. International Journal of Mass Spectrometry and Ion Processes. 1988,
86, 137-154.
107. Kassel, D.B. and Biemann, K. Differentiation of Hydroxyproline Isomers and
Isobars in Peptides by Tandem Mass Spectrometry. Analytical Chemistry.
1990, 62, 1691-1695.
108. Hunt, D.F., Yates, J.R., Shabanowitz, J., Winston, S., and Hauer, C.R. Protein
Sequencing by Tandom Mass Spectrometry. Proceedings of the National
Academy of Sciences of the United States of America. 1986, 83, 6233-6237.
109. Zubarev, R.A., Kelleher, N.L., and Mclafferty, F.W. Electron Capture
Dissociation of Multiply Charged Protein Cations. A Nonergodic Process.
Journal of the American Chemical Society. 1998, 120, 3265-3266.
110. Kjeldsen, F., Haselmann, K.F., Budnik, B.A., Jensen, F., and Zubarev, R.A.
Dissociative Capture of Hot (3-13 Ev) Electrons by Polypeptide Polycations:
An Efficient Process Accompanied by Secondary Fragmentation. Chemical
Physics Letters. 2002, 356, 201-206.
111. Kjeldsen, F., Haselmann, K.F., Sorensen, E.S., and Zubarev, R.A.
Distinguishing of Ile/Leu Amino Acid Residues in the Pp3 Protein by (Hot)
Electron Capture Dissociation in Fourier Transform Ion Cyclotron Resonance
Mass Spectrometry. Analytical Chemistry. 2003, 75, 1267-1274.
112. Williams, J.P., Creese, A.J., Roper, D.R., Green, B.N., and Cooper, H.J. Hot
Electron Capture Dissociation Distinguishes Leucine from Isoleucine in a
Novel Hemoglobin Variant, Hb Askew, Beta 54(D5)Val -&Gt; Ile. Journal of
the American Society for Mass Spectrometry. 2009, 20, 1707-1713.
113. Roher, A.E., Lowenson, J.D., Clarke, S., Wolkow, C., Wang, R., Cotter, R.J.,
Reardon, I.M., Zurcherneely, H.A., Heinrikson, R.L., Ball, M.J., and
Greenberg, B.D. Structural Alterations in the Peptide Backbone of Beta-
Amyloid Core Protein May Account for Its Deposition and Stability in
Alzheimers-Disease. Journal of Biological Chemistry. 1993, 268, 3072-3083.
114. Capasso, S. Estimation of the Deamidation Rate Ol Asparagine Side Chains.
Journal of Peptide Research. 2000, 55, 224-229.
64
115. Capasso, S. and Di Cerbo, P. Kinetic and Thermodynamic Control of the
Relative Yield of the Deamidation of Asparagine and Isomerization of
Aspartic Acid Residues. Journal of Peptide Research. 2000, 56, 382-387.
116. Cournoyer, J.J., Lin, C., and O'connor, P.B. Detecting Deamidation Products
in Proteins by Electron Capture Dissociation. Analytical Chemistry. 2006, 78,
1264-1271.
117. Sargaeva, N.P., Lin, C., and O'connor, P.B. Identification of Aspartic and
Isoaspartic Acid Residues in Amyloid Beta Peptides, Including a Beta 1-42,
Using Electron-Ion Reactions. Analytical Chemistry. 2009, 81, 9778-9786.
118. Sargaeva, N.P., Lin, C., and O'connor, P.B. Unusual Fragmentation of 
Linked Peptides by Exd Tandem Mass Spectrometry. Journal of the
American Chemical Society For Mass Spectrometry. 2010.
119. Li, X.J., Lin, C., and O'connor, P.B. Glutamine Deamidation: Differentiation
of Glutamic Acid and Gamma-Glutamic Acid in Peptides by Electron
Capture Dissociation. Anal Chem. 2010, 82, 3606-3615.
120. Yang, H., Fung, Y.M.E., Zubarev, A.R., and Zubarev, R.A. The Use of ECD
for Proteomics-Wide Identification and Quantification of Iso-Asp Residues.
Molecular and Cellular Proteomics. 2009, S13-S13.
121. Yang, H.Q., Fung, E.Y.M., Zubarev, A.R., and Zubarev, R.A. Toward
Proteome-Scale Identification and Quantification of Isoaspartyl Residues in
Biological Samples. Journal of Proteome Research. 2009, 8, 4615-4621.
122. Cooper, H.J., Hudgins, R.R., and Marshall, A.G. Electron Capture
Dissociation Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
of Cyclodepsipeptides, Branched Peptides, and Epsilon-Peptides.
International Journal of Mass Spectrometry. 2004, 234, 23-35.
123. O'connor, P.B. and Costello, C.E. Internal Calibration on Adjacent Samples
(Incas) with Fourier Transform Mass Spectrometry. Analytical Chemistry.
2000, 72, 5881-5885.
124. Zaia, J. Mass Spectrometry and Glycomics. Omics- a Journal of Integrative
Biology. 2010, 14, 401-418.
125. Zaia, J. Mass Spectrometry of Oligosaccharides. Mass Spectrometry Reviews.
2004, 23, 161-227.
126. Cooper, H.J., Hakansson, K., and Marshall, A.G. The Role of Electron
Capture Dissociation in Biomolecular Analysis. Mass Spectrometry Reviews.
2005, 24, 201-222.
127. Zubarev, R., in Principles of Mass Spectrometry Applied to Biomolecules, ed.
J. Laskin, Lifshitz, C. John Wiley & Sons, Inc.: New Jersey, 2006, vol. 1, pp
475-518.
128. Macht, M., Asperger, A., and Deininger, S.O. Comparison of Laser-Induced
Dissociation and High-Energy Collision-Induced Dissociation Using Matrix-
Assisted Laser Desorption/Ionization Tandem Time-of-Flight (Maldi-
Tof/Tof) for Peptide and Protein Identification. Rapid Communications in
Mass Spectrometry. 2004, 18, 2093-2105.
129. Zhang, L.Y. and Reilly, J.P. Peptide Photodissociation with 157 Nm Light in
a Commercial Tandem Time-of-Flight Mass Spectrometer. Analytical
Chemistry. 2009, 81, 7829-7838.
130. Soltwisch, J. and Dreisewerd, K. Discrimination of Isobaric Leucine and
Isoleucine Residues and Analysis of Post-Translational Modifications in
Peptides by Maldi in-Source Decay Mass Spectrometry Combined with
Collisional Cooling. Analytical Chemistry. 2010, 82, 5628-5635.
65
131. Strupat K, K.V., Bui H, Viner R, Stafford R, Horning S. Ap Maldi Produced
Ions Inspected with an Exactive Mass Spectrometer. in Proceedings of the
59th Annual Conference on Mass Spectrometry and Allied Topics. 2011.
Denver, Colorado, June 5-9.
132. Woodhead, J. Collagen: The Anatomy of a Protein. Studies in Biology No.
117. 1980.
133. Okada, K. and Kawase, M. Mass-Spectral Differentiation of Alpha-Linkages
and Gamma-Linkages in Glutamyl Oligopeptides and Its Application for
Structure Elucidation of Naturally Occurring Peptides. Chemical &
Pharmaceutical Bulletin. 1977, 25, 1497-1508.
134. Papayannopoulos, I.A. and Biemann, K. Fast-Atom-Bombardment and
Tandem Mass-Spectrometry of Synthetic Peptides and by-Products. Peptide
Research. 1992, 5, 83-90.
135. Carr, S.A., Hemling, M.E., Bean, M.F., and Roberts, G.D. Integration of
Mass Spectormetry in Analytical Biotechnology. Analytical Chemistry. 1991,
63, 2802-2824.
136. Schindler, P., Muller, D., Marki, W., Grossenbacher, H., and Richter, W.J.
Characterization of a Beta-Asp33 Isoform of Recombinant Hirudin Sequence
Variant 1 by Low-Energy Collision-Induced Dissociation. Journal of Mass
Spectrometry. 1996, 31, 967-974.
137. Lehmann, W.D., Schlosser, A., Erben, G., Pipkorn, R., Bossemeyer, D., and
Kinzel, V. Analysis of Isoaspartate in Peptides by Electrospray Tandem Mass
Spectrometry. Protein Science. 2000, 9, 2260-2268.
138. Schlosser, A. and Lehmann, W.D. Special Feature: Commentary - Five-
Membered Ring Formation in Unimolecular Reactions of Peptides: A Key
Structural Element Controlling Low-Energy Collision-Induced Dissociation
of Peptides. Journal of Mass Spectrometry. 2000, 35, 1382-1390.
139. Cournoyer, J.J., Lin, C., Bowman, M.J., and O'connor, P.B. Quantitating the
Relative Abundance of Isoaspartyl Residues in Deamidated Proteins by
Electron Capture Dissociation. Journal of the American Society for Mass
Spectrometry. 2007, 18, 48-56.
140. Sargaeva, N.P., Lin, C., and O’connor, P.B. Differentiating N-Terminal
Aspartic and Isoaspartic Acid Residues in Peptides. Analytical Chemistry.
2011, 6675-6682.
141. O'connor, P.B., Cournoyer, J.J., Pitteri, S.J., Chrisman, P.A., and Mcluckey,
S.A. Differentiation of Aspartic and Isoaspartic Acids Using Electron
Transfer Dissociation. Journal of the American Society for Mass
Spectrometry. 2005, 17, 15-19.
142. Potter, S.M., Henzel, W.J., and Aswad, D.W. In-Vitro Aging of Calmodulin
Generates Isoaspartate at Multiple Asn-Gly and Asp-Gly Sites in Calcium-
Binding Domain-Ii, Domain-Iii, and Domain-Iv. Protein Science. 1993, 2,
1648-1663.
143. Wang, B., Shang, J., Qin, Y., Yan, B., and Guo, X. Differentiation of Α- or 
Β-Aspartic Isomers in the Heptapeptides by the Fragments of 
[M + Na]&Lt;Sup&Gt;+&Lt;/Sup&Gt; Using Ion Trap Tandem Mass 
Spectrometry. Journal of the American Society for Mass Spectrometry. 2011,
22, 1453-1462.
144. Andreazza, H.J., Wang, T., Bagley, C.J., Hoffmann, P., and Bowie, J.H.
Negative Ion Fragmentations of Deprotonated Peptides. The Unusual Case of
Isoasp: A Joint Experimental and Theoretical Study. Comparison with
66
Positive Ion Cleavages. Rapid Communications in Mass Spectrometry. 2009,
23, 1993-2002.
145. Wright, H.T. Nonenzymatic Deamidation of Asparaginyl and Glutaminyl
Residues in Proteins. Critical Reviews in Biochemistry and Molecular
Biology. 1991, 26, 1-52.
146. Capasso, S., Mazzarella, L., Sica, F., and Zagari, A. 1st Evidence of
Spontaneous Deamidation of Glutamine Residue Via Cyclic Imide to Alpha-
Glutamic and Gamma-Glutamic Residue under Physiological Conditions.
Journal of the Chemical Society-Chemical Communications. 1991, 1667-
1668.
147. Nagasawa, H.T., Magnan, S.D.J., and Foltz, R.L. Differentiation of Alpha-
Glutamyl from Gamma-Glutamyl-Transferase Dipeptides by Chemical
Ionization Mass-Spectrometry. Biomedical Mass Spectrometry. 1982, 9, 252-
256.
67
Chapter 2: Development of a
methodology to monitor deamidation of
collagen I
_______________________________
1This chapter has been partially/entirely reproduced from
Hurtado, P. P., O'Connor, P. B., Deamidation of Collagen. Analytical Chemistry. 2012,
84. 3017-3025.
68
2.1. INTRODUCTION
For the last three decades, extensive research into protein analysis has generated new
tools that allow archaeologists to predict the age of ancient materials. So far, the
most popular methodologies to achieve these are based on chronometric techniques
such as radiocarbon dating, and amino acid dating (using Asp racemisation).1, 2
Radiocarbon dating has significant upper and lower limits. Due to the logarithmic
decay rate of 14C, the practical upper limit is about 50,000 years. This is because so
little 14C remains after almost 9 half-lives that it may be hard to detect and obtain an
accurate reading, regardless of the size of the sample.3 The latter technique (amino
acid racemisation) allows the study of a wider range of ages, up to 2 million years
old, but it relies on the ability of certain amino acids such as Asp, Leu, and Glu to
racemise.4-7
FIGURE 2.1: Representation of the structure of collagen type I. Adapted from
http://atlasgeneticsoncology.org/Genes/COL1A2ID411ch7q22.html. Accessed on: May 17th 2013.
Collagen represents an ideal molecule for analysis in dating materials. Collagen is
the major component of skin, tendons, ligaments, teeth and bones providing the
framework that holds most multi-cellular animals together. Type I constitutes the
major fibrillar collagen of bone. This protein is found, in at least small quantities, in
most animal phyla and it is located in the connective tissues providing strength and
conferring form while allowing flexibility.8 Due to its triple helix structure (see Fig.
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2.1) and the solid components of the bone matrix, collagen persists with
extraordinary longevity under extreme conditions,9, 10 but unfortunately the same
strong structure that characterizes collagen also minimises Asp racemisation,11-13
thus limiting its utility for current dating tool analyses. Recent reports have shown
that certain protein modifications such as deamidation are remarkably increased in
collagen from old bone in mammals.14 This observation could potentially contribute
towards the possibility of using this diagenetic modification as a means of assessing
the age of archaeological materials.
The relationship between aging and deamidation is a topic of continuous debate.
One of the most relevant pieces of experimental evidence about deamidation and
aging relates to in vivo accumulation of deamidated proteins of different kinds with
age.15 It was hypothesized16 and then experimentally demonstrated17-19 that
deamidation can serve as a biologically relevant molecular clock that regulates the
timing of in vivo processes. Two of the pioneering groups that have extensively
reported deamidation studies in proteins and peptides are the groups of Arthur
Robinson and Noah Robinson. A significant library of sequence-determined Asn
deamidation rates has been published by these groups.20, 21 Also a comprehensive
book related to deamidation has been published by the same groups.22
Smith and collaborators have significantly contributed towards deamidation research
by their studies in PTMs in human lens crystallins using FAB.23-27 The correlation of
developing cataracts with old age constituted the starting point in the crystalline
research carried out by Smith’s group. Crystallins are highly soluble and they
constitute about 90 % of lens proteins. The accumulation of many PTMs in
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crystallins has been demonstrated.28-30 Amongst these, deamidation of Asn and Gln
is one of the major modifications,27, 31, 32 which affect lens transparency, decreases
crystalline solubility, and is related to cataract formation.33 Smith and collaborators
have reported that the amount of deamidated proteins was increased with age in a
range of samples from 20 to 27 years old.23 In their experiments, deamidation half-
life was estimated to be 41,000 days in the >30 kD fraction and 56,000 days in the 13
to 30 kD fraction.34 This was screened in 50-65 years old subjects. Their findings
also shown that a difference in deamidation as a function of molecular weight or
aggregation was observed in a range of 6 Gln and 2 Asn deamidation in αA, αB, αB1,
and γS-crystallins.  Findings from Smith and collaborators support the basis of the 
potential use of Asn deamidation as a way of assessing the age of materials.
As previously described in Chapter 1, Asn deamidation results in a +0.984 Da mass
shift and a charge shift making it relatively straightforward to detect.20, 35, 36 Several
mass spectrometric methodologies have been utilized to monitor the shift of mass
caused by peptide deamidation; amongst these are LC-MS37, 38 and MALDI-TOF-
MS.39-42 Asp isomerisation can be challenging to detect using mass spectrometry.43-
45 Early methods were developed to differentiate the two isomeric forms46, 47 based
on relative fragment ion abundance, but the introduction of new fragmentation
techniques in mass spectrometry such as electron capture (ECD) and electron transfer
dissociation (ETD) has improved the differentiation of aspartyl from isoaspartyl
residues in protein modifications.43-45, 48
Considering that deamidation follows first-order reaction kinetics, several
methodologies can be applied to determine the half-life of the deamidating Asn.
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One way is making use of ECD along with high resolution mass spectrometry, in
which the peak intensity ratio of IsoAsp/Asp is monitored at different points of the
reaction.44, 45, 49, 50 The drawback of this method is that it relies on the appearance of
the diagnostic fragment ions for these two isomers. Other methods, such as isotopic
deconvolution and the mass defect method overcome this issue but cannot
distinguish the isomers of IsoAsp.
The other methods to measure the extent of deamidation (isotopic deconvolution and
mass defect) have been previously discussed in Chapter 1. The present work aims to
show a methodology to measure the extent of deamidation using the mass defect
method in tryptic peptides of collagen I. The differentiation of Asp from IsoAsp
using ECD was also explored as a potential alternative methodology, but was found
so far to be unsuitable for kinetic measurements. The study also attempts to measure
deamidation rates and half-lives to assess the feasibility of using Asn deamidation as
an age dating method for collagen.
2.2. EXPERIMENTAL METHODOLOGY
2.2.1. Materials
Collagen type I, trypsin sequencing-grade, ammonium acetate (CH3COONH4), and
ammonium bicarbonate (NH4HCO3) were purchased from Sigma Aldrich,
Gillingham, UK. HPLC grade methanol and formic acid (HCOOH) were obtained
from Fisher Scientific, Leicestershire, UK.
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2.2.2. Digestion of collagen
Prior to digestion, 3 mg of collagen type I (triplicate) was weighed out and denatured
in 0.5 mL of 50 mM ammonium bicarbonate (pH 7.5) at 62 °C, which was found to
be the optimum temperature to get collagen into solution, after several trials using
temperatures ranging from 40 to 75°C. This was repeated varying the denaturation
time (40, 60, 80, 100, and 120 minutes). The samples were centrifuged at 11,298 g
for 20 min at 21°C.  The supernatant (350 μL) was collected and 12 μL of trypsin 
solution (2 μg/μL) was added using a ratio of 1:40 enzyme:protein.  To minimise 
deamidation during tryptic digestion, the mixture was allowed to react for 4 hours at
37 °C,51 the reaction was halted by adding 5% formic acid, and the samples were
dried in a SpeedVac system (Savant SPD121P Fisher Scientific, Leicestershire, UK)
to evaporate volatiles at 35 °C, they were then stored at -80°C until analyses were
carried out (≈ 1 day).  The samples were reconstituted into a mixture of 1:1 
MeOH:H2O, and diluted into a mixture of 49.5:49.5:1 MeOH:H2O:formic acid to a
final solution of an approximate concentration of 2.5 μM, which is based on maximal 
quantity from collagen starting material.
2.2.3. FT-ICR-MS measurements
The experiments were carried out on a Bruker solarix 12 T FT-ICR-MS. In order to
identify deamidation sites, samples of digested collagen were electrosprayed at
approximately 2.5 µM concentration in 49.5:49.5:1 MeOH:H2O:formic acid. For
CAD experiments,52 the parent ions were isolated using the quadrupole, and were
fragmented in the collision cell (q, typical collision energies ~10-30 eV), and then
transmitted into the ion cyclotron resonance cell (ICR) for detection, see Fig. 1.3.
For ECD experiments, the parent ions were isolated in the quadrupole and externally
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accumulated in a hexapole collision cell (at injection energies <5 eV) for 1-10 s.
After being transferred to and trapped in the ICR cell, ions were irradiated with 1.5
eV electrons from a heated hollow cathode (1.7 A) for 20 to 90 ms.53 The mass
spectrometer was externally calibrated using tuning mixture (HP mix). After
performing CAD and ECD to characterize 30 tryptic peptides, the instrument was
then internally calibrated with tryptic peptides from collagen I that have been
previously identified by manually interpretation of their CAD and ECD spectra. The
ECD spectra for the three peptides chosen to monitor deamidation were also
internally calibrated using c and z• ions corresponding to the known peptides. The
assigned mass tables for each spectrum are provided in section 2.6 of this chapter.
2.3. RESULTS AND DISCUSSION
2.3.1. Peptide Characterization
Collagen (I) is a heterotrimer composed of two α1 and one α2 chains and contains an 
uninterrupted triple helical domain (~1000 residues from each chain) of
approximately 400 kDa molecular weight. The triple helix is stabilized by a high
fractional content of the amino acids Pro ~12% and Hyp ~10%, by the close packing
of the three chains, by hydrogen bonding between the chains, hydroxylysine
crosslinks, and by an extensive hydration network. The folding of the three chains
requires every third residue to be a Gly, generating a repeating (Gly-X-Y)n sequence
pattern, where X and Y are any other amino acid residue (see Fig. 2.2.).54
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FIGURE 2.2: Sequence structure of collagen type 1. Figure adjusted from protein data bank:
http://www.rcsb.org/pdb/101/motm.do?momID=4. Accessed on: May 17th 2013.
The most frequent tripeptide unit (triplet) is Gly-Pro-Hyp, which also contributes the
maximal stability to the triple helix.55 In general, Pro residues in collagen appear in
positions 2 and 3 of the triplet, Hyp is confined exclusively to position 3 and very
few Pro in that position are not hydroxylated (see table 2.1 for sequences and mass
accuracy information.). This clearly suggests a steric effect in the enzymatic
modification of prolines, thus increasing the challenge of locating the modification in
a single peptide from collagen.56 In order to locate and differentiate the Hyp residues
(113.04768 Da) from Leu/Ile (113.08406 Da) in the peptides, high resolving power
was necessary.
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Thermal denaturation of collagen introduces a “statistical random coil” state when
the molecule is in solution.8 The breakage of the three helices and subsequent tryptic
digestion produces a significant number of peptides with similar mass, as shown in
table 2.1 and the spectrum in Fig. 2.3. In order to characterize the peptides in
collagen, the use of ECD and CAD was necessary; this is due to the high content of
Pro and Hyp in these types of peptides. It is well known that ECD does not cleave
the N-terminal to Pro,57 thus the complementary information provided by CAD was
essential in this case. The high resolving power of FT-ICR-MS along with its ability
to fragment peptides by CAD and ECD, facilitated the reliable identification of 30
peptides using these fragmentation techniques, from which three were chosen for
deamidation studies, because they were the only peptides that showed a shift of 0.984
Da in the spectrum as highlighted in red boxes in Fig 2.3.
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TABLE 2.1: Tryptic peptides of Collagen I. Confirmed using CAD
Length coll-I(chain) Identified peptides MW [M+H]1+ [M+2H]2+ Exp. Error ppm
1084-1092 (α1) GPAGPQGPR 835.43002 836.43730 418.72229 418.72251 -0.53
268-276 (α1) GFSGLDGAK 850.41845 851.42573 426.21651 426.21651 -0.01 
994-1003 (α2) GPSGPQGIR  867.45624 868.46352 434.73540 434.73529 0.25 
361-369 (α1) GSEGPQGVR 885.43042 886.43770 443.72249 443.72219 0.68 
1052-1062 (α2) GPAGPSGPAGK 894.45589 895.46317 448.23523 448.23495 0.61 
958-966 (α1) GVVGLPGQR 897.50319 898.51047 449.75888 449.75869 0.41
412-421 (α2) AGVMGPAGSR 901.44396 902.45124 451.72926 451.72913 0.29 
697-708 (α1) GANGAPGNDGAK 1045.43119 1046.43847 523.72288 523.72337 -0.95
493-504 (α1) GFPGADGVAGPK 1087.52978 1088.53706 544.77217 544.77229 -0.22
1066-1078 (α2) IGQPGAVGPAGIR1 1191.67236 1192.67964 596.84346 596.84333 0.22
485-496 (α2) GEPGNIGFPGPK 1200.57747 1201.58475 601.29602 601.29594 0.12
1066-1078 (α2) IGQPGAVGPAGIR1 1207.66728 1208.67456 604.84092 604.84092 0.00
538-551 (α1) GLTGSPGSPGPDGK 1257.58368 1258.59096 629.79912 629.79896 0.25
449-462 (α2) GFPGSPGNIGPAGK 1286.62548 1287.63276 644.32002 644.31970 0.50
970-983 (α1) GFPGLPGPSGEPGK 1327.64079 1328.64807 664.82768 664.82761 0.10
415-429 (α1) GPSGPQGPSGPPGPK 1331.64694 1332.65422 666.83075 666.83077 -0.03
970-983 (α1) GFPGLPGPSGEPGK 1343.63571 1344.64299 672.82514 672.82520 -0.10
415-429 (α1) GPSGPQGPSGPPGPK 1347.64186 1348.64914 674.82821 674.82815 0.09
472-486 (α1) GEPGPAGLPGPPGER 1434.67388 1435.68116 718.34422 718.34419 0.04
865-881 (α1) GSAGPPGATGFPGAAGR 1458.68511 1459.69239 730.34984 730.35006 -0.31
775-792 (α2) GDGGPPGATGFPGAAGR 1472.66437 1473.67165 737.33947 737.33971 -0.33
977-994 (α2) GEPGPAGAVGPAGAVGPR2 1515.77932 1516.78660 758.89694 758.89666 0.37
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TABLE 2.1: Tryptic peptides of Collagen I. Confirmed using CAD (Continued)
Length coll-I(chain) Identified peptides MW [M+H]1+ [M+2H]2+ Exp. Errorppm
977-994 (α2) GEPGPAGAVGPAGAVGPR2 1531.77424 1532.78152 766.89440 766.89480 -0.52
674-691 (α2) GAPGAIGAPGPAGANGDR 1537.71204 1538.71932 769.86330 769.86295 0.45
1066-1083 (α1) GETGPAGPAGPIGPVGAR 1559.80554 1560.81282 780.91005 780.90981 0.31 
1152-1167 (α1) DGLNGLPGPIGPPGPR 1560.78958 1561.79686 781.40207 781.40222 -0.19
1152-1167 (α1) DGLNGLPGPIGPPGPR 1561.77359 1562.78087 781.89408 781.89371 0.47
397-414 (α1) GANGAPGIAGAPGFPGAR 1584.76442 1585.7717 793.38949 793.38943 0.08
397-414 (α1) GANGAPGIAGAPGFPGAR 1585.74843 1586.75571 793.88150 793.88087 0.79
612-630 (α1) DGEAGAQGPPGPAGPAGER 1705.76553 1706.77281 853.89005 853.88995 0.11
1022-1051 (α2) GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR 2783.35994 2784.36722 696.84726(+4) 696.84696 0.43
1022-1051 (α2) GHDGLQGLPGLAGHHGDQGAPGAVGPAGPR 2784.34395 2785.35123 697.09326(4+) 697.09295 0.44
713-736 (α2) GEVGPAGPNGFAGPAGAAGQPGAK 2066.96567 2067.97295 1034.49012 1034.49083 -0.69
1,2Same peptide (different modification)
P: Hydroxyproline (Hyp)
N: Deamidation of N (D)
Underlined peptides (+1 and +2) were used to calibrate de instrument
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FIGURE 2.3: Mass spectrum of collagen tryptic digest. Peptides marked with N (Asn) were selected for deamidation studies. P represents Hyp. Insert a) shows the
isotopic pattern for the non-deamidated, m/z [696.84696]4+, and the deamidated peptide, m/z [697.09326]4+, where the triangles represent the non-deamidated peptide and
the circles represent the deamidated peptide. Insert b) shows the theoretical isotopic distribution for the peptides.
78
79
2.3.2. Identification of Deamidation Sites in Collagen by Using FT-ICR-MS
In order to assess deamidation, a shift of +0.984 Da was monitored in all peptides in
the mass spectrum of the collagen tryptic digest (see red boxes and insert in Fig 2.3.).
Analysis of the spectrum showed three of the six possible peptides that may undergo
Asn deamidation due to the presence of Asn in the sequence. These three observed
peptides corresponded well with the expected mass (<1 ppm). Therefore, they were
chosen for further deamidation studies: [coll_I (α2) 1022-1051]4+, [coll_I (α1) 1152-
1167]2+, and [coll_I (α1) 397-414]2+.
Fig. 2.4 shows the ECD spectra corresponding to [coll_I (α2) 1022-1051]4+. With
ECD, 80% cleavage coverage can be achieved for the peptide shown in Fig 2.4
(excluding cleavages next to Pro, the fragmentation of this peptide shows 100% of
the expected cleavages). After manual interpretation of the spectrum, the
deamidation site was easily identified as position 3 from the N-terminus.
Fragmentation with CAD for this peptide showed the location of two Hyp at
positions 10 and 22 from the C-terminus.  ECD spectrum for [coll_I (α1) 1152-
1167]2+ and coll_I (α1) 397-414 are shown in Figs. 2.5 and 2.6 respectively; they
show less fragmentation than the CAD spectra due to the number of prolines present
in each peptide. However, the deamidation sites were easily located in each peptide.
Figs. 2.7, 2.8 and 2.9 show the CAD spectra showing the positions of Hyp for each
peptide. The data obtained from the CAD spectra complemented the data from ECD
to complete the sequences. Isotopic distributions and high mass accuracy were used
to increase the confidence in assignments of each peptide and its fragments. The
complete list of masses is included at the end of the chapter.
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FIGURE 2.4: ECD of tryptic digest peptide [coll_I (α2) -1022-1051]4+ ion at m/z 697.09326. Asn highlighted in red shows the deamidation site. P highlighted in green
show hydroxylation site. Insert shows the charge reduced species at m/z 929.4584. (*) represents noise peaks and (?) represents unknown peaks, (▲) represents a different
peptide present in the mixture.80
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FIGURE 2.5: ECD of tryptic digest peptide [coll_I (α1) 1152-1167]2+ ion at m/z 781.89408. Asn highlighted in red shows the deamidation site. P highlighted in green show
hydroxylation site. Insert show the region where IsoAsp diagnostic ion appears (z13●-57, m/z 1204.63171) indicating position 13, and the lost CO2 from z16 (z16-44, m/z
1502.77117) represents the diagnostic ion for the presence of Asp in position 16. Ions labelled with blue are originated from another peptide present in the digestion mixture
at m/z 780.90998.
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FIGURE 2.6: ECD of tryptic digest peptide [coll_I (α1) 397-414]2+ ion at 793.88150 m/z. Asn highlighted in red shows the deamidation site. P highlighted in green show
hydroxylation site. The insert show the region where the Asp diagnostic ion (z16-57, m/z 1385.68082) appears, this one correspond to position 3 (N-terminal), 16 (C-
terminal) in the peptide. Ions labelled with purple and brown are originated from other two peptides present in the digestion mixture with m/z 790.88673 and m/z 795.90975.
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FIGURE 2.7: CAD of tryptic digest peptide [coll_I (α2) -1022-1051]4+ ion at m/z 697.09326. Asn highlighted in red shows the deamidation site. P highlighted in green
show hydroxylation site.83
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FIGURE 2.8: CAD of tryptic digest peptide [coll_I(α1) -1152-1167 ]2+ ion at m/z 781.89408. Asn highlighted in red shows the deamidation site. P highlighted in green
show hydroxylation site. Ions labelled with blue are originated from another peptide present in the digestion mixture at m/z 780.90998.84
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FIGURE 2.9: CAD of tryptic digest peptide [coll_I (α1) 397-414, coll_I(α1) ] 2+ ion at m/z 793.88150. Asn highlighted in red shows the deamidation site. Prolines
highlighted in green show hydroxylation site.85
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2.3.3. Deamidation Rates
To study the deamidation of these peptides, collagen was denatured (heated) at
different times (40, 60, 80, 100, and 120 minutes) holding the temperature at 62 °C.
First order reaction was assumed, which, to date, is the most accepted mechanism for
this particular post-translational modification.58-60 As previously described in
Chapter 1, this assumption implies that the reaction occurs spontaneously under
physiological conditions through a succinimide intermediate. The rate of the
deamidation reaction is affected by both the amino acid sequence and the three-
dimensional structure. In addition to the latter, other parameters play a significant
role in deamidation rates such as pH, temperature, ionic strength, buffer ions, and
other solution properties. For temperatures above 70 °C, collagen peptides were not
detected in the spectra. This can be explained by the temperature of gelatinization or
shrinkage temperature, at which the coils of collagen shrink. One of the most
significant studies about the behavior of collagen in solution at different temperatures
was reported by Sinex in 1960,61 in which it is explained that the deamidation of
collagen follows a temperature dependent relationship only above the temperature at
which the triple helix melts (Tm), which for all collagen molecules is above
physiological temperatures. At this melting temperature, or Tm, the three alpha
helices break and they start to exist as “statistical random coils” in solution. Once
the temperature has reached the gelatinization point, or Ts (shrinkage temperature),
which is above ≈ 65 °C for collagen molecules, the coils start to shrink.61 The
shrinkage of collagen will affect its solubility. Therefore, there is a narrow window
of temperatures which allow the study of this molecule in solution.
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Optimization of the temperature for deamidation of collagen was the most difficult
step. After several trials of denaturation of collagen at different times ( 40, 60, 80,
100, 120 min) at temperatures ranging from 40 °C to 85 °C the optimal temperature
for the denaturation experiment was found to be around 62 °C. The extent of
deamidation of the peptides was calculated by measuring the intensity ratios between
the non-deamidated and the deamidated species at different points in the reaction
(See Fig 2.10 and 2.11). Non-deamidated and deamidated peptides behave similarly
under ESI conditions,62 thus allowing a relationship to be established between the
peak intensities of each peptide. Deamidation at time zero was determined by using
the first order equation and extrapolating back to time zero as previously explained in
Chapter 1.
A = A0e-kt (2.1)
Where A = concentration of species A (N(t), intensity of the non-deamidated
monoisotopic peak), A0 = initial concentration of species A (N(t)+D(t), where D is the
intensity of the monoisotopic peak of the deamidated species), k = rate constant, t =
time. The exponential coefficient in equation (2.1) represents the deamidation rate
constant for the reaction. By constructing a rate curve following a first order
mechanism for each peptide, as shown in Fig 2.11, it is possible to extrapolate back
to time zero and obtain the initial extent of deamidation for each peptide before
sample preparation, which is given by the value in the “y” axis or (N(t)/ N(t)+D(t),),
when time or “x” = 0 (Table 2.2).
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FIGURE 2.10: Snapshot of the deamidation reaction of peptides at 80 min after denatured time at 62 °C. A. [coll_Iα2) -1022-1051]4+ ion at m/z 697.09326, B. [coll_I (α1) -
1152-1167]2+ ion at m/z 781.89408, and C. [coll_I (α1) 397-414, coll_I (α1) ] 2+ ion at m/z 793.88150. Triangles represent the non-deamidated peptides and the circles
represent the deamidated peptides. Inserts to the right are the theoretical isotopic distributions. Inserts to the left are expansion of the A+1 isotope of the non-deamidated and
the A isotope of the deamidated species.88
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FIGURE 2.11: Exponential decay curves of the non-deamidated peptide at 62 °C. A. [coll_I (α2) -1022-1051]4+ ion at m/z 697.09326, B.[coll_I (α1) -1152-1167]2+ ion at
m/z 781.89408, and C. [coll_I (α1) 397-414, coll_I (α1)]2+ ion at m/z 793.88150. The exponential coefficients represent the rate constants of deamidation for each peptide.
The intercept at the y axis represents the extent of deamidation before sample preparation in each case.89
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TABLE 2.2: Deamidation rates and extent of deamidation of collagen peptides at 62
°C
Peptide
coll_I(α2) -1022-1051 
62°C
coll_I(α1) -1152-1167 
62°C
coll_I(α1) 397-414 
62°C
k sec-1 ± SD (2.02±0.23)E-4 (1.23±0.10)E-4 (2.69±0.28)E-4
t1/2 (sec) ± SD 3428±389 5629±463 2575±269
(N(t)/N(t)+D(t)) 0.99 1.04 1.17
% D(t) 1.0 -1.8 -0.6
It is important to point out that by inducing deamidation in the denaturation step and
assuming proportionality in the increase of deamidation during protein digestion (or
no deamidation at all),51 it is possible to create a curve and measure the initial extent
of deamidation by extrapolating back to zero time. This assumption was proved by
monitoring deamidation during protein digestion. The experiment that validates this
assumption will be shown in Chapter 3.
Deamidation half lives were (3428±389) s, (5629±463) s, and (2575±269) s for
coll_I (α2) -1022-1051, coll_I (α1) -1152-1167, and coll_I (α1) 397-414 respectively 
at 62 °C. The extent of deamidation of these collagen samples was given by the
intercept in the “y” axis of the exponential curves shown in Fig. 2.11 (N(t)/N(t)+D(t))
when t = 0.  The extent of deamidation the peptides: coll_I (α2) -1022-1051, coll_I 
(α1) -1152-1167, and coll_I (α1) 397-414 was found to be 0.99, 1.05, and 1.16 
respectively, which means that the extent of deamidation was not elevated in the
sample before preparation. The author recommends using these peptides as potential
indicators of deamidation of bovine collagen. Therefore, the presence of these
peptides needs further investigation in real samples.
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The deamidation half lives were found to be shorter when compared to calculated
models for pentapeptides used by Robinson’s group.20 According to Robinson’s
pentapeptide deamidation calculation model, the half-lives for the Asn located
between histidine (His) and glycine (Gly) is predicted to be 98,496 s, between Leu
and Gly is 93,312 s, and between alanine (Ala) and Gly is 90,720 s respectively.
These half-lives were measured at 37 °C, and they range between 10 and 40 times
the half-lives obtained in the work presented here, but this is mainly due to the use of
high temperature which is known to accelerate the reaction remarkably.22 The
complexity of collagen molecules provides a real challenge to establish a direct
correlation with this model at the protein level, but it provides an idea in terms of
velocity of the reaction at different temperatures.
Another published study available in the literature has reported a range of 10,800-
17,400 s to release 50% of all the labile amides of whole collagen from kangaroo tail
at similar temperatures.61 This last study was performed in all the amides present in
collagen,, and the reaction would be expected to take longer than individual releases
of amides in each peptide, which is the case in the present study.
2.3.4. Differenciation of IsoAsp from Asp
The ECD of tryptic peptide [coll_I (α1) 1152-1167]2+ ion at m/z 781.89408 (Fig. 2.5)
shows the region where the IsoAsp diagnostic ion appears (z●13-57, m/z 1204.63171)
indicating deamidation at position 4 from the N-terminus or 13 from the C-terminus,
and the lost of CO2 from z16 (z16-44, m/z 1502.77117) represents the diagnostic ion
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for the presence of Asp in position 16. Ions labelled with blue originated from
another peptide present in the digestion mixture with m/z 780.90998. It is important
to mention that mass accuracy is critical in these experiments in order to allow the
extent of deamidation to be calculated. The ECD of tryptic digest peptide [coll_I
(α1) 397-414]2+ ion at 793.88150 m/z (Fig. 2.6), shows the region where the IsoAsp
diagnostic ion (z●16-57, m/z 1385.68082) appears. This one corresponds to position 3
(N-terminal), 16 (C-terminal) in the peptide. Ions labelled with purple and brown,
originated from other two peptides present in the complex digestion mixture with
mass-to-charge m/z 790.88673 and m/z 795.90975 respectively.
In the ECD spectrum of the chosen collagen peptides, only the isoAsp diagnostic
peaks (z●-57) corresponding to the deamidated Asn were observed in two of the
peptides Fig. 2.5 and 2.6. One possible reason to explain the lack of Asp diagnostic
ions may be interference with high intensity peaks located in the (M+nH)(n-1)+●- 60
region where Asp ions should appear. Due to the absence of these peaks,
deamidation rates could not be calculated using the peak intensity ratio of these two
isomers.
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2.4. CONCLUSIONS
A total of 30 tryptic peptides from collagen were successfully identified using FT-
ICR-MS, three of which were chosen to monitor deamidation and are recommended
to serve as indicators of deamidation in collagen from bovine bone. ECD was shown
to be the best fragmentation technique to sequence the peptides in the study and
identify the deamidation site. The use of FT-ICR-MS was critical in the
differentiation of Hyp (113.04768 Da) from Leu/Ile (113.08406 Da). High
resolution was needed to monitor the intensity ratios of the non-deamidated and the
deamidated peptide. The first order kinetic mechanism fitted the deamidation
process for each peptide and the extent of deamidation at time zero was successfully
determined to be ≈ 1 %.  The method can be used to determine the extent of 
deamidated peptide present in the sample before sample preparation, which can be
advantageous when deamidation is artificially induced.
IsoAsp diagnostic peaks (z●-57) were only observed in the spectra of two peptides.
One possible reason to explain the lack of Asp peaks may be the overlapping with
high intensity peaks located in the (M+nH)(n-1)+●- 60 region where Asp ions should
show.
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2.6. MASS ACCURACY AND PEPTIDE ASSIGNMENTS
100
TABLE 2.3: Peak list generated from the externally calibrated CAD spectrum of [GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR+4H]4+
m/z 697.09326
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z)
Error
(ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z)
Error
(ppm)
y102+ 447.74322 447.74341 -0.42 b243+ 744.68952 744.69007 -0.74
y5 497.28304 497.28328 -0.48 [b25-H2O-NH3]3+ 752.01804 752.01822 -0.24
y112+ 483.261775 483.26201 -0.49 b253+ 763.69667 763.69727 -0.78
y6 554.30450 554.3048 -0.54 b8 778.38420 778.38479 -0.76
b183+ 588.61178 588.61214 -0.62 y9 781.43148 781.43207 -0.76
[b19-H2O-NH3]3+ 595.94029 595.9403 -0.01 b172+ 818.38474 818.38542 -0.84
b193+ 607.61893 607.6193 -0.61 b273+ 819.72663 819.72722 -0.72
[b20-H2O-NH3]3+ 619.61933 619.61933 0.00 y273+ 826.08616 826.0868 -0.77
[b20-H2O]3+ 625.29482 625.29482 0.00 y182+ 827.39564 827.3963 -0.80
b203+ 631.29797 631.29835 -0.61 y192+ 862.91419 862.91495 -0.88
y7 653.37291 653.37333 -0.64 y283+ 864.42847 864.42921 -0.85
b213+ 668.98053 668.98098 -0.68 y10 894.47916 894.4799 -0.83
y223+ 669.99629 669.99674 -0.68 b192+ 910.92476 910.9256 -0.93
b223+ 687.98768 687.98813 -0.65 [b20-H2O-NH3]2+ 928.92509 928.92558 -0.53
[MH-H2O]4+ 692.59104 692.59109 -0.07 [b20-H2O]2+ 937.43832 937.43891 -0.63
[M+4H]4+ 697.09327 697.09374 -0.68 b202+ 946.44331 946.44417 -0.91
[b23-H2O-NH3]3+ 699.98808 699.98819 -0.16 y222+ 1004.49079 1004.49182 -1.03
[b23-H2O]3+ 705.66357 705.66361 -0.05 y12 1022.53773 1022.53877 -1.02
b233+ 711.66672 711.66720 -0.68 b222+ 1031.47788 1031.47926 -1.34
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TABLE 2.3: Peak list generated from the externally calibrated CAD spectrum of [GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR+4H]4+
m/z 697.09326 (Continued)
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z)
Error
(ppm) Assignments
Calc. Mass
(m/z) Exp. Mass(m/z)
Error
(ppm)
y8 724.41002 724.41053 -0.70 [b23-H2O]2+ 1057.99145 1057.99228 -0.79
y8 724.41002 724.41053 -0.70 [b23-H2O]2+ 1057.99145 1057.99228 -0.79
y243+ 726.69813 726.69857 -0.61 b232+ 1066.99644 1066.99751 -1.01
y162+ 730.35545 730.35592 -0.64 b242+ 1116.53064 1116.53185 -1.08
[b24-H2O-NH3]3+ 733.01088 733.011 -0.16 b252+ 1145.04137 1145.0427 -1.16
[b24-H2O]3+ 738.68638 738.68657 -0.26 y13 1150.59631 1150.59768 -1.19
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TABLE 2.4: Peak list generated from the ECD spectrum of [GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR+4H]4+ m/z 697.09326
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
z3 313.17445 313.17445 0.00 c11 1078.56395 1078.56399 -0.04
y3 329.19317 329.19326 -0.27 z242+● 1081.53419 1081.53434 -0.14
z4● 384.21156 384.21163 -0.18 z242+ 1082.03581 1082.03588 -0.06
c5 497.24665 497.24667 -0.04 y242+ 1089.54355 1089.54399 -0.40
z6● 538.28578 538.28579 -0.02 c242+ 1125.043915 1125.04394 -0.02
a6 581.29159 581.29126 0.57 y13-NH3 1133.569836 1133.56947 0.32
c6 625.30523 625.30517 0.10 z13● 1134.57759 1134.57768 -0.08
z7● 637.35419 637.35414 0.08 z252+● 1145.56348 1145.56277 0.62
c7 682.32669 682.3267 -0.01 c12 1149.60106 1149.60096 0.09
[M+3H]3+ 689.99584 689.99498 1.24 c262+ 1202.081025 1202.08104 -0.01
[z23-NH3]3+ 691.33672 691.33759 -1.26 c13 1206.62252 1206.62251 0.01
[M+4H]4+ 697.09327 697.09272 0.79 y262+ 1210.11487 1210.1146 0.22
z8● 708.3913 708.39126 0.06 y14-H2O-2NH3 1213.559787 1213.55928 0.42
a152+ 718.86699 718.86622 1.07 z.272+ 1230.61624 1230.6161 0.11
z16 2+● 722.34609 722.34611 -0.03 z272+ 1231.12015 1231.11936 0.64
y8 724.41002 724.40995 0.10 c272+ 1237.59958 1237.59952 0.05
c152+ 740.87381 740.87384 -0.04 y272+ 1238.6256 1238.6256 0.00
z9● 765.41276 765.41291 -0.20 y14-NH3 1248.596776 1248.59636 0.33
c162+ 769.38454 769.3845 0.05 z14● 1249.60453 1249.60468 -0.12
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TABLE 2.4: Peak list generated from the ECD spectrum of [GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR+4H]4+ m/z 697.09326 (Continued)
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
y9 781.43148 781.43118 0.38 z282+● 1288.12971 1288.12981 -0.08
z182+● 819.386275 819.38635 -0.09 z15● 1306.62599 1306.62596 0.02
c172+ 826.89801 826.89782 0.23 c292+ 1314.63669 1314.63653 0.12
z192+● 854.90483 854.90465 0.21 y15 1322.64471 1322.64465 0.05
a182+ 868.92048 868.92031 0.20 c14● 1342.67361 1342.67348 0.10
c182+ 890.9273 890.92736 -0.07 c14 1343.68143 1343.68138 0.04
a192+ 897.43121 897.43052 0.77 z302+ 1385.673805 1385.67385 -0.03
c9 908.45843 908.4585 -0.08 [M+4H]2+●● 1394.187615 1394.18696 0.47
z202+● 911.44686 911.44699 -0.14 z16●-H2O 1425.674385 1425.67534 -0.67
c192+ 919.43803 919.43813 -0.11 z16● 1443.6849 1443.68545 -0.38
[z30●-NH3]3+ 923.7827167 923.78237 0.38 z16 1444.69272 1444.69268 0.03
[M+3H]3+ 929.12193 929.12269 -0.82 c15 1480.74034 1480.74034 0.00
[M+4H]3+● 929.45841 929.4579 0.55 c16 1537.7618 1537.76187 -0.05
z212+● 939.95759 939.95731 0.30 z17 1581.75163 1581.75193 -0.19
y11-NH3 948.489796 948.48938 0.44 z18 1638.77309 1638.77306 0.02
z11● 949.49755 949.4975 0.05 c17 1652.78874 1652.78875 -0.01
c10 965.47989 965.47989 0.00 z19-H2O 1675.804765 1675.8032 0.93
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TABLE 2.4: Peak list generated from the ECD spectrum of
GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR+4H]4+ m/z 697.09326 (Continued)
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
z12● 1006.51901 1006.5192 -0.19 z19 1709.8102 1709.81047 -0.16
c212+ 1011.480425 1011.48064 -0.21 z20 1822.89426 1822.89436 -0.05
y12 1022.53773 1022.53768 0.05 c19 1837.86878 1837.86939 -0.33
c222+ 1039.991155 1039.99121 -0.05 z21 1879.91572 1879.91525 0.25
z232+● 1053.02346 1053.02357 -0.10
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TABLE 2.5: CAD peak table [DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assignments
Calc. Mass
(m/z) Exp. Mass(m/z) Error (ppm)
b4 401.16667 401.16687 -0.50 (b10-H2O) 777.35261 777.35343 -1.06
y4 442.24085 442.24110 -0.57 [M+2H]2+ 780.91005 780.91088 -1.06
b5 458.18813 458.18843 -0.65 [M+2H]2+ 781.89408 781.89497 -1.14
(b6-2H2O) 477.20930 477.20951 -0.44 y8 822.44681 822.44770 -1.08
y102+ 496.76162 496.76195 -0.67 y9 823.47843 823.47934 -1.11
y5 499.29869 499.29903 -0.68 y9 879.46827 879.46929 -1.16
b6 513.23033 513.23070 -0.72 y10 894.51554 894.51662 -1.21
(b7-2H2O) 534.23076 534.23104 -0.52 b10-2H2O 915.45712 915.45811 -1.08
b6-2H2O 535.25116 535.25146 -0.56 a10 924.49106 924.49082 0.26
a.6 543.27734 543.27769 -0.64 b10-H2O 933.46764 933.46878 -1.23
(b7-H2O) 552.24128 552.24166 -0.70 b10 951.47815 951.47936 -1.27
b6-H2O 553.26168 553.26206 -0.70 b11-2H2O 972.47858 972.47973 -1.18
y6 556.32015 556.32058 -0.77 (b12-H2O) 987.48943 987.49075 -1.34
b7 570.25179 570.25224 -0.79 y11 991.56830 991.56969 -1.40
b6 571.27219 571.27264 -0.79 y10 992.51595 992.51699 -1.05
y122+ 581.81438 581.81482 -0.76 (b13-H2O) 1044.51089 1044.51221 -1.27
y142+ 608.84346 608.84399 -0.88 y12 1048.58976 1048.59116 -1.34
y6 612.30999 612.31001 -0.03 b13 1062.52140 1062.52299 -1.50
y132+ 639.32785 639.32841 -0.88 y11 1105.60001 1105.60154 -1.38105
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TABLE 2.5: CAD peak table [DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408 (Continued)
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assignments
Calc. Mass
(m/z) Exp. Mass(m/z) Error (ppm)
[y16-H2O]2+ 678.87304 678.87342 -0.56 y13 1119.62687 1119.62839 -1.36
y162+ 687.87803 687.87868 -0.95 y12 1162.62147 1162.62318 -1.47
y142+ 695.86988 695.87059 -1.03 (b15-H2O) 1240.63206 1240.63403 -1.59
(b9-2H2O) 702.32063 702.32124 -0.87 b15 1258.64257 1258.64448 -1.52
z7 710.38315 710.38335 -0.28 y15 1273.70109 1273.70316 -1.63
(b9-H2O) 720.33115 720.33184 -0.96 y13 1277.64841 1277.65028 -1.46
y7 725.39405 725.39473 -0.94 (b16-H2O) 1297.65352 1297.65532 -1.39
b9 738.34166 738.34241 -1.02 b16 1315.66403 1315.66629 -1.72
(b10-2H2O) 759.34209 759.34281 -0.95 (b17-H2O) 1368.69063 1368.69292 -1.68
y8 766.45697 766.45780 -1.08 b17 1386.70114 1386.70340 -1.63
[y18-H2O]2+ 771.90506 771.90562 -0.72
Ions labelled with colour blue are generated from the peptide GETGPAGPAGPIGPVGAR with m/z 780.90998
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TABLE 2.6: Peak-list generated from the ECD spectrum of [DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z)
Error
(ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z)
Error
(ppm)
z3 314.18227 314.18224 0.10 z12● 1146.60275 1146.60289 -0.12
y4 442.24085 442.24085 0.00 y12 1162.62147 1162.62144 0.03
z6 541.30925 541.30924 0.02 z13●-57 1204.63209 1204.63171 0.32
y5 555.28853 555.28871 -0.32 z15● 1257.68237 1257.68187 0.40
z6 597.29909 597.29902 0.12 z13● 1261.62969 1261.62935 0.27
y6 612.30999 612.31001 -0.03 y15 1273.70109 1273.70100 0.07
z7 710.38315 710.38335 -0.28 c16● 1331.68276 1331.68298 -0.17
y7 725.39405 725.39422 -0.23 (y16-NH3) 1357.72230 1357.72180 0.37
b18 2+ 771.90477 771.90467 0.12 z16 1359.73787 1359.73759 0.21
[M+2H]2+ 780.91005 780.90998 0.09 z14● 1374.71375 1374.71388 -0.09
[M+2H]2+ 781.89408 781.89399 0.11 c17● 1402.71987 1402.71961 0.19
z9● 807.45971 807.45940 0.38 c15● 1404.68792 1404.68640 1.08
z9 808.46753 808.46752 0.01 z16●-CO2 1502.77235 1502.77117 0.79
y9 823.47843 823.47865 -0.27 a16 1517.78321 1517.78225 0.63
z9● 863.44955 863.44947 0.09 (z18●-NH3) 1527.76763 1527.76514 1.63
z9 864.45737 864.45730 0.08 z18● 1544.79410 1544.79270 0.91
z10● 878.49682 878.49666 0.18 z16● 1546.76215 1546.76170 -0.29
y10 992.51595 992.51586 0.09 [M+H]+ 1560.81282 1560.81188 0.60
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TABLE 2.6: Peak list generated from the ECD spectrum of [DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408
(Continued)
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z)
Error
(ppm) Assignments
Calc. Mass
(m/z)
Exp.
Mass(m/z)
Error
(ppm)
z11● 1089.58129 1089.58071 0.53 [M+2H]+● 1563.78923 1563.78801 0.78
z13● 1103.60815 1103.60669 1.32
Ions labelled with colour blue are originated from the peptide GETGPAGPAGPIGPVGAR with m/z 780.90998
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TABLE 2.7: Peak list generated from the externally calibrated CAD spectrum of [GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
Assigments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm) Assigments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
y132+ 608.30946 608.30957 -0.19 [M+2H]2+ 793.88150 793.88202 -0.66
b8-H2O 637.29404 637.29378 0.40 b11-H2O 836.389715 836.38951 0.25
y142+ 643.82801 643.82811 -0.16 b11 854.40023 854.40100 -0.90
b8 655.30455 655.30464 -0.14 y9 861.42132 861.42173 -0.48
b9-H2O 708.33115 708.33106 0.12 y10 932.45843 932.45776 0.72
b9 726.34166 726.34182 -0.22 b14-H2O 1153.527265 1153.52593 1.16
y162+ 729.85221 729.85244 -0.32 b14 1171.53778 1171.53679 0.85
y7 733.36275 733.36295 -0.27 y13 1215.61163 1215.61007 1.28
b182+ 784.87621 784.87719 -1.25
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TABLE 2.8: Peak list generated from the ECD spectrum of [GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
Assigments Calc. Mass(m/z) Exp. Mass(m/z) Error (ppm) Assigments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
z4 401.21430 401.21450 -0.50 y12 1040.5483 1040.54833 -0.03
y4 416.22520 416.22520 0.00 y'12 1051.49286 1051.49291 -0.05
z.5 547.27489 547.27480 0.16 y12 1052.50068 1052.5008 -0.11
z5 548.28271 548.28270 0.02 z12● 1086.54523 1086.54563 -0.37
y5 563.29361 563.29348 0.23 y12 1102.56395 1102.56413 -0.16
z6 571.31982 571.31979 0.05 c13● 1104.59217 1104.59229 -0.11
y6 586.33072 586.33079 -0.12 c13 1105.59999 1105.59996 0.03
z6● 604.29635 604.29605 0.50 z13● 1111.56161 1111.56136 0.22
z6 605.30417 605.30423 -0.10 z13 1112.56943 1112.57062 -1.07
y132+ 608.30946 608.30924 0.35 x12 1129.55104 1129.55067 0.33
b8-2H2O 619.28352 619.28326 0.42 b14-2H2O 1135.51675 1135.51701 -0.23
y6 620.31507 620.31500 0.11 (b14-2H2O)◊ 1141.60004 1141.6002 -0.14
(y7-NH3) 670.35193 670.35187 0.08 b14-H2O 1153.527265 1153.52668 0.51
b9-2H2O 690.32063 690.32074 -0.16 y13 1215.61163 1215.61167 -0.03
b9-H2O 708.331145 708.33075 0.56 z14● 1270.63002 1270.63002 0.00
z7 718.35185 718.35193 -0.11 c15● 1288.67696 1288.67543 1.19
y7 733.36275 733.36275 0.00 c15 1289.68478 1289.6849 -0.09
z9 770.36788 770.36799 -0.14 z15● 1303.64024 1303.64032 -0.06
b182+ 784.87621 784.87612 0.11 z15● 1327.65148 1327.65151 -0.02110
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TABLE 2.8: Peak list generated from the ECD spectrum of [GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
(Continued)
Assigments Calc. Mass(m/z) Exp. Mass(m/z) Error (ppm) Assigments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
z8● 788.38114 788.38099 0.19 y'15 1342.66238 1342.66306 -0.51
z8 789.38896 789.3889 0.08 y15 1343.6702 1343.67047 -0.20
y8 804.39986 804.3998 0.07 c16 1346.70624 1346.70633 -0.07
b11-2H2O 818.37920 818.37906 0.17 c16● 1357.62565 1357.62566 -0.01
z9● 825.43390 825.43411 -0.25 z16● -57 1385.68082 1385.68082 0.00
z9 826.44172 826.44169 0.04 (y16-NH3) 1403.680166 1403.67985 0.23
b11-H2O 836.389715 836.38973 -0.02 z16● 1404.68792 1404.68965 -1.23
y9 841.45262 841.45256 0.07 z16 1405.69574 1405.69616 -0.30
z9● 845.40260 845.40239 0.25 (c17-2H2O) 1425.71215 1425.70959 1.80
z9 846.41042 846.41046 -0.05 c17● 1428.66276 1428.66298 -0.15
b11 854.40023 854.40048 -0.29 z16● 1442.67842 1442.67857 -0.10
y9 861.42132 861.42123 0.10 c17 1461.73318 1461.73348 -0.21
z10● 896.47101 896.47081 0.22 z17● 1513.71553 1513.71553 0.00
z10 897.47883 897.47926 -0.48 z17● 1517.77198 1517.77245 -0.31
z10● 916.43971 916.43986 -0.16 z18●-CO2 1526.74719 1526.74724 -0.03
z10 917.44753 917.44761 -0.09 x17● 1559.76997 1559.76861 0.87
y10 932.45843 932.45847 -0.04 z18● 1564.74756 1564.74658 0.63
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TABLE 2.8: Peak list generated from the ECD spectrum of [GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
(Continued)
Assigments Calc. Mass(m/z) Exp. Mass(m/z) Error (ppm) Assigments
Calc. Mass
(m/z)
Exp.
Mass(m/z) Error (ppm)
c11● 976.5336 976.53346 0.14 z18 1565.75538 1565.75122 2.66
c11 977.54142 977.54175 -0.34 z18● 1570.73699 1570.73707 -0.05
z12● 1024.52958 1024.52976 -0.18 [M+2H]+● 1581.77464 1581.77467 -0.02
z12 1025.5374 1025.53756 -0.16 [M+H]+ 1586.75571 1586.75567 0.03
z11● 1029.52377 1029.52394 -0.17 [M+2H]+● 1587.76407 1587.76373 0.21
z12● 1036.48196 1036.4819 0.06 [M+2H]+● 1591.82052 1591.82019 0.21
z12 1037.48978 1037.48973 0.05
Ions labelled with colour purple are originated from the peptide GPPGESGAAGPTGPIGSR with m/z 790.88673
Ions labelled with colour brown are generated from the peptide GLTGPIGPPGPAGAPGDK with m/z 795.90975
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Chapter 3: FT-ICR-MS Approach to
monitor asparagine deamidation in
collagen from archaeological material
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3.1. INTRODUCTION
For the last 40 years, the preservation of ancient biomolecules in fossil materials has
been a topic of extensive debate and controversy. Several studies have reported the
detection of biomolecules isolated from dinosaur tissues and bones. The first report
of this type was published in 1972.1 Since then, extensive research has focused on
the recovery of molecules such as DNA from fossils.2-5 However, the conclusions of
many fossil-derived DNA reports have been challenged due to the presence of
contaminants.6-8 Conversely, the conclusions of fossil-derived protein analyses are
considered to be more reliable.9 For example, collagen has been isolated from
different fossil types such as bird, mammal, and reptile bones, including dinosaurs;10-
12 in the latter case the presence of intact collagen has been heavily criticized, partly
based on the presence of intact Asn residues that suggest the material might have
originated from intra-lab contamination.
Due to the triple helical structure and intimate association with bone mineral,
collagen can persist with extraordinary longevity in preserved animal remains.13, 14
Asp racemisation in collagen has been explored as a possible method of
archeological dating.15 However the higher order structure of collagen minimises
succinimide formation and concomitant Asx (Asp & Asn) racemisation,16-18 thus
limiting its utility for amino acid dating analyses.
Recent reports have shown that certain protein modifications such as deamidation are
elevated in collagen from older mammal bones,13, 19, 20 and these observations could
potentially provide the basis for developing the measure of this post-translational
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modification as a means of assessing the age of archaeological materials as an
alternative to amino acid racemisation.
The mass defect method has been previously used to determine the extent of
deamidation of collagen peptides and other proteins. In this chapter, a methodology
is reported to measure the extent of deamidation, using the mass defect method, in
tryptic digested peptides of collagen I extracted from archaeological bones (≈ 1,000 
years old), using FT-ICR-MS. Further, deamidation rates and half-lives have been
measured, to assess the feasibility of using Asn deamidation as a relative age dating
technique in collagen and whether this is adversely affected by local environmental
differences (e.g. temperature, pH, soil chemistry). A preliminary study reported in
Chapter 221 provided the characterization of three peptides that were recommended
as potential indicators of deamidation in bovine collagen. However, the presence of
these indicators was not tested in collagen extracted from bones; it was only tested in
standard collagen.
Therefore, the aim of this study was to test that the previously identified indicators
reported in Chapter 2 could be used successfully to identify the presence of bovine
collagen from archeological samples. A further aim is to provide information on the
potential value of archeological dating that could be provided from analysis of the
extent of deamidation in ancient collagen by applying the methodology reported in
Chapter 2 to real samples.
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3.2. EXPERIMENTAL METHODOLOGY
3.2.1. Materials
A cattle bone sample, excavated from the Anglo-Viking levels at the Coppergate
archaeological site (York) was used for this study. The sample was provided by
professors Terry O’Connor and Matthew Collins from the University of York. These
bones were recovered in 1973 and have been subsequently stored above ground at
ambient temperature. Sequencing-grade trypsin, ammonium acetate (CH3COONH4),
and ammonium bicarbonate (NH4HCO3) were purchased from Sigma Aldrich,
Gillingham, UK. HPLC-grade methanol and formic acid (HCOOH) were obtained
from Fisher Scientific, Leicestershire, UK.
3.2.2. Collagen extraction from bovine bones obtained from a Coventry (UK)
butcher.
Bones were frozen to -80 °C and smashed with a hammer to small pieces (see Figs..
3.1 and 3.2). Since these modern bones contained high levels of fat, a cleaning
procedure was necessary. This was achieved by soaking the samples in concentrated
HCl in the freezer for an hour, which removes surface proteins and mineralization.
After rinsing with purified water to reach neutral pH, a mixture of
chloroform:methanol (CH3Cl:MeOH) 87:13 v/v was added, while constantly stirring,
for another hour. Bones were rinsed with MeOH and kept in the -80 °C freezer
overnight. After the cleaning procedure was completed a coffee grinder was used to
grind the bones to powder (see Fig. 3.3). Triplicates of 14 mg of this powder were
weighed and demineralised with 1 mL of HCl (0.6 M) at 4 °C for 4 hours. From this
extraction, the non-soluble, collagen-containing fraction was rinsed 3 times with pure
water until neutral pH was reached.
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FIGURE 3.1: Pieces of bovine bone obtained from a Coventry UK butcher.
FIGURE 3.2: Size of the bones after hammering.
FIGURE 3.3: Resulting bone powder obtained from the grinding process.
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3.2.3. Digestion of collagen
Prior to digestion, the non-soluble fraction was denatured in 1 mL of 50 mM
ammonium bicarbonate following a previously described methodology in Chapter
2.21 Adjustments to the enzyme:protein ratio had to be optimized. The supernatant
(700 μL) was collected and 24 μL of trypsin solution (2 μg/μL) was added using an 
approximate ratio of 1:200 (w/w) enzyme:protein. To minimise deamidation during
tryptic digestion the mixture was allowed to react for 4 hours at 37°C,22 the reaction
was halted by adding 5 % (v/v) of formic acid, and the samples were dried in a
SpeedVac system (Savant SPD121P Fisher Scientific, Leicestershire, UK) to
evaporate volatiles at 35 °C, following storage at -80 °C until time of analysis (≈ 1 
day). The samples were reconstituted into a mixture of 1:1 MeOH:H2O, and diluted
into a mixture of 49.5:49.5:1 MeOH:H2O:formic acid to a final approximate
concentration of 2.5 μM.    
3.2.4. Collagen extraction from archeological bones
In order to extract the collagen from archaelogical bones the procedure explained
above was followed, with the difference that no fat was present in the samples. Thus
no previous cleaning procedure was needed.
3.2.5. FT-ICR-MS measurements
The experiments were carried out on a Bruker 12T solariX FT-ICR-MS (Bruker
Daltonics). In order to identify deamidation sites, samples of digested collagen were
electrosprayed at approximately 2.5 µM concentration in 49.5:49.5:1
MeOH:H2O:formic acid. An average of 200 scans was taken.
119
For CAD experiments,23 the parent ions were isolated using a quadrupole and were
fragmented in the collision cell (q, typical collision energies ~10-30 eV), and then
transmitted into the ICR cell for detection. For ECD experiments, the parent ions
were isolated using a quadrupole and accumulated in a hexapole collision cell (at
injection energies <5 eV) for 1-10 s. After being transferred and trapped in the ICR
cell, ions were irradiated with 1.5 eV electrons from a heated hollow cathode (1.7 A)
for 20 to 90 ms.24 The mass spectrometer was initially externally calibrated using
collagen I from Sigma Aldrich. After confident assignments using mass accuracy
and isotopic distributions, the spectra were internally calibrated using peptides
present in the samples (See section 3.6 of this chapter for more information about
mass accuracy).
3.3. RESULTS AND DISCUSSION
3.3.1. Characterization of marker peptides from bovine collagen
The spectrum of modern bone shown in Fig. 3.4a, shows the presence of the three
peptides indicators of deamidation corresponding to bovine collagen assigned in the
previous study.21
Curiously collagen from contemporary bones is more difficult to purify than from
ancient bones. This is mainly due to the high fat content. Thus, collagen was
extracted and analyzed from ancient bovine bones. These bones originated from the
excavation performed in Coppergate, York, in 1973 by the York Archaeological
Trust.
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FIGURE 3.4: a) Mass spectrum of tryptic digest of collagen extracted from contemporary cow bones.
N/D represents deamidation site. P represents Hyp. The inserts show three possible deamidated
peptides corresponding to m/z [697.09326]4+, m/z [781.89408]2+, and m/z [793.88133]2+. b) Tryptic
digest collagen extracted from 1,050 year-old bone. Inserts (1) and (2) show the experimental and
theoretical isotopic distributions respectively.
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Dating back to 960 AD (Viking period) these bones were well preserved due to the
moist peaty layers in the region, where flooding hinders influx of oxygen from the
atmosphere, thus reducing rates of degradation.25 Such anaerobic preservation
allowed us to extract the collagen from the bone and analyse the tryptic peptides
using FT-ICR-MS. Figure 3.4b shows the spectrum of the digested collagen
extracted from the archaeological samples.
Twelve peptides, including peptides with N/D, were successfully assigned to tryptic
peptides predicted from the published bovine collagen sequence (P02453 and
P02465 Uniprot database).26 This was achieved using mass accuracy, isotopic
distributions, and in some cases fragmentation using CAD and ECD (see Table 3.1
and tables in section 3.6 of this chapter). These sequences were compared against
known sequences for human collagen, in order to test for any sample handling
contamination issues.  The peptide corresponding to 970-983 (α1) was found to be a 
marker for bovine collagen, rather than that from a human source.
TABLE 3.1: Assignments of peptides in archeological bone material
Length coll-I
(chain) Identified peptides MW [M+2H]
2+ [M+3H]3+ [M+4H]4+ Exp. Error ppm
958-966 (α1) GVVGLPGQR 897.50319 449.75888 300.17501 449.75884 0.08
970-983 (α1) IGQPGAVGPAGIR 1343.63571 604.84092 403.56304 604.84091 0.02
326-340 (α2) GIPGPVGAAGATGAR 1266.66800 634.34128 423.22995 634.34122 0.09
572-586 (α2) GIPGEFGLPGPAGAR (2oxi) 1426.72043 714.36750 476.58076 714.36734 0.22
685-708 (α1) GVQGPPGPAGPRGANGAPGNDGAK (4oxi) 2162.01002 1082.01229 721.67729 721.67757 -0.39
1152-1167 (α1) DGLNGLPGPIGPPGPR 1560.78958 781.40207 521.27047 781.40189 0.23
1152-1167 (α1) DGLDGLPGPIGPPGPR 1561.77359 781.89408 521.59848 781.89408 0.00
397-414 (α1) GANGAPGIAGAPGFPGAR 1584.76442 793.38949 529.26209 793.38933 0.20
397-414 (α1) GADGAPGIAGAPGFPGAR 1585.74843 793.88150 529.59009 793.88133 0.21
762-795(α1) GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR (2oxi) 2852.40520 1427.20988 951.80901 951.80833 0.72
1022-1051 (α2) GHNGLQGLPGLAGHHGDQGAPGAVGPAGPR 2783.35994 1392.68725 928.79393 696.84726 696.84722 0.06
1022-1051 (α2) GHDGLQGLPGLAGHHGDQGAPGAVGPAGPR 2784.34395 1393.17926 929.12193 697.09326 697.09377 -0.73
P: Hydroxyproline
N: Deamidated
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3.3.2. Identification of deamidation sites in collagen extracted from
archeological bones using FT-ICR-MS
In order to assess deamidation, a shift of +0.984 Da was monitored in the spectrum
of the collagen tryptic digest (Fig. 3.4.b). Analysis of the spectra showed two
potential deamidating peptides, and these two observed peptides corresponded well
with the expected masses (<1 ppm). Therefore, these 2 peptides were chosen for
further deamidation studies, [coll_I (α1) 1152-1167]2+, and [coll_I (α1) 397-414]2+.
Fig. 3.5 and 3.6 show the ECD spectrum for each of these peptides.
The use of infrared multiphoton dissociation (IRMPD) along with ECD assisted
sequencing of each peptide. The advantages of performing IRMPD along with ECD
rest on the ability of photon irradiation to produce extensive peptide backbone
fragmentation, including sites next to Pro, while ECD provides complementary
sequence information. IR-photon irradiation also increases the orbit of the ion packet
improving interaction with the electron beam.27, 28 Consequently, more efficient
fragmentation is achieved. In this particular case, the use of both techniques
facilitated the localisation of the Hyp, which are a marker for the presence of
collagen.
Deamidation sites were also easily located in each peptide. CAD spectra for each of
the selected peptides are shown in Fig. 3.7 and 3.8. Isotopic distributions and high
mass accuracy were used to increase the confidence in assignments of each peptide
and its fragments. The complete list of masses and assignments are included in the
section 3.6 of this chapter.
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FIGURE 3.5:  ECD-IRMPD of tryptic digest peptide [coll_I (α1) 1152-1167]2+ ion at m/z 781.89408.
The deamidation is located in position 4 from the N-terminus (D). P highlighted in green represent
the modification of hydroxylation.  Ions labelled with superscript (◊) originate from another peptide 
present in the digestion mixture at m/z 780.90998.
The ECD of the tryptic digest peptide [coll_I (α1) 1152-1167]2+ ion at m/z 781.89408
(Fig. 3.5) shows the region where the IsoAsp diagnostic ion appears (z●13-57, m/z
1204.63209) indicating deamidation at position 13. Due to the density of peaks in
the collagen spectrum (~ 400 peaks in a window of 400-1300 m/z), ions labelled with
superscript (◊) originate from another peptide present in the digestion mixture with 
m/z 780.90998, which could not be isolated using the quadrupole, but which could be
assigned from the resulting MS/MS spectrum.
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FIGURE 3.6:  ECD-IRMPD of tryptic digest peptide [coll_I (α1) 397-414] 2+ ion at m/z 793.88150.
The deamidation site is located in position 3 from the N-terminus (D), in the peptide. P highlighted in
green represent the modification of hydroxylation. Ions labelled with superscript (‡) are originated
from other peptide present in the digestion mixture with m/z 790.88678.
FIGURE 3.7: CAD of tryptic digest peptide [coll_I(α1) -1152-1167 ]2+ ion at m/z 781.89408. Red
colour represent the deamidation site, green indicates the presence of Hyp.
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FIGURE 3.8: CAD of tryptic digest peptide [coll_I (α1) 397-414, coll_I(α1) ] 2+ ion at m/z
793.88150. Red colour represent the deamidation site, green indicates the presence of Hyp.
The ECD of the other tryptic digest peptide which showed evidence of deamidation
[coll_I (α1) 397-414]2+ ion at m/z 793.88150 (Fig. 3.6), shows the region where the
IsoAsp diagnostic ion (z●16-57, m/z 1385.68082) appears, corresponding to position 3
(from the N-terminus) in the peptide. (Ions labelled with superscript (‡) originated
from yet another peptide present in the complex digestion mixture (790.88678 m/z)).
This peptide was assigned due to the presence of additional fragments in the ECD
spectrum (Fig. 3.6).
In the ECD spectrum of the chosen collagen peptides, the IsoAsp diagnostic peaks
(z●-57) corresponding to the deamidated Asn were observed in the spectrum, Fig. 3.5
and 3.6. The Asp diagnostic fragment ion also appeared in the spectrum shown in
Fig. 3.6. A possible explanation for the lack of the Asp diagnostic ion in the
spectrum shown in Fig. 3.5 may be interference with high intensity peaks located in
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the (M+nH)(n-1)+●- 60 region where Asp ions should appear; this effect has been
previously observed by Cournoyer et al.29
3.3.3. Determination of the reaction rates for deamidation reaction
In order to study the deamidation of the peptides present in the protein, deamidation
was deliberately induced by heating the sample as previously explained in the
experimental section. Consequently, a deamidation decay curve was produced and
the extent of deamidation is back calculated by extrapolating the curve to time zero.
A first order reaction was assumed, as explained in previous chapters.
It is important to note that, by inducing deamidation in the denaturation step and
assuming no deamidation during acidic treatment and protein digestion,22 it is
possible to create a curve and measure the initial extent of deamidation by
extrapolating back to zero. Fig. 3.9 shows the exponential decay curves for the
peptides in study. This assumption was later tested by monitoring the deamidation
during acidic treatment and protein digestion.
Deamidation half lives were calculated to be (5639±823) and (4127±981) s for coll_I
(α1) 1152-1167 and coll_I (α1) 397-414 respectively at 62 °C, as shown in table 3.2.  
The extent of deamidation (expressed as the remaining non-deamidated fraction) of
these collagen samples was given by the “y” axis intercept of the exponential curves
Nt/(Nt+Dt), and was found to be (0.93±0.09), and  (0.66±0.03) for coll_I (α1) 1152-
1167, and coll_I (α1) 397-414 respectively.  This means that the coll_I (α1) 1152-
1167 peptide in the sample, prior to the deliberate deamidation in this experiment,
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was 7 % deamidated and the coll_I (α1) 397-414 peptide in the sample was 34% 
deamidated.
FIGURE 3.9: Exponential decay curves of the non-deamidated peptide at 62 °C.  A. [coll_I (α1) -
1152-1167]2+ ion at m/z 781.89408, and B. [coll_I (α1) 397-414, coll_I (α1)]2+ ion at m/z 793.88150.
The exponential coefficients represent the rate constants of deamidation reaction for each peptide.
The intercept represents the extent of deamidation in each case.
TABLE 3.2: Deamidation rates and grade of deamidation of collagen peptides from
young collagen and ancient collagen at 62°C
Peptide
coll_I(α1) -1152-1167 (62°C) coll_I(α1) 397-414
(62°C)
Young Ancient Young Ancient
k (×104s-1)±SD 1.23 ± 0.10 1.23 ± 0.17 2.69 ± 0.28 1.13 ± 0.13
t1/2 (s) ± SD 5629 ± 463 5639 ± 823 2575 ± 269 4127 ± 981
(Nt/(Nt+Dt)) 1.05 ± 0.08 0.93 ± 0.09 1.18 ± 0.12 0.66 ± 0.03
% D (t=0) ≈3 ≈7 ≈6 ≈34 
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An elevated extent of deamidation in the ancient sample would be expected for the
peptide [coll_I(α1)-1152-1167] corresponding to a sequence of 
DGLNGLPGPIGPPGPR. As shown in table 3.2, the extent of deamidation for this
peptide in the ancient sample is ≈ 7 %.  The difference in the extent of deamidation 
for this peptide when compared to the peptide [coll_I(α1) 397-414], with a sequence 
of GANGAPGIAGAPGFPGAR, could be explained by structure impediment of
deamidation due to the presence of a Leu next to Asn in the former peptide. The
presence of a small amino acid such as alanine (Ala) would facilitate the deamidation
in the latter peptide showing an extent of deamidation of ≈ 34 %, which correspond 
well with previous studies.30
3.3.4. Estimation of the Activation Energy
The rates of Asn deamidation are influenced by several factors including protein
primary sequence, pH, and temperature.31 It has been previously reported that the
deamidation rate increases proportionally with temperature. For example in the case
of the peptide (VYPNGA) the rate increases 2.4 fold per 10 °C in basic buffer.32 It
was shown that some of deamidation inhibition in protein is essentially stable at
normal temperature. Unless a specific structural impediment to deamidation is
greatly interrupted as a function of temperature, the temperature dependence of that
inhibition would be expected to be diminished.
Since the future desire is to use the extent of deamidation as a measure of the relative
age of ancient materials, it is necessary to account for the temperature dependence of
the reaction. Thus the kinetic molecular theory can be used, which states that the
higher the temperature the higher the kinetic energy of the molecules. An increase in
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temperature means that molecules have more chance to collide each other and react.
In order to find the necessary activation energy for deamidation, the Arrhenius
approximation was used. The rate constant dependence of temperature was
monitored by using the following equation:
Where A is a factor which accounts for the frequency of collision and the probability
that the molecules are in correct orientation, Ea is activation energy, R is the gas
constant (8.314 J/molK) and T is temperature in Kelvin. By applying natural log to
equation 3.1, equation 3.2 is obtained and when plotted gives a straight line.
The activation energy for deamidation was determined through the use of
experimental data obtained at the temperatures of 50 °C and 62 °C for the peptide
coll_I(α1) 397-414 present in collagen, which so far is the most recognizable marker 
throughout a range of different bovine bone samples. The activation energy was
calculated by using equation 3.3.
Where k1 and k2 are deamidation rate constants at 50 °C and 62 °C respectively.
These values are directly extracted from the exponential decays of the non-
deamidated species (Fig. 3.10). By using equation 3.3 a value for activation energy
was calculated to be 49 kJ/mol,33 which is significantly less than previous reports for
deamidation of collagen (173 kJ/mol).19 A possible explanation for the difference
could be that in the present study the Ea was calculated for one particular peptide,
and not for the entire population of deamidated peptides.
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This value of activation energy can be used to calculate the rate constants at any
desired temperature, which will enable a more reliable calculation of the sample’s
age by adjusting the deamidation rates at a more realistic temperature (e.g. 10 °C).
FIGURE 3.10: Exponential decay curves of the non-deamidated peptide [coll_I (α1) 397-414, coll_I 
(α1)]2+ ion at m/z 793.88150 at A) 50 °C and B) 62 °C. The exponential coefficients represent the rate
constants of deamidation reaction. The intercept represents the extent of deamidation in each case.
3.3.5. Effect of digestion treatment on deamidation
It was hypothesised that the protein digestion step in the experimental method could
have artificially induced extra deamidation which would affect the result. Therefore,
an experiment was performed to test the effect of protein digestion on deamidation,
by isolating the digestion treatment. This was achieved by adjusting the length of
time given for digestion from 2 hours up to 24 hours, at 37 °C, and keeping the rest
of the parameters in the process constant. Fig. 3.11. A-B shows that the extent of
measured deamidation can indeed be affected by the conditions used in the digestion
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step. These results show that the time window for this part of the procedure should
be kept to less than 4 hours, where the effect is kept to a minimum. It has been
previously reported that 4 hours is enough time for tryptic digestion.13, 22
FIGURE 3.11: Exponential decay curves of the non-deamidated peptide at 62 °C. A, B. Effect of
digestion conditions on [coll_I (α1) -1152-1167]2+ ion at m/z 781.89408, and [coll_I (α1) 397-414, 
coll_I (α1)]2+ ion at m/z 793.88150  respectively.  C, and D.  Effect of acidic treatment on [coll_I (α1) 
-1152-1167]2+ ion at 781.89408 m/z, and [coll_I (α1) 397-414, coll_I (α1)]2+ ion at m/z 793.88150
respectively.
3.3.6. Effect of acidic treatment on deamidation
A similar experiment was performed to test the effect of acidic treatment on the
measured extent of deamidation. The isolation of the acidic treatment step was
carried out at times ranging from 2 hours to 24 hours. Fig. 3.10. C-D shows that
acidic treatment had little effect on deamidation over the course of 24 hours.
However, the time window selected for the denaturation experiment was 4 hours,
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which has been previously reported to be sufficient time to extract the inorganic
material from the bone matrix.
3.3.7. Effect of pH and buffers
Bada and Shou (1980)34 reported a study of racemisation rates of Asp in modern
bone fragments. In this experiment they proved that the rates were independent of
pH in the range 3-9 at a temperature of 96 °C. They suggest that the bone matrix
itself acts as a buffer that stabilises the pH of the system. Thus they believe that
environmental acid pH is not important with respect to archaeological bones.
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3.4. CONCLUSIONS
A total of eight tryptic peptides from bovine collagen were successfully assigned in a
Viking period bone sample (~1,000 years old) using FT-ICR-MS. Two of the
peptides were chosen as probes to monitor the extent of deamidation.
ECD combined with IRMPD was shown to be a good fragmentation technique to
sequence the peptides in the study and identify the deamidation sites. The use of FT-
ICR-MS facilitated the differentiation of Hyp (113.04768 Da) from Leu/Ile
(113.08406 Da). Ultrahigh resolution was needed to monitor the intensity ratios of
the non-deamidated and the deamidated peptides.
The first order kinetic mechanism fitted the deamidation process for each peptide and
the extent of deamidation at time zero was successfully determined accordingly. The
method can be used to determine the extent of deamidation of the peptides present in
samples of archaeological interest (in this case bovine bone) before sample
preparation, which can be advantageous when deamidation is artificially induced.
The study proved that deamidation was elevated in one of the peptides in the ancient
sample. However this deamidation was subject to structural composition of the
peptide.
It is proposed that the deamidated peptides identified in this study could be potential
age markers in these types of samples. However their presence needs to be further
investigated in older samples (> 1,000 years old).
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3.6. Mass accuracy and peptide ions assignments
TABLE 3.3: CAD peak table [DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408
Assignments Calc. Mass (m/z) Exp.Mass(m/z) Error (ppm)
b4 401.16667 401.16667 0.00
y4 442.24085 442.24067 0.41
b5 458.18813 458.18807 0.13
y102+ 496.76162 496.76181 -0.39
b6-2H2O 535.25116 535.25107 0.17
b6-H2O 553.26168 553.26146 0.39
y5 555.28853 555.28857 -0.07
b6 571.27219 571.27213 0.11
y6 612.30999 612.31005 -0.10
y132+ 639.32785 639.32836 -0.81
y7 725.39405 725.39453 -0.66
y8 822.44681 822.44565 1.41
y10 992.51595 992.51693 -0.99
y12 1162.62147 1162.62145 0.02
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TABLE 3.4: Peak list generated from the ECD spectrum of
[DGLNGLPGPIGPPGPR+2H]2+ m/z 781.89408
Assignments Calc. Mass (m/z) Exp.Mass(m/z)
Error
(ppm)
z3 314.18227 314.18227 0.00
z4 427.22995 427.22965 0.70
y4 442.24085 442.24046 0.88
c112+◊ 455.224855 455.22465 0.45
y5-H2O 537.278015 537.27802 -0.01
y5 555.28853 555.28832 0.38
z6 597.29909 597.29908 0.02
y7 725.39405 725.39371 0.47
[M+2H]2+◊ 780.90998 780.90943 0.70
[M+2H]2+ 781.89408 781.89443 -0.45
z9◊ 808.46753 808.46771 -0.22
z●9 863.44955 863.44960 -0.06
z9 864.45737 864.45729 0.09
y10 992.51595 992.51693 -0.99
z●11 1089.58129 1089.58134 -0.05
z●12 1146.60275 1146.60252 0.20
z●13-57 1204.63209 1204.63302 -0.77
z●15◊ 1257.68237 1257.68125 0.89
z●13 1261.62969 1261.63019 -0.40
c●15 1404.68792 1404.68755 0.26
a16 1517.78321 1517.78263 0.38
z●18◊ 1544.79410 1544.79335 0.49
z●16 1546.76215 1546.76263 0.31
[M+2H]+●◊ 1561.82118 1561.82075 0.28
[M+2H]+● 1563.78923 1563.79001 -0.50
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TABLE 3.5: Peak list generated from CAD spectrum of
[GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z)
Error
(ppm)
b4-2H2O* 309.11943 309.11920 0.74
b5-H2O 354.140835 354.14077 0.18
b5 372.15135 372.15135 0.00
y4-NH3 399.19873 399.19870 0.07
y4 416.22520 416.22524 -0.10
y5-2NH3* 465.24574 465.24567 0.15
b6-H2O 467.18852 467.18862 -0.22
y5 563.29361 563.29370 -0.16
y132+ 608.30946 608.30957 -0.19
b8-2H2O 619.28352 619.28360 -0.13
y6 620.31507 620.31518 -0.18
b8-H2O 637.29404 637.29408 -0.07
y142+ 643.82801 643.82815 -0.22
b8 655.30455 655.30469 -0.21
b9-2H2O 690.32063 690.32069 -0.09
b9-H2O 708.33115 708.33124 -0.13
b9 726.34166 726.34180 -0.19
y162+ 729.85221 729.85232 -0.15
y7 733.36275 733.36276 -0.01
b10-H2O 765.352605 765.35264 -0.05
b182+ 784.87621 784.87642 -0.27
[M+2H]2+ 793.88150 793.88158 -0.11
y8 804.39986 804.40001 -0.19
b11-2H2O 818.37920 818.37929 -0.11
b11-H2O 836.389715 836.38980 -0.10
b11 854.40023 854.40041 -0.21
y9 861.42132 861.42142 -0.12
y10 932.45843 932.45841 0.02
y11 1045.54249 1045.54233 0.15
y12 1102.56395 1102.56383 0.11
b14-H2O 1153.527265 1153.52629 0.85
b14 1171.53778 1171.53751 0.23
y13 1215.61163 1215.61162 0.01
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TABLE 3.6: Peak list generated from the ECD spectrum of
[GANGAPGIAGAPGFPGAR]2+ m/z 793.88150
Assigments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm)
z4 401.21430 401.21430 0.00
y'4 415.21738 415.21741 -0.07
y4 416.22520 416.22523 -0.07
x4 443.21229 443.21229 0.00
z●5 547.27489 547.27481 0.15
z5 548.28271 548.28269 0.04
y'5 562.28579 562.28587 -0.14
y5 563.29361 563.29363 -0.04
z‡6 571.31982 571.32000 -0.32
z●6 604.29635 604.29635 0.00
z6 605.30417 605.30414 0.05
y132+ 608.30946 608.30944 0.02
b8-2H2O 619.28352 619.28341 0.18
y6 620.31507 620.31507 0.00
x6 647.30216 647.30209 0.11
y‡7-NH3 670.35193 670.35176 0.25
b9-H2O 708.331145 708.33112 0.04
z●7 717.34403 717.34419 -0.22
z7 718.35185 718.35192 -0.10
y162+ 729.85221 729.85249 -0.38
y'7 732.35493 732.35488 0.07
y7 733.36275 733.36286 -0.15
z●8 788.38114 788.38110 0.05
z8 789.38896 789.38895 0.01
[M+2H]2+‡ 790.88678 790.88692 -0.18
[M+2H]2+ 793.881495 793.88139 0.13
y'8 803.39204 803.39218 -0.17
y8 804.39986 804.39986 0.00
b11-2H2O 818.37920 818.37920 0.00
b11-H2O 836.389715 836.38976 -0.05
z●9 845.40260 845.40256 0.05
z9 846.41042 846.41043 -0.01
b11 854.40023 854.40046 -0.27
y'9 860.4135 860.41354 -0.05
y9 861.42132 861.42132 0.00
141
Continued
Assignments Calc. Mass(m/z)
Exp.
Mass(m/z) Error (ppm)
z●10 916.43971 916.43967 0.04
z10 917.44753 917.44754 -0.01
y10 932.45843 932.45842 0.01
x10 959.44552 959.44529 0.24
z●11 1029.52377 1029.52376 0.01
y'11 1044.53467 1044.53470 -0.03
z●12 1086.54523 1086.54527 -0.04
y'12 1101.55613 1101.55615 -0.02
y12 1102.56395 1102.56413 -0.16
x12 1129.55104 1129.55113 -0.08
b14-2H2O 1135.51675 1135.51566 0.96
b14-H2O 1153.527265 1153.52723 0.03
y13 1215.61163 1215.61167 -0.03
z●14 1270.63002 1270.62990 0.09
y14 1286.64874 1286.64832 0.33
c15 1301.61201 1301.61260 -0.45
z●15 1327.65148 1327.65144 0.03
y15 1343.6702 1343.67078 -0.43
c●16 1357.62565 1357.62596 -0.23
z●16 -57 1385.68082 1385.68068 0.10
c●17 1428.66276 1428.66237 0.27
z●16 1442.67842 1442.67828 0.10
z●17 1513.71553 1513.71553 0.00
z●18-CO2 1526.74719 1526.74746 -0.18
[M+2H]+●-
60 1527.74297 1527.74169 0.84
a18 1541.75805 1541.75742 0.41
z●18 1570.73699 1570.73669 0.19
[M+H]+ 1586.75571 1586.75553 0.11
[M+2H]+● 1587.76407 1587.76360 0.30
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TABLE 3.7: Internal calibrants used in the MS mode
Molecular
Formulae
Cal. Mass
m/z
Exp. Mass
m/z
Error
(ppm)
C35H57N13O11 418.72229 418.72229 0.001
C38H67N13O12 449.75888 449.75888 0.005
C48H73N13O16 544.77217 544.77216 -0.018
C52H89N17O16 604.84092 604.8409 -0.004
C65H105N21O22 766.89440 766.8944 0.052
C38H67N13O12 898.51047 898.5104 -0.036
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Chapter 4: Monitoring deamidation and
differentiation of the reaction products in
ancient collagen using ECD
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4.1. INTRODUCCION
Deamidation of Asn and isomerisation of Asp have been closely linked to long-lived
proteins and have been related with the concept of molecular timers of biological
events.1, 2 Deamidation and Asn isomerisation have also been associated with
ageing,3, 4 type 2 diabetes mellitus,5 eye lens anomalies,6 and Alzheimer disease.7, 8
The study of these types of modifications brings potentially new alternatives to
different treatments of these diseases and also a new approach to relative dating.
Deamidation is very straightforward to determine in mass spectrometry by following
a shift of +0.984 Da in the spectrum. Isomerisation is not as simple. Numerous
tactics have been developed to successfully differentiate the two isomers using non-
MS methods as well as MS-based methods. Most of the MS tactics are based around
the separation of the two isomers by liquid-chromatography and the detection of
characteristic immoniun ions at low m/z.9-11
4.1.1. Non-MS Methods to Determine IsoAsp residues
IsoAsp Antibody
Some antibodies have been successfully used in the localisation of racemisation and
deamidation products.12-14 The use of antibodies against IsoAsp residues has focused
principally on the study of Alzheimer’s disease by the multiple antigen peptide
system procedure (MAP).15 In general, the antibodies produced are specific to the
IsoAsp residue.
145
Proteolytic Digestion
The most common enzyme capable of cleaving at the N-terminus side of L-Asp and
not at D-Asp or D/L-IsoAsp residues is endoproteinase Asp-N. It was first used by
Kameoka and co-workers., to detect deamidation of Asn and isomerisation of Asp
residues in a protein.16 Although the use of mass spectrometry to detect deamidation
is very straightforward (following the shift of +0.948 Da), proteolytic digestion is a
simple and quick method to detect Asp isomerisation, when it works successfully.
PIMT enzyme
Protein L-IsoAsp-O-methyltransferase (PIMT) is an enzyme that selectively
methylates IsoAsp residues. Consequently, the enzyme can be used to detect
deamidation of Asn and isomerisation of Asp. The reaction involves the transfer of
methyl groups from S-adenosyl-L-methionine (Adomet) to the alpha side chain
carboxyl groups of the IsoAsp residue as seen in Scheme 4.1. IsoAsp detection using
PIMT is commonly monitored by HPLC. Recent developments using PIMT enzyme
and HPLC are used to detect and measure the abundance of IsoAsp residues. The
process is monitored by following the change in UV absorbance of Adomet before
and after methylation.17
Edman Degradation
The Edman reaction involves the nucleophilic attack from the nitrogen of the N-
terminus of the protein under investigation to the carbon of the cyanate group of
phenylisothiocyanate (Scheme 4.2). This interaction leads to a cyclic intermediate
that facilitates hydrolysis of the adjacent amide bond.
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SCHEME 4.1: Methyl transfer into the protein IsoAsp residue.
The effect of this reaction is to specifically remove the N-terminal amino acid from
the protein and thereby generate a cleaved derivative of that amino acid and a protein
that is shortened by one amino acid and has a new N-terminal. The term degradation
suitably describes the effect of repeated applications of the Edman reaction to
repeatedly degrade the protein amino acid by amino acid from the N-terminal. This
process was found to be particularly useful to locate the presence of an IsoAsp
residue in a sequence in 1962.18
Asp isomerisation can be challenging to detect using mass spectrometry, as there is
no mass difference.19-21 Early methods were developed to differentiate the two
isomeric forms9, 10 based on relative fragment ion abundance, but the introduction of
new fragmentation techniques in mass spectrometry such as electron capture (ECD)
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and electron transfer dissociation (ETD) has improved the ability of researchers to
differentiatie between Asp and IsoAsp residues in proteins.19-22
SCHEME 4.2: Edman degradation reaction.
4.1.2. MS methods to determine IsoAsp from Asp residues
An extensive discussion about MS methodologies to differentiate IsoAsp from Asp
has been presented in Chapter 1 of this thesis. This section shows a summary to
remind the reader about the different methodologies.
Reversed phase High-Performance Liquid Chromatography (RP-HPLC)
Separation of the isomer products of the deamidation reaction can be achieved by
HPLC, and the resultant eluent can be analyzed by mass spectrometry. The usual
order of elution has been previously reported to be as follows; IsoAsp, Asp, and then
the aminosuccinyl form.20, 23-26
A typical HPLC experiment to separate the isomers consists of a linear gradient, a
C18 column, and a mobile phase constituted by an acidic solution such as 0.1%
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trifluoroacetic acid (TFA), and an organic phase such as acetonitrile (ACN). The
acidic solution plays an important role in the separation. Changing the pH of the
mobile phase can assist the overall separation by varying the position of interfering
species in the chromatogram. For instance, pH 6 was found to be useful to separate
four forms of a peptide that was deamidated and isomerized.27 Because the
IsoAsp/Asp forms are ionised at pH 6, the non-deamidated form is displaced to
higher retention times, therefore separating them for an easier analysis of the
chromatogram.
Diagnostic b+H2O for IsoAsp residues in CAD MS spectra
Several reports of the use of MS to differentiate between IsoAsp from Asp appeared
around 1990’s.28, 29 The differentiation was achieved by the presence of the fragment
corresponding to the IsoAsp [bn-l + H2O]+ in the spectrum, where n is the position of
the Asp/IsoAsp; this fragment was not found in the spectrum corresponding to the
Asp form of the same peptide. The same fragment was also used to differentiate the
IsoAsp from Asp forms of a deamidated proteolytic peptide, from hirudin, an
anticoagulant peptide.30 The formation of the fragment [bn-l + H2O]+ could be
explained using the mechanism proposed by Papayannopoulos,28 where nucleophilic
attack of the carboxyl OH group of β-Asp at carbonyl-protonated serine can be 
assumed to form an oxazolidone intermediate. This intermediate should easily
decompose to the observed [bn-l + H2O]+ ion, along with CO and a C-terminal
aldimine-type moiety that represent a pair of highly stable neutral species. Since the
IsoAsp side chain resembles the C–terminus, generation of [bn-l + H2O]+ for IsoAsp
residues is suggested to resemble the fragmentation channel shown to occur in the
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low-energy MS/MS spectra of peptides where a C–terminal hydroxyl rearrangement
generates [bn-l + H2O]+ fragment ions.
Immonium ions of IsoAsp residues
Immonium ions are small internal fragments with a single side chain formed by a
combination of a type and y type cleavage, as previously shown in Scheme 1.3.
Immonium ions can be used to differentiate the IsoAsp from Asp. Reports have
shown that the intensity of the Asp immonium ion in the MS/MS spectrum of an
IsoAsp peptide is decreased compared to the intensity of the immonium ion from the
Asp form.
In 2000, a study by Gonzalez and co-workers9 made use of immonium ions to
differentiate IsoAsp from Asp. In their spectrum a signal at 70 Da was shown, which
was not detected for the Asp isoform. A mechanism for the formation of this
immonium ion was proposed via a rearrangement of a primary carbocation (unstable
structure), since it was not found in the IsoAsp spectrum. The loss of water and a
further rearrangement yields a more stable acylium ion (C3H4NO+), detected at m/z
70.02928. Regardless, these immonium ions could not be used to predict the
presence of an IsoAsp residue because Pro also yields an intense immunium ion
(C4H8N+) at m/z 70.06567.
Use of ECD to differentiate IsoAsp from Asp species
O’Connor and co-workers proposed an alternative way of identifying Asp from
IsoAsp.19, 20, 22 This method uses ECD to differentiate the isomers products of the
deamidation reaction and it has been discussed in depth in Chapter 1. Thus the scope
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of the work presented in this chapter is to show the application of this method to
differentiate the isomer products of the deamidation reaction in collagen peptides
extracted from ancient bones (≈ 3,000 years old).  The application can be further 
investigated as an alternative method of calculating the extent of deamidation of Asn.
To date, no reports of this type are recorded in the literature.
4.2. EXPERIMENTAL METHODOLOGY
4.2.1. Materials
Bovine bone samples used for this study were provided by Thomas Higham from the
University of Oxford (see Figs. 4.1-4.5). Sequencing-grade trypsin, ammonium
acetate (CH3COONH4), and ammonium bicarbonate (NH4HCO3) were purchased
from Sigma Aldrich, Gillingham, UK. HPLC-grade methanol and formic acid
(HCOOH) were obtained from Fisher Scientific, Leicestershire, UK.
4.2.2. Collagen extraction from archeological bones
Bones were ground into a powder using a coffee grinder (see Fig. 4.6). Triplicates of
14 mg of this powder were weighed and demineralised with 1 mL of HCl (0.6M) at 4
°C for 4 hours. From this extraction, the non-soluble, collagen containing fraction
was rinsed three times with pure water until neutral pH was reached. Prior to
digestion, the non-soluble fraction was denatured in 1 mL of 50 mM ammonium
bicarbonate following a previously described methodology.26
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FIGURE 4.1: Samples labeled with number 8 (left) and number 9 (right). Both are bovine phalanx
from Cooldrinagh, Dublin. Age according to radio carbon date is (915±50) and (1235±30) years
respectively.
FIGURE 4.2: Samples labeled with number 10 (left) and number 11 (right). Both samples are bone
from bovine, Ness of Brodgar, Scotland. Age according to radio carbon date is (3829±27) and
(3878±26) years old respectively.
FIGURE 4.3: Samples labeled with number 12 (left) and number 13 (right). Both are bone from Bos
Taurus, Magura. Age according to radio carbon date is (6354±37) and (6484±37) years old
respectively.
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FIGURE 4.4: Samples labeled with number 14 (left) and number 15 (right). Both are bone from
Bovini, La Ferrassie, France. Age according to radio carbon date is (31400±400) and (32100±450)
years old respectively.
FIGURE 4.5: Samples labeled with number 16 (left) and number 17 (right). Both are bone from
Bovini, La Ferrassie, and La Chauverie, France. Age according to radio carbon date is (32550±450)
and (50000±3900) years old respectively.
FIGURE 4.6: Powder bone obtained from the grinding process.
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Adjustments to the ratio enzyme:protein had to be considered. The supernatant (700
μL) was collected and 24 μL of trypsin solution (2 μg/μL) was added using an 
approximate ratio of 1:200 (w/w) enzyme:protein. To minimise deamidation during
tryptic digestion the mixture was allowed to react for 4 hours at 37°C,31 the reaction
was halted by adding 5 % (v/v) of formic acid, and the samples were dried in a
SpeedVac system (Savant SPD121P Fisher Scientific, Leicestershire, UK) to
evaporate volatiles at 35 °C, following storage at -80 °C until analysis (≈ 1 day).  The 
samples were reconstituted into a mixture of 1:1 MeOH:H2O, and diluted into a
mixture of 49.5:49.5:1 MeOH:H2O:formic acid to a final approximate concentration
of 2.5 μM.    
4.2.3. FT-ICR-MS measurements
The experiments were carried out on a Bruker 12T solariX FT-ICR-MS (Bruker
Daltonics). In order to identify deamidation sites, samples of digested collagen were
electrosprayed at approximately 2.5 µM concentration in 49.5:49.5:1
MeOH:H2O:formic acid. An average of 200 scans was taken.
CAD and ECD experiments were carried out following procedures explained in
Chapter 2 and 3 respectively.. See tables in section 4.6 of this chapter for
information in mass assigments.
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4.3. RESULTS AND DISCUSSION
4.3.1. Identification of collagen peptides originated from ancient cow bones
A range of different ages of bone samples were provided by Professor Thomas
Higham from the University of Oxford. The purpose of the analysis was to identify
potential deamidation sites in peptides extracted from the samples, that could serve
as markers to measure the extent of deamidation, using the previous methodology
developed in our laboratory.32 Tables 4.1 and 4.2 in section 4.6 of this chapter show
the assigned peptides throughout the range of samples selected.
Figure 4.7 shows the mass spectrum of a potential deamidated peptide of collagen
extracted from a range of cow bone samples aged from 900 years to 33,000 years
old. This peptide corresponds to m/z [793.88153]2+, which is consistent with
previous studies.26 Figs. 4.8 and 4.9 show other two potential deamidated peptides
corresponding to m/z [927.78113]3+, and m/z [829.74176]3+. From this range of
samples, the spectrum with the best signal-to-noise ratio was selected to show the
presence of the three potential marker peptides (Fig. 4.10). Consequently, this
particular sample was chosen to carry out the experiments for the differentiation of
IsoAsp from Asp using ECD. This spectrum relates to a bone sample aged around
(3,829±27) years old according to radio carbon dating.
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FIGURE 4.7: a) to i) Enlargement of the m/z [793.88153]2+ ion present in the spectrum, which
corresponds to a fully deamidated peptide of collagen extracted from archaeological bones. The age of
the bones used in the experiment are shown in the figure.
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FIGURE 4.8: a) to f): Enlargement of the m/z [829.74176]3+ ion present in the spectrum, which
corresponds to a deamidated peptide of collagen extracted from cattle bone. The figure shows the age
of the bone used.
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FIGURE 4.9: a) to h): Enlargement of the m/z [927.78113]3+ ion present in the spectrum, which
correspond to a deamidated peptide of collagen extracted from bone, which ages are shown in the
figure.
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FIGURE 4.10: Mass spectrum of tryptic digest of collagen extracted from 3,000 year-old cow bones.
N/D represents deamidation site. P represents Hyp. The inserts show three possible deamidated
peptides corresponding to m/z [793.88153]2+, m/z [927.78113]3+, and m/z [829.74176]3+. a) and b) are
real and simulated isotopic distributions respectively.
4.3.2. Differentiation of Asp from IsoAsp in collagen using ECD
Since Asp and IsoAsp residues have exactly the same mass, their differentiation
using mass spectrometry can be challenging, but the accessibility to ECD assisted the
analysis.20 Under ECD conditions the peptides with Asp residues are likely to suffer
neutral loss of the Asp side chain, which are not normally observed in the IsoAsp
equivalents.19 Unique fragmentation patterns have been previously observed in the
ECD spectra of peptides with IsoAsp residues that do not appear in the spectra of the
peptides with Asp residues only.19 However, these observations were obtained in
model peptides with aspartyl residues and their IsoAsp analogues. In the peptides
originate from the deamidation reaction, a mixture of the isomers is expected. This
mixture is generally at a ratio of 3:1 IsoAsp:Asp at pH 7.4.33
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The differentiation of IsoAsp from Asp in collagen from ancient samples is
highlighted here, particularly as an alternative way of measuring the extent of
deamidation, which was reported in Chapter 2 and 3. Although the mass defect
method is a faster and a simpler method, its utility is limited to ultrahigh resolution
mass spectrometers. The extent of deamidation could be calculated by assuming that
the peak intensities of the diagnostic ions for Asp and IsoAsp are additive and
equivalent to the peak intensity of D. This can be achieved by plotting Nt/(Nt+Dt) vs
time, and using Dt = IsoAsp+Asp. This approach is particularly useful when the
separation of the isotopes involved in the deamidation reaction cannot be achieved,
which was the case in this study due to a failure of the instrument as is shown in Fig.
4.11.
Figure 4.12 shows the ECD and CAD spectra of the peptide with the sequence
GANGAPGIAGAPGFPGAR [coll_I (α1)-397-414], which corresponds to the ion 
m/z [793.88153]2+. Deamidation of the Asn located at position 3 from the N-
terminus is highlighted in red in Fig. 4.12. The ion z●16-57 with m/z 1385.68101 is
the diagnostic ion that indicates the presence of IsoAsp in position three from the N-
terminus in the peptide. Asp diagnostic ion [M+2H]+●-60 was also found in the
spectrum, which m/z corresponds to 1527.74192. The clear distinction between the
two ions in this particular peptide could be further used to determine the extent of
deamidation before sample preparation.
The use of CAD complemented the fragmentation obtained from ECD, which
contributed to sequence the Hyp present in the peptide with higher level of
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confidence. For more information related to mass accuracy and assignments of the
ions see tables 4.2 and 4.3 in section 4.6 of this chapter.
FIGURE 4.11: a) Narrowband spectrum corresponding to m/z [793.88153]2+ ion in a mixture of the
non-deamidated and the deamidated form. The insert represents the zoom of the peak where the two
isotopes should appear. b) Narrowband spectrum of the deamidated form of the peptide m/z
[793.88153]2+.
Figure 4.13 shows the ECD of another possible deamidated peptide with a sequence
GPPGSAGSPGKDGLNGLPGPIGPPGPR [coll_I (α1)-1141-1167], which relates to 
the ion m/z [829.74184]3+. The presence of the IsoAsp diagnostic ion m/z
1284.59434 c14●+58 indicates the presence of IsoAsp. On the other hand, the loss of
Asp side chain from the reduced charged species [M+3H]2+●-60 m/z 1184.59142
could not be used to determine the presence of Asp at position 15 from the N-
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terminus. This is due to the presence of another Asp at position 12 from the N-
terminus.
FIGURE 4.12: Up: ECD and Down: CAD of tryptic digest peptide [coll_I (α1) 397-414] 2+ ion at m/z
793.88150. The deamidation site is located in position 3 (N-terminal), in the peptide (N). Diagnostic
ion corresponding to the deamidation at position 3 is labelled as z●16-57. P in green represent the
modification of hydroxylation.
Looking across figure 4.14, which corresponds to the spectrum of the peptide with
sequence “GAPGAIGAPGPAGANGDRGEAGPAGPAGPAGPR” at [927.78145]3+
m/z no diagnostic ions of the isomers were found in the ECD spectrum of this
peptide. Due to the absence of these ions, it will not be possible to calculate the
extent of deamidation for this particular peptide using the IsoAsp/Asp ratios.
The preliminary analysis reported here shows the presence of potential deamidated
peptides in remarkable aged samples, which brings the possibility of mapping the
162
extent of deamidation against radio carbon date of the sample. Thus, information
about the relationship between deamidation and ageing can be further investigated.
In general, the presence of diagnostic ions (z●-57 and [M+nH]n+●-60) along with the
mass defect method can be used to determine the extent of deamidation in the
sample. In some cases, the absence of the diagnostic ions does not allow the use of
the peak intensities, thus limiting its use.
FIGURE 4.13: Up: ECD and Down: CAD of tryptic digest peptide [coll_I (α1) 1141-1167] 3+ ion at
m/z 829.74184. The deamidation site is located in position 15 (N-terminal) labelled as (N), in the
peptide. Diagnostic ion corresponding to the deamidation site is labelled as c●14+58 in the ECD
spectrum. P in green represent the modification of hydroxylation.
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FIGURE 4.14: Up: ECD and Down: CAD of tryptic digest peptide [coll_I (α2) 674-706]3+ ion at m/z
927.78145. The deamidation site is located in position 15 (N-terminal), labelled as (N) in the peptide.
P highlighted in green represent the modification of hydroxylation.
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4.4. CONCLUSIONS
The use of FT-ICR-MS allowed the localisation of several deamidation sites in the
peptides found in the bone samples studied. Specifically, the use of ECD assisted in
the differentiation of IsoAsp from Asp in some cases. The peptides that showed
deamidation and the differentiation of the isomers were possible can be utilized in
the analysis of IsoAsp+Asp peak intensities to calculate the extent of deamidation in
the samples.
This study represents a preliminary investigation of the peptides, which deamidation
extent needs to be further investigated. The proposal is to determine the extent of
deamidation of the peptides reported here using a combination of the methodology
presented in Chapter 2 and the use of IsoAsp+Asp peak intensities method. The
study needs to be carried out throughout the range of different aged samples in order
to establish a relationship between age and deamidation.
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4.6. MASS ACCURACY AND PEPTIDE ASSIGNMENTS
TABLE 4.1: Molecular formulae and ion masses of the peptides assigned across the
range of samples analyzed
Elemental
composition [M+H]
1+ [M+2H]2+ [M+3H]3+
C26H45N9O10 644.33621 322.67175 215.45026
C35H57N13O11 836.43730 418.72230 279.48395
C37H58N10O13 851.42573 426.21652 284.48010
C36H61N13O12 868.46352 434.73540 290.15936
C35H59N13O14 886.43770 443.72250 296.15075
C38H62N12O13 895.46317 448.23524 299.15924
C38H67N13O12 898.51047 449.75888 300.17501
C38H67N13O12 898.51049 449.75888 300.17502
C48H73N13O16 1088.53700 544.77219 363.51722
C48H73N13O16 1088.53710 544.77219 363.51722
C44H74N18O15 1095.56538 548.28633 365.85998
C47H76N16O15 1105.57488 553.29108 369.19648
C51H80N14O16S1 1177.56702 589.28715 393.19386
C51H79N13O17S1 1178.55104 589.77916 393.52186
C52H85N15O17 1192.63206 596.81967 398.21554
C53H80N14O18 1201.58478 601.29603 401.19978
C53H79N13O19 1202.56879 601.78804 401.52778
C52H89N17O16 1208.67460 604.84094 403.56305
C52H88N16O17 1209.65861 605.33294 403.89106
C51H83N15O22 1258.59099 629.79913 420.20185
C53H90N18O18 1267.67533 634.34130 423.22996
C53H90N18O18 1267.67533 634.34130 423.22996
C56H86N16O19 1287.63279 644.32003 429.88245
C56H85N15O20 1288.61681 644.81204 430.21045
C59H89N15O20 1328.64811 664.82769 443.55422
C57H89N17O20 1332.65422 666.83075 444.88959
C59H89N15O21 1344.64302 672.82515 448.88586
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TABLE 4.1: Molecular formulae and ion masses of the peptides assigned across the
range of samples analyzed (Continued)
Elemental
composition [M+H]
1+ [M+2H]2+ [M+3H]3+
C63H98N18O20 1427.72775 714.36752 476.58077
C60H94N18O23 1435.68120 718.34424 479.23192
C61H94N20O22 1459.69243 730.34985 487.23567
C61H92N20O23 1473.67170 737.33949 491.89542
C65H105N21O22 1532.78158 766.89443 511.59871
C67H109N21O22 1560.81288 780.91008 520.94248
C67H107N19O24 1562.78091 781.89409 521.59849
C65H105N21O25 1580.76632 790.8868 527.593626
C67H103N21O24 1586.75576 793.88152 529.59011
C70H113N21O25 1648.82893 824.91810 550.28116
C69H107N23O28 1706.77287 853.89007 569.59581
C78H121N23O27 1812.88750 906.94739 604.967352
C79H124N22O28 1829.90282 915.45505 610.639124
C79H124N22O29 1845.89773 923.45251 615.970762
C82H134N28O29 1975.99443 988.50085 659.33633
C84H134N26O32 2019.97302 1010.49015 673.99586
C89H146N28O28 2056.09341 1028.55035 686.03599
C85H133N29O31 2056.97951 1028.99339 686.33135
C85H132N28O32 2057.96352 1029.485399 686.659358
C89H146N28O29 2072.08833 1036.54780 691.36682
C92H151N27O31 2131.11421 1066.06074 711.04292
C105H167N31O39 2487.21102 1244.10915 829.74186
C101H163N37O37 2487.20834 1244.10781 829.74096
C115H181N39O42 2781.32991 1391.16859 927.78155
C121H193N37O43 2853.41258 1427.20993 951.80904
C121H193N37O44 2869.40749 1432.207383 957.140681
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples
Sample 8 Sample 9 Sample 10
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C26H45N9O10 GLPGER/304-309 (α1) 644.33626 -0.08 - - 644.33614 0.11 
C35H57N13O11 GPAGPQGPR/1084-1092 (α1) 418.72229 0.03 418.72231 -0.02 418.72200 0.72 
C37H58N10O13 GFSGLDGAK/268-276 (α1) 426.21685 -0.78 - - 426.21651 0.02 
C36H61N13O12 GPSGPQGIR/994-1003 (α2)  434.73506 0.78 434.73524 0.37 434.73509 0.71 
C35H59N13O14 GSEGPQGVR/361-369 (α1) 443.72227 0.51 443.72235 0.33 443.72221 0.65 
C38H62N12O13 GPAGPSGPAGK/1052-1062 (α2) 448.23508 0.36 448.23532 -0.17 448.23499 0.56 
C38H67N13O12 GVVGLPGQR/958-966 (α1) 449.75865 0.50 449.75885 0.06 449.75891 -0.08 
C38H67N13O12 GVVGLPGQR/958-966 (α1) 898.51045 0.05 - - 898.51048 0.01 
C48H73N13O16 GFPGADGVAGPK/493-504 (α1) 544.77215 0.07 544.77218 0.01 544.77225 -0.11 
C48H73N13O16 GFPGADGVAGPK(1oxi)/493-504 (α1) - - - - 1088.53706 0.04 
C44H74N18O15 GPRGDQGPVGR/818-828 (α2) - - - - - - 
C47H76N16O15 GVQGPPGPAGPR(1oxi)/685-696 (α1) 553.29105 0.05 553.29106 0.03 553.29108 0.00 
C51H80N14O16S1 GQAGVMGFPGPK(2oxi)/574-585 (α1) 589.28701 0.23 589.28706 0.15 589.28706 0.15 
C51H79N13O17S1 GQAGVMGFPGPK/574-575 (α1) - - - - - - 
C52H85N15O17 GVPGPPGAVGPAGK(2oxi)/598-611 (α1) 596.81974 -0.12 596.81983 -0.27 596.81978 -0.18 
C53H80N14O18 GEPGNIGFPGPK/485-496 (α2) 601.29630 -0.45 601.29615 -0.20 601.29644 -0.69 
C53H79N13O19 GEPGNIGFPGPK/485-496 (α2) - - - - - - 
C52H89N17O16 IGQPGAVGPAGIR/1066-1078 (α2) 604.84105 -0.19 604.84084 0.16 604.84093 0.01 
C52H88N16O17 IGQPGAVGPAGIR/1066-1078 (α2) - - - - - - 
C51H83N15O22 GLTGSPGSPGPDGK/538-551(α1) 629.79932 -0.30 629.79944 -0.49 629.79936 -0.36 
C53H90N18O18 GIPGPVGAAGATGAR(1oxi)/326-340 (α2) 634.34119 0.17 634.34128 0.03 634.34122 0.13170
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples (Continued)
Sample 8 Sample 9 Sample 10
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C53H90N18O18 GIPGPVGAAGATGAR(1oxi)/326-340 (α2) - - - - 1267.67549 -0.13 
C56H86N16O19 GFPGSPGNIGPAGK/449-462 (α2) 644.31982 0.33 644.32002 0.02 644.31982 0.33 
C56H85N15O20 GFPGSPGNIGPAGK/449-462 (α2) - - - - - - 
C59H89N15O20 GFPGLPGPSGEPGK/970-983 (α1) 664.82747 0.33 664.82790 -0.31 664.82761 0.12 
C57H89N17O20 GPSGPQGPSGPPGPK/415-429 (α1) 666.83079 -0.06 666.83100 -0.37 666.83119 -0.66 
C59H89N15O21 GFPGLPGPSGEPGK/970-983 (α1) 672.82552 -0.55 672.82550 -0.52 672.82512 0.04 
C63H98N18O20 GIPGEFGLPGPAGAR(2oxi)/572-586 (α2) 714.36755 -0.05 714.36773 -0.30 714.36739 0.17 
C60H94N18O23 GEPGPAGLPGPPGER/472-486 (α1) 718.34441 -0.24 718.34429 -0.07 718.34438 -0.20 
C61H94N20O22 GSAGPPGATGFPGAAGR/865-881 (α1) 730.35013 -0.38 - - 730.34982 0.05 
C61H92N20O23 GDGGPPGATGFPGAAGR/775-792 (α2) 737.33936 0.17 737.33956 -0.10 737.33924 0.33 
C65H105N21O22 GEPGPAGAVGPAGAVGPR/977-994 (α2) 766.89477 -0.44 766.89433 0.13 766.89403 0.52 
C67H109N21O22 GETGPAGPAGPIGPVGAR/1066-1083 (α1) 780.91051 -0.55 - - 780.91006 0.02 
C67H107N19O24 DGLNGLPGPIGPPGPR/1152-1167 (α1) 781.89451 -0.53 - - 781.89385 0.31 
C65H105N21O25 GPPGESGAAGPTGPIGSR(1oxi)/590-607 (α2) - - - - 790.88697 -0.21 
C67H103N21O24 GANGAPGIAGAPGFPGAR/397-414 (α1) 793.88162 -0.13 793.88175 -0.29 793.88153 -0.02 
C70H113N21O25 GSTGEIGPAGPPGPPGLR(2oxi)/380-397 (α2) 824.91815 -0.06 824.91850 -0.48 824.91764 0.56 
C69H107N23O28 DGEAGAQGPPGPAGPAGER/612-630 (α1) 853.89007 0.00 - - 853.89008 -0.01 
C78H121N23O27 VGPPGPSGNAGPPGPPGPAGK(3oxi)/881-902 (α1) - - - - 906.94742 -0.03 
C79H124N22O28 TGPPGPSGISGPPGPPGPAGK(3oxi)/793-813 (α2) - - - - 915.45463 0.46 
C79H124N22O29 TGPPGPSGISGPPGPPGPAGK(4oxi)/793-813 (α2) - - - - 923.45208 0.46 
C82H134N28O29 SGDRGETGPAGPAGPIGPVGAR/1062-1083 (α1) 659.33634 -0.02 659.33646 -0.20 659.33671 -0.58 171
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples (Continued)
Sample 8 Sample 9 Sample 10
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C84H134N26O32 GEPGPTGIQGPPGPAGEEGKR(2oxi)/448-468 (α1) 673.99547 0.58 673.99640 -0.80 673.99604 -0.27 
C89H146N28O28 EGPVGLPGIDGRPGPIGPAGAR(1oxi)/463-484 (α2) 686.03623 -0.35 686.03616 -0.25 686.03585 0.20 
C85H133N29O31 TGPPGPAGQDGRPGPPGPPGAR(4oxi)/552-573 (α1) 686.33172 -0.53 - - 686.33119 0.24 
C85H132N28O32 TGPPGPAGQDGRPGPPGPPGAR (4oxi)/552-573 (α1) - - - - - - 
C89H146N28O29 EGPVGLPGIDGRPGPIGPAGAR(2oxi)/463-484 (α2) 691.36742 0.30 691.36739 0.34 691.36742 -0.87 
C92H151N27O31 GLPGVAGSVGEPGPLGIAGPPGAR(3oxi)/881-904 (α2) - - - - 1066.06137 -0.59 
C105H167N31O39 GPPGSAGSPGKDGLNGLPGPIGPPGPR/1141-1167 (α1) 829.74214 -0.34 829.74226 -0.48 829.74176 0.12 
C101H163N37O37 AGEDGHPGKPGRPGERGVVGPQGAR(3oxi)/139-163 (α2) - - - - 829.74176 -0.96 
C115H181N39O42 GAPGAIGAPGPAGANGDRGEAGPAGPAGPAGPR/674-706 (α2) 927.78201 -0.50 927.78141 0.15 927.78113 0.45 
C121H193N37O43
GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR(2oxi)/763-795
(α1)  
951.80912 -0.08 951.80917 -0.13 951.80815 0.94
C121H193N37O44
GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR(3oxi)/763-795
(α1) 
- - - - 957.14073 -0.05
P: Hydroxyproline (Hyp), N: Deamidation of N (D), Q: Deamidation of Q (E)
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples (Continued)
Sample 12 Sample 14
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C26H45N9O10 GLPGER/304-309 (α1) 644.33640 -0.29 - - 
C35H57N13O11 GPAGPQGPR/1084-1092 (α1) 418.72228 0.05 418.72227 0.07 
C37H58N10O13 GFSGLDGAK/268-276 (α1) 426.21675 -0.55 - - 
C36H61N13O12 GPSGPQGIR/994-1003 (α2) 434.73523 0.39 - - 
C35H59N13O14 GSEGPQGVR/361-369 (α1) - - - - 
C38H62N12O13 GPAGPSGPAGK/1052-1062 (α2) 448.23542 -0.40 - - 
C38H67N13O12 GVVGLPGQR/958-966 (α1) 449.75890 -0.06 449.75917 -0.66 
C38H67N13O12 GVVGLPGQR/958-966 (α1) - - - - 
C48H73N13O16 GFPGADGVAGPK/493-504 (α1) 544.77215 0.07 544.77228 -0.17 
C48H73N13O16 GFPGADGVAGPK(1oxi)/493-504 (α1) - - - - 
C44H74N18O15 GPRGDQGPVGR/818-828 (α2) 548.28642 -0.17 548.28597 0.65 
C47H76N16O15 GVQGPPGPAGPR(1oxi)/685-696 (α1) 553.29085 0.41 553.29098 0.18 
C51H80N14O16S1 GQAGVMGFPGPK(2oxi)/574-585 (α1) 589.28665 0.85 - - 
C51H79N13O17S1 GQAGVMGFPGPK/574-575 (α1) 589.77878 0.64 589.77879 0.62 
C52H85N15O17 GVPGPPGAVGPAGK(2oxi)/598-611 (α1) 596.81938 0.49 596.81957 0.17 
C53H80N14O18 GEPGNIGFPGPK/485-496 (α2) 601.29628 -0.42 - - 
C53H79N13O19 GEPGNIGFPGPK/485-496 (α2) 601.78774 0.49 601.78769 0.57 
C52H89N17O16 IGQPGAVGPAGIR/1066-1078 (α2) 604.84056 0.62 604.84061 0.54 
C52H88N16O17 IGQPGAVGPAGIR/1066-1078 (α2) 605.33278 0.27 605.33289 0.09 
C51H83N15O22 GLTGSPGSPGPDGK/538-551(α1) 629.79894 0.30 - - 
C53H90N18O18 GIPGPVGAAGATGAR(1oxi)/326-340 (α2) 634.34102 0.44 634.34088 0.66173
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples (Continued)
Sample 12 Sample 14
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C53H90N18O18 GIPGPVGAAGATGAR(1oxi)/326-340 (α2) - - - - 
C56H86N16O19 GFPGSPGNIGPAGK/449-462 (α2) 644.31971 0.50 - -
C56H85N15O20 GFPGSPGNIGPAGK/449-462 (α2) 644.81200 0.07 - -
C59H89N15O20 GFPGLPGPSGEPGK/970-983 (α1) 664.82708 0.92 - -
C57H89N17O20 GPSGPQGPSGPPGPK/415-429 (α1) 666.83097 -0.33 - -
C59H89N15O21 GFPGLPGPSGEPGK/970-983 (α1) - - - -
C63H98N18O20 GIPGEFGLPGPAGAR(2oxi)/572-586 (α2) 714.36729 0.31 714.36723 0.40
C60H94N18O23 GEPGPAGLPGPPGER/472-486 (α1) 718.34424 0.00 718.34398 0.36
C61H94N20O22 GSAGPPGATGFPGAAGR/865-881 (α1) 730.34969 0.22 730.34915 0.96
C61H92N20O23 GDGGPPGATGFPGAAGR/775-792 (α2) 737.33949 -0.01 - -
C65H105N21O22 GEPGPAGAVGPAGAVGPR/977-994 (α2) - - - -
C67H109N21O22 GETGPAGPAGPIGPVGAR/1066-1083 (α1) - - - -
C67H107N19O24 DGLNGLPGPIGPPGPR/1152-1167 (α1) 781.89471 -0.79 - -
C65H105N21O25 GPPGESGAAGPTGPIGSR(1oxi)/590-607 (α2) - - - -
C67H103N21O24 GANGAPGIAGAPGFPGAR/397-414 (α1) 793.88181 -0.37 793.88114 0.48
C70H113N21O25 GSTGEIGPAGPPGPPGLR(2oxi)/380-397 (α2) - - - -
C69H107N23O28 DGEAGAQGPPGPAGPAGER/612-630 (α1) - - - -
C78H121N23O27 VGPPGPSGNAGPPGPPGPAGK(3oxi)/881-902 (α1) - - - -
C79H124N22O28 TGPPGPSGISGPPGPPGPAGK(3oxi)/793-813 (α2) - - - -
C79H124N22O29 TGPPGPSGISGPPGPPGPAGK(4oxi)/793-813 (α2) - - - -
C82H134N28O29 SGDRGETGPAGPAGPIGPVGAR/1062-1083 (α1) 659.33619 0.21 659.33575 0.88174
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TABLE 4.2: Sequences and mass error of the peptides assigned across the range of bone samples (Continued)
Sample 12 Sample 14
Elemental
composition Identified peptides/Length coll-I(chain)
Observed
mass
Error
ppm
Observed
mass
Error
ppm
C84H134N26O32 GEPGPTGIQGPPGPAGEEGKR(2oxi)/448-468 (α1) 673.99585 0.01 - -
C89H146N28O28 EGPVGLPGIDGRPGPIGPAGAR(1oxi)/463-484 (α2) 686.03617 -0.26 686.03541 0.84 
C85H133N29O31 TGPPGPAGQDGRPGPPGPPGAR(4oxi)/552-573 (α1) 686.33120 0.22 - -
C85H132N28O32 TGPPGPAGQDGRPGPPGPPGAR (4oxi)/552-573 (α1) - - 686.66 0.67
C89H146N28O29 EGPVGLPGIDGRPGPIGPAGAR(2oxi)/463-484 (α2) 691.36769 -0.09 691.36729 0.49
C92H151N27O31 GLPGVAGSVGEPGPLGIAGPPGAR(3oxi)/881-904 (α2) - - - - 
C105H167N31O39 GPPGSAGSPGKDGLNGLPGPIGPPGPR/1141-1167 (α1) 829.74217 -0.38 829.74265 -0.95
C101H163N37O37 AGEDGHPGKPGRPGERGVVGPQGAR(3oxi)/139-163 (α2) - - - - 
C115H181N39O42 GAPGAIGAPGPAGANGDRGEAGPAGPAGPAGPR/674-706 (α2) 927.78241 -0.99 927.78172 -0.25
C121H193N37O43
GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR(2oxi)/763-795
(α1)  
951.80899 0.05 951.80918 -0.14
C121H193N37O44
GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR(3oxi)/763-795
(α1) 
- - - -
P: Hydroxyproline (Hyp), N: Deamidation of N (D), Q: Deamidation of Q (E)
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TABLE 4.3: List of assigned ions from the ECD spectrum of m/z [793.88150]2+
Theoretical
mass
Experimental
mass Fragment
Error
(ppm) Position
401.21431 401.21430 z4 -0.03 C_Pos_4
548.28272 548.28306 z5 0.62 C_Pos_5
788.38114 788.38145 z8● 0.39 C_Pos_8
789.38897 789.38901 z8 0.05 C_Pos_8
793.88150 793.88160 [M+2H]2+ 0.13 Parent ion
845.40260 845.40271 z9● 0.13 C_Pos_9
846.41043 846.41045 z9 0.02 C_Pos_9
861.42132 861.42106 y9 -0.30 C_Pos_9
916.43971 916.43972 z10● 0.01 C_Pos_10
917.44754 917.44756 z10 0.02 C_Pos_10
1029.52377 1029.52371 z11● -0.06 C_Pos_11
1030.53160 1030.53162 z11 0.02 C_Pos_11
1086.54523 1086.54496 z12● -0.25 C_Pos_12
1087.55306 1087.55314 z12 0.07 C_Pos_12
1102.56395 1102.56374 y12 -0.19 C_Pos_12
1270.63002 1270.62995 z14● -0.06 C_Pos_14
1327.65148 1327.65136 z15● -0.09 C_Pos_15
1357.62565 1357.62495 c16● -0.51 N_Pos_16
1385.68020 1385.68101 z16● -57 0.59 N_Pos_16
1428.66276 1428.66300 c17● 0.17 N_Pos_17
1442.67842 1442.67843 z16● 0.01 C_Pos_16
1513.71553 1513.71579 z17● 0.17 C_Pos_17
1527.74297 1527.74192 [M+2H]+.-60 0.69 Asp diagnostic ion
1526.74719 1526.74753 z18● - CO2 -0.22 IsoAsp diagnostic ion
1570.73699 1570.73732 z18● -0.21 C_Pos_18
1586.75571 1586.75551 [M+H]+ 0.13 Single charge Parent
1587.76407 1587.76413 [M+2H]+● -0.04 Charged reducedspecies
* Mean: 0.05
* Std. Dev.: 0.27
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TABLE 4.4: List of assigned ions from the CAD spectrum of m/z [793.88150]2+
Theoretical
mass
Experimental
mass Fragment
Error
(ppm) Position
354.14084 354.14080 b5-H2O 0.10 N_Pos_5
372.15136 372.15135 b5 -0.01 N_Pos_5
416.22520 416.22519 y4 -0.02 C_Pos_4
467.18847 467.18852 b6-H2O 0.11 N_Pos_6
524.20993 524.20993 b7-H2O 0.00 N_Pos_7
542.22050 542.22046 b7 -0.07 N_Pos_7
563.29361 563.29359 y5 -0.04 C_Pos_5
608.30945 608.30946 y132+ 0.01 C_Pos_13
619.28342 619.28343 b8-2H2O 0.01 N_Pos_8
620.31507 620.31508 y6 0.02 C_Pos_6
637.29399 637.29401 b8-H2O 0.03 N_Pos_8
643.82801 643.82802 y142+ 0.02 C_Pos_14
655.30456 655.30456 b8 0.01 N_Pos_8
672.33874 672.33879 y152+ 0.07 C_Pos_15
708.33110 708.33112 b9-H2O 0.03 N_Pos_9
726.34167 726.34169 b9 0.03 N_Pos_10
729.85221 729.85220 y162+ -0.01 C_Pos_16
733.36275 733.36273 y7 -0.03 C_Pos_7
765.35256 765.35255 b10-H2O -0.01 N_Pos_10
783.36312 783.36316 b10 0.05 N_Pos_10
784.87621 784.87623 b182+ 0.02 N_Pos_18
793.88150 793.88151 [M+2H]2+ 0.01 Parent ion
804.39986 804.39989 y8 0.04 C_Pos_8
818.37910 818.37913 b11-2H2O 0.03 N_Pos_11
836.38967 836.38971 b11-H2O 0.05 N_Pos_11
854.40023 854.40025 b11 0.02 N_Pos_11
861.42132 861.42133 y9 0.01 C_Pos_9
932.45843 932.45844 y10 -0.01 C_Pos_10
1024.46937 1024.46963 b13 0.25 N_Pos_13
1045.54249 1045.54252 y11 0.03 C_Pos_11
1102.56395 1102.56402 y12 0.06 C_Pos_12
1135.51665 1135.51586 b14-2H2O -0.70 N_Pos_14
1153.52722 1153.52718 b14-H2O -0.04 N_Pos_14
1171.53679 1171.53778 b14 0.85 N_Pos_14
1215.61163 1215.61162 y13 0.01 C_Pos_13
* Mean: 0.03
* Std. Dev.: 0.19
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TABLE 4.5: List of assigned ions from the ECD spectrum of m/z [829.74184]3+
Theoretical
mass
Experimental
mass Fragment
Error
(ppm) Position
314.18227 314.18227 z3 0.00 C_Pos_3
429.20921 429.20921 c5 0.00 N_Pos_5
500.24632 500.24634 c6 -0.04 N_Pos_6
557.26778 557.26778 c7 0.00 N_Pos_7
814.36895 814.36898 c10 -0.04 N_Pos_10
829.74184 829.74176 [M+3H]3+ 0.10 Parent ion
863.44955 863.44946 z9● 0.10 C_Pos_9
864.45737 864.45738 z9 -0.01 C_Pos_9
941.45609 941.45614 c11● -0.05 N_Pos_11
942.46391 942.46396 c11 -0.05 N_Pos_11
1057.49085 1057.49075 c12 0.09 N_Pos_12
1089.58129 1089.58114 z11● 0.14 C_Pos_11
1114.51231 1114.51230 c13 0.01 N_Pos_13
1146.60275 1146.60285 z12● -0.09 C_Pos_12
1147.61057 1147.61074 z12 -0.15 C_Pos_12
1162.62147 1162.62149 y12 -0.02 C_Pos_12
1184.59247 1184.59142 [M+3H]2+●-60 0.89 Asp diag. ion
1227.59637 1227.59614 c14 0.19 N_Pos_14
1236.09976 1236.09953 z272+● 0.19 C_Pos_27
1244.61331 1244.61287 [M+3H]2+● 0.35 Charged reduced species
1261.62969 1261.62967 z13● 0.02 C_Pos_13
1284.59395 1284.59434 c14●+ 58 -0.30 N_Pos_14
1342.62331 1342.62331 c15 0.00 N_Pos_15
1374.71375 1374.71376 z14● -0.01 C_Pos_14
1399.64477 1399.64428 c16 0.35 N_Pos_16
1431.73521 1431.73512 z15● 0.06 C_Pos_15
1447.75393 1447.75342 y15 0.35 C_Pos_15
1546.76215 1546.76217 z16● -0.01 C_Pos_16
1624.76869 1624.76812 c18● 0.35 N_Pos_18
1625.77651 1625.77690 c18 -0.24 N_Pos_18
1931.95828 1931.95779 z20● 0.25 C_Pos_20
* Mean: 0.08
* Std. Dev.: 0.22
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TABLE 4.6: List of assigned ions from the CAD spectrum of m/z [829.74184]3+
Theoretical
mass
Experimental
mass Fragment Error (ppm) Position
412.18266 412.18266 b5 0.00 N_Pos_5
465.20925 465.20920 b6-H2O 0.11 N_Pos_6
483.21977 483.21977 b6 0.00 N_Pos_6
496.76161 496.76160 y102+ 0.02 C_Pos_10
522.23072 522.23063 b7-H2O 0.16 N_Pos_7
540.24123 540.24123 b7 0.00 N_Pos_7
553.30365 553.30360 y112+ 0.08 C_Pos_11
555.28852 555.28850 a8 -2CO2 0.04 N_Pos_8
570.25181 570.25174 a8-CH4N2 0.11 N_Pos_8
591.25223 591.25215 b8-2H2O 0.14 N_Pos_8
596.78356 596.78337 [b14-H2O]2+ 0.32 N_Pos_14
605.78855 605.78849 b142+ 0.10 N_Pos_14
609.26275 609.26269 b8-H2O 0.09 N_Pos_8
627.27326 627.27325 b8 0.02 N_Pos_8
639.32785 639.32789 y132+ -0.07 C_Pos_13
654.29703 654.29670 [b15-H2O]2+ 0.51 N_Pos_15
663.30202 663.30200 b152+ 0.03 N_Pos_15
682.80776 682.80750 [b16-H2O]2+ 0.38 N_Pos_16
721.33894 721.33894 [b17-3H2O]2+ -0.01 N_Pos_17
724.38061 724.38062 y152+ -0.02 C_Pos_15
730.34454 730.34422 [b17-2H2O]2+ 0.43 N_Pos_17
734.35733 734.35736 a172+ -0.05 N_Pos_17
739.34979 739.34947 [b17-H2O]2+ 0.44 N_Pos_17
748.35478 748.35476 b172+ 0.03 N_Pos_17
822.44681 822.44683 y8 -0.02 C_Pos_8
823.73832 823.73827 b273+ 0.06 N_Pos_27
829.74184 829.74180 [M+3H]3+ 0.05 Parent ion
879.46827 879.46824 y9 0.03 C_Pos_9
925.43736 925.43739 b11 -0.03 N_Pos_11
930.976125 930.97607 y192+ 0.06 C_Pos_19
938.457765 938.45781 [a22-C2H3]2+ -0.05 N_Pos_22
974.49214 974.49213 y202+ 0.01 C_Pos_20
992.51595 992.51593 y10 0.02 C_Pos_10
1003.00287 1003.0029 y212+ -0.03 C_Pos_21
1038.521425 1038.52158 y222+ -0.15 C_Pos_22
1040.4643 1040.46425 b12 0.05 N_Pos_12
1082.03744 1082.03745 y232+ -0.01 C_Pos_23
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TABLE 4.6: List of assigned ions from the CAD spectrum of m/z [829.74184]3+
(Continued)
Theoretical
mass
Experimental
mass Fragment Error (ppm) Position
1158.067023 1158.06675 [y25-H2O]2+ 0.24 C_Pos_25
1162.62147 1162.62143 y12 0.03 C_Pos_12
1167.07201 1167.07201 y252+ 0.00 C_Pos_25
1192.55931 1192.55918 b14-H2O 0.10 N_Pos_14
1210.56982 1210.56988 b14 -0.05 N_Pos_14
1277.64841 1277.64843 y13 -0.02 C_Pos_13
1325.59676 1325.59710 b15 -0.26 N_Pos_15
1382.61822 1382.61838 b16 -0.12 N_Pos_16
1447.75393 1447.75389 y15 0.03 C_Pos_15
1459.68125 1459.68110 b17-2H2O 0.10 N_Pos_17
1477.691765 1477.69171 b17-H2O 0.04 N_Pos_17
1495.70228 1495.70258 b17 -0.20 N_Pos_17
* Mean: -0.05
* Std. Dev.: 0.15
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TABLE 4.7: List of assigned ions from the ECD spectrum of m/z [927.78145]3+
Theoretical
mass
Experimental
mass Fragment
Error
(ppm) Position
314.18228 314.18227 z3 -0.03 C_Pos_3
385.21939 385.21937 z4● -0.05 C_Pos_4
538.28578 538.28585 z6● 0.13 C_Pos_6
539.29359 539.29365 z6 0.10 C_Pos_6
609.32289 609.32282 z7● -0.12 C_Pos_7
741.38895 741.38886 c9 -0.12 N_Pos_9
763.39711 763.39712 z9● 0.01 C_Pos_9
779.41583 779.41553 y9 -0.39 C_Pos_9
834.43422 834.43398 z10● -0.29 C_Pos_10
895.46317 895.46314 c11 -0.03 N_Pos_11
966.50028 966.50051 c12 0.24 N_Pos_12
988.50844 988.50835 z12● -0.09 C_Pos_12
1023.52174 1023.52237 c13 0.62 N_Pos_13
1059.54555 1059.54565 z13● 0.09 C_Pos_13
1093.55103 1093.55058 c14● -0.41 N_Pos_14
1094.55885 1094.55897 c14 0.11 N_Pos_14
1188.58814 1188.58816 z14● 0.02 C_Pos_14
1266.60725 1266.60674 c16 -0.40 N_Pos_16
1381.63419 1381.63394 c17 -0.18 N_Pos_17
1383.15918 1383.15850 z332+● -0.49 C_Pos_33
1391.67273 1391.67228 [M+3H]2+● -0.32 Charged reducedspecies
1402.71854 1402.71801 z16 -0.37 C_Pos_16
1517.74547 1517.74682 z17 0.89 C_Pos_17
1594.75676 1594.75606 c19 -0.44 N_Pos_19
1689.79388 1689.79273 z19 -0.68 C_Pos_19
1794.83646 1794.83593 c21 -0.30 N_Pos_21
* Mean: -0.10
* Std. Dev.: 0.33
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TABLE 4.8: List of assigned ions from the CAD-MS2 spectrum of m/z
[927.78145]3+
Theoretical
mass
Experimental
mass Fragment Error (ppm) Position
370.1721 370.17209 b5 -0.01 N_Pos_5
455.26124 455.26119 a6 -0.11 N_Pos_6
465.24559 465.24552 b6-H2O -0.15 N_Pos_6
483.25615 483.25617 b7 0.03 N_Pos_7
522.26705 522.26698 b7-H2O -0.13 N_Pos_7
540.27761 540.27747 b7 -0.27 N_Pos_7
554.3045 554.30448 y6 -0.04 C_Pos_6
583.31981 583.31986 a8 0.09 N_Pos_8
593.30416 593.30413 b8-H2O -0.05 N_Pos_8
611.31472 611.3147 b8 -0.04 N_Pos_8
709.36835 709.36836 y162+ 0.01 C_Pos_16
722.39437 722.39435 y8 -0.03 C_Pos_8
779.41583 779.41587 y9 0.05 C_Pos_9
786.38727 786.38709 [y18-H2O]2+ -0.23 C_Pos_18
795.39256 795.39255 y182+ -0.01 C_Pos_18
843.90074 843.90059 [y19-H2O]2+ -0.18 C_Pos_19
852.90603 852.90597 y192+ -0.06 C_Pos_19
885.09526 885.09521 y313+ -0.06 C_Pos_31
916.93531 916.93543 y212+ 0.13 C_Pos_21
947.5057 947.5057 y11 0.00 C_Pos_11
1000.98025 1000.98024 y232+ -0.01 C_Pos_23
1004.52716 1004.52719 y12 0.03 C_Pos_12
1020.48569 1020.4862 [y24-H2O]2+ 0.50 C_Pos_24
1029.49097 1029.49096 y242+ -0.02 C_Pos_24
1068.00425 1068.00394 [y25-2H2O]2+ -0.29 C_Pos_25
1075.56427 1075.56439 y13 0.11 C_Pos_13
1077.00953 1077.00971 [y25-H2O]2+ 0.17 C_Pos_25
1086.01482 1086.01483 y252+ 0.01 C_Pos_25
1112.52809 1112.52856 [y26-H2O]2+ 0.43 C_Pos_26
1121.53337 1121.53383 y262+ 0.41 C_Pos_26
1141.03882 1141.03887 [y27-H2O]2+ 0.05 C_Pos_27
1150.0441 1150.04406 y272+ -0.04 C_Pos_27
1206.58613 1206.58618 y282+ 0.04 C_Pos_28
1242.10469 1242.10512 y292+ 0.35 C_Pos_29
1261.62832 1261.62848 y15 0.13 C_Pos_15
1270.61542 1270.61454 y302+ -0.69 C_Pos_30
1400.70343 1400.70321 y16-NH3 -0.16 C_Pos_16
1417.72943 1417.72947 y16 0.03 C_Pos_16
* Mean: -0.11
* Std. Dev.: 0.20
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Chapter 5: Conclusions and future
directions
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5.1. CONCLUSIONS
The work presented in this thesis illustrates the use of FT-ICR-MS to investigate Asn
deamidated marker peptides identified in archaeological ancient bones and the
determination of their extent of deamidation, which could be further implemented for
relative age determination. As highlighted throughout the thesis deamidation and
isomerisation of Asn has gained interest from the archaeological point of view. So
far the progress in mass spectrometry fragmentation techniques has allowed the
confident analysis of these types of modifications in samples such as bone, tissue,
blood, etc. For example ECD was applied to characterize the different deamidated
peptides present in ancient bone samples, and also was useful to differentiate the
isomers produced in the deamidation reaction.
Deamidation of Asn in collagen represents a potential alternative to measure the
relative age of ancient materials. However, so far the fact of artificially induced
deamidation by sample prep has kept researchers away from using this modification
for this purpose. In this thesis, a methodology was developed to address this issue by
determine the extent of deamidation before sample preparation. Some of the most
predominant deamidated peptides were observed throughout a range of different
bovine bone samples, these peptides were selected as markers for bovine and were
also chosen for deamidation studies. The extent of deamidation was calculated
successfully for these peptides.
It is proposed that the deamidated peptides identified in the study are potential age
markers in these types of samples. Their presence was further investigated in older
samples. One particular peptide was consistently present in all the analysis.
Perhaps, this peptide was continually used and referred to throughout the thesis.
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A comparison of the extent of deamidation from young collagen (< 10 years) to
ancient collagen (≈1,000 years) was established, the general trend was clearly 
pointing that the older collagen presented an elevated percent of deamidation (36%)
compared to its younger version (6%). This preliminary study was discussed with
collaborators in the area of archaeology, where they highlighted the importance of
this finding towards age dating.
Since amino acid reactions are temperature dependent, this factor was also
considered. The approach was to calculate the activation energy of the deamidation
reaction, which has to be taken into account in future calculation of age involving
deamidation of Asn. The value of activation energy obtained was considerably lower
than previous reports, being a possible explanation that it was calculated for one
peptide and not for a whole population.
An alternative way of calculating the extent of deamidation was introduced in
Chapter 4. This method can only be used when IsoAsp/Asp diagnostic ions show up
in the spectrum. The advantage of using IsoAsp/Asp peak intensities is that it can be
performed when high resolution cannot be achieved, and the method is also useful
for ion trap analysis using ETD.
In conclusion, the author is confident that the results of the work presented in this
thesis have introduced a valuable contribution that can be further incorporated to
calculations of relative age of ancient materials. Another major contribution, which
was highlighted in numerous conferences by pharmaceutical companies, was that a
way of calculating how much artificial deamidation introduced by sample
preparation was addressed in the study.
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5.2. FUTURE DIRECTIONS
The next step in this project will be to map out the extent of deamidation of the age
marker peptides against the radio carbon age of the sample. This graph will give
preliminary information of the relationship between age and deamidation of collagen.
Either the mass defect method or the IsoAsp+Asp peak intensities method using
ECD can be useful to determine the extent of deamidation to build the graph. The
preliminary studies exploring the use of ECD have been performed, but a larger
number of samples would be necessary to completely characterize this last
methodology.
Since amino acid reactions are temperature dependent the data obtained from the
extent of deamidation needs to be further calibrated. In order to achieve this, more
temperature measurements are needed to accurately calculate the activation energy of
the reaction. The author proposes to calibrate the data by using an assumed
temperature history of the sample. A plot of the adjusted extent of deamidation at 10
°C against the thermal age of the sample is needed. Thermal age is defined as the
time taken to produce a given degree of DNA degradation when temperature is held
at a constant 10 °C. The thermal age adjusts the chronological sites according to their
individual thermal histories, using the known temperature dependence of DNA
depurination estimated in aqueous solution. An estimate of the thermal age of the
sample can be obtained from the following reference software http://beta.thermal-
age.eu/ developed by archaeologist Matthew Collins and collaborators.
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Appendix
Use of High Resolution Mass
Spectrometry in the Analysis of
Polymeric Excipients in Drug Delivery
Formulations
_______________________________
1This appendix has been partially/entirely reproduced from
Perez P., Lam P., Kilgour D., Bristow A., McBride E., O’Connor P., Use of High
Resolution Mass Spectrometry for the Analysis of Polymeric Excipients in Drug
Formulations. Analytical Chemistry, 2012. 84 (20), 8579–8586
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A.1. INTRODUCTION
Improving the bioavailability of poorly water soluble drugs is one of the most
significant challenges for the pharmaceutical industry, and a wide variety of different
excipients are used to overcome this issue. Enabling formulations often employ
polymeric excipients to enhance solubility and therefore bioavailability; two of
which are Gelucire® 44/14 and polysorbate 80; these are known to improve solubility
of poorly-water-soluble drugs, and hence, increase their bioactivities.1-3 In addition to
the use of Gelucire® 44/14 and polysorbate 80 as excipients in drugs, they are also
widely used as cosmetic4 and food additives.5 Gelucire® 44/14 and polysorbate 80
can improve solubility of the drug within the formulation and in vivo through
association with the drug molecule, for example by micelle formation in the
intestinal environment. Therefore the excipient composition and variability can be
critical to product performance and drug absorption. Gelucire® 44/14 is formed by
polyglycolysis of hydrogenated palm kernel oil with polyethylene glycol (PEG)
1500. Gelucire® 44/14 is a semisolid wax, which is composed of approximately 72%
mono- and di-fatty acid esters of polyethylene glycol (PEG) 1500; 20% mono-, di,
and triglycerides and 8% free PEG (see Fig. A.1 for structures).1, 6 Different
microscopy, NMR, x-ray diffraction, and HPLC-MS techniques have been used for
characterisation of Gelucire® 44/14.1,7-9
189
FIGURE A.1: Expected Compounds in Gelucire® 44/14.
Polysorbate 80 is formed by the reaction of fatty acids (commonly stearic
(C18H36O2), oleic (C18H34O2) or linoleic (C18H32O2) acid) with sorbitol in the
presence of an acid catalyst.10 The products of this reaction are a mixture of sorbitan
polyethoxylates, polysorbate diesters, polysorbate monoesters, isosorbide
polyethoxylates and free PEG (see Fig. A.2 for structures). Infrared
spectrophotometry (IR), thin-layer chromatography (TLC), gas chromatography
(GC), and high performance liquid chromatography (HPLC) have been used for
analysis of polysorbate 80.10, 11 In the 2000s, components of Polysorbate 80 were
investigated by MALDI-TOF MS,12 indicating the presence of polyoxyethylene
isosorbide and sorbitan polyethoxylate monolinoleate. However, neither experiment
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could differentiate sorbitan polyethoxylate (1507.84 m/z), sorbitol polyethoxylate
monooleate (1507.93 m/z) and sorbitol polyethoxylate dioleate (1507.02 m/z)
because of the proximity in mass (±0.1 Da) (see Fig. A.2). Furthermore, the
heterogeneity of polysorbates makes characterization of these molecules a significant
analytical challenge. The use of LC-MS has enhanced the characterization of such
molecules.9 However, to date, there is no study reported in the literature using high
resolution mass spectrometry for the analysis of Gelucire® 44/14 and Polysorbate 80,
although, FT-ICR has been commonly applied for structural analysis of other
polymers.13-22 This study aims to identify the different components that can be found
in the batches of polysorbate 80 and Gelucire® 44/14 respectively using FT-ICR-MS,
to provide a better understanding about the potential impact of variability in these
complex excipients on drug product performance.
A.2: Expected Compounds in Polysorbate 80.
191
A.2. EXPERIMENTAL SECTION
A.2.1. Materials
Two different batches of Gelucire® 44/14 (a product of Gattefosse S.A., St Priest,
France), identified as (A and B), and polysorbate 80, identified as [Acros (A) and
Fisher (B)], were provided by Astrazeneca. Chloroform, HPLC grade methanol and
sodium hydroxide were obtained from Fisher Scientific, Leicestershire, UK.
A.2.2. Sample Preparation
Sample preparation was carried out by master student Yuko Lam. Gelucire® 44/14
samples were dissolved in 1:9 Chloroform/MeOH. Polysorbate 80 samples were
dissolved in HPLC grade methanol. All solutions were then further diluted in 1 mM
sodium hydroxide down to an approximate final concentration of (1 μM). 
A.2.3. FT-ICR-MS
The experiments were carried out on a Bruker Solarix 12 T FT-ICR-MS (Bruker
Daltonics. Bremen, Germany). Solutions of Gelucire® 44/14 and Polysorbate 80
(described above) were electrosprayed at a flow rate of 300 μL/h.  An average of 400 
scans using ESI in positive ion mode were obtained. The mass spectrometer was
externally calibrated using a standard mixture (HP mix) within the range of interest.
External calibration of mass spectra produced a mass accuracy of ≤5 ppm. Internal 
calibration was also performed using confidently assigned PEGs as internal
calibrants, improving the mass accuracy to values <1 ppm. Ion accumulation time
varied from 0.1 to 0.5 sec depending on the sample. Front and back trap voltages
were kept about 0.45 V. Electrospray voltage was kept at 4.5 kV. The mass range for
broadband detection was (200 – 3000 m/z).
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A.3. RESULTS AND DISCUSSION
As part of a master project the student Yuko Lam carried out most of the analysis
and interpretation of the data shown in this chapter.
A.3.1. End-Group Determination
The most significant challenge in a mixture of polymeric components is the
determination of the end-group mass. The analysis relies on distinguishing the end-
group(s) from the repeat unit. The most common method to achieve this is by using
the mass of the observed peak in the spectrum.16, 23 This method has been applied in
polymeric compounds analyzed by FT-ICR and MALDI-TOF. The principle of the
method is based on the following equation:
where Mpeak is the mass of the observed peak in the spectrum, n is the number of the
repeat unit, Mmono is the mass of monomer, Mend is the mass of end group, and Madduct
is the mass of the adduct added. In an experiment, the mass of the adduct ion, (eg.
Fe+ or Na+), is usually known, and it will depend on the solution added to the sample
during preparation. In order to simplify the equation, the mass of the adduct ion can
be deducted. The simplified equation can be written as follows:
where M[peak-adduct] is the mass of the molecule only. The mass of the monomer c and
be determined from the spectrum which is the space unit between two peaks.
However, Mend and n cannot be determined directly from the spectrum, and must be
inferred. An equation is required for the connection between Mend and n. Therefore,
the equation can be further developed:
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where i is the maximum integer value obtained by:
Mres is the smallest possible end-group mass. Taking the example of a mass
spectrum of Gelucire® 44/14 (A), there is a peak at 1009.5772 with a mass error of
0.17 ppm (see Table A.27). The information for equat m/z ion A.4 can be extracted
from the spectrum. Mpeak-adduct is calculated by subtracting Madduct, the mass of the
adduct is: Na = 22.989770 Da, so M(peak-adduct) = 986.5875. The monomer unit is
(CH2-CHO-) (Mmono = 44.0262), thus i ≤ 22. Introducing these values in equation 
(6.3) the mass of the end group is (Mres is 18.0107). This corresponds to the mass of
a water molecule. Therefore, the chemical formula related to the peak at m/z
1009.5772 is proposed to be [H(OCH2CH2)22OHNa]+. This method can be directly
applied to cases where the end-group mass is smaller than the mass of the repeat unit.
In this particular case the Mres is directly equal to the mass of the end group.
In the cases where the end-group mass is bigger than the mass of the repeat unit,
several steps are required for the end-group determination. An example for this case
is the peak at m/z 1307.8277 with a mass error of 0.10 ppm, which is taken from
PEG series extracted from the spectrum (See Table A.7). Using equation A.4, the
value of the maximum integer value can be calculated by introducing the values
corresponding to the monomer unit (Mmono = 44.0262), and the assumed adduct
mass, Na+, M[peak-adduct] = 1284.8379 m/z. The maximum integer value, i, is therefore
estimated to be 29, leaving a residual mass (Mres) of 8.077718. There is no
acceptable combination with mass corresponding to 8.077718. Therefore, in order to
obtain a possible end-group mass, Mmono is added to Mres following equation A.3:
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8.0777 + (1) * 44.0262 = 52.1034
8.0777 + (2) * 44.0262 = 96.1296
8.0777 + (3) * 44.0262 = 140.1558
8.0777 + (4) * 44.0262 = 184.1820
8.0777 + (5) * 44.0262 = 228.2082
8.0777 + (6) * 44.0262 = 272.2350
In the case of Gelucire® 44/14, fatty acids react with free PEG to form monoester or
diester PEG. Therefore, the mass of the end-group is possibly coming from the mass
of the fatty acid. Myristic acid (C14) gives the same molecular mass m/z 228.2089,
which is close to an end group mass of 228.2082. The repeat unit is equal to 29-5 =
24. The chemical formula of m/z 1307.8277 is therefore proposed to be
[H(OCH2CH2)24C14H27O2].
With the equation Mpeak = n(Mmono.) + Mend + Madduct, consistency of the end-group
mass and the monomer mass can be shown graphically. If three free PEG series,
from the mass spectrum of Gelucire® 44/14 (A), are taken as example, the peak
masses can be plotted versus the repeat unit. A best fit line can be calculated through
these points using linear least squares (see Fig. A.3). The three plots in Fig. A.3
corresponds to the masses of members of three polymeric series: [PEG.Na],
[PEG.Na2] and [PEG.Na3]. As expected, the mass difference between the linear
regression lines in each case is Madduct (Na = 22.9898). The gradient of each line can
be used to determine the mass of the monomer unit and also to show that this unit is
consistent along the length of the polymer chain. The intercept for each line
corresponds to the mass of the end unit and the adduct [Mres+ Madduct].
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FIGURE A.3: Consistency of the end-group mass and monomer mass of free PEG present in
Gelucire 44/14® (A).
A.3.2. Comparison between the batches of Gelucire® 44/14
With the end-group determination methods described above, different polymeric
series and compounds were identified in the samples: A and B, corresponding to
Gelucire® 44/14. The identification of at least 6 common polymeric series was
successfully achieved. Fig. A.4A shows the various polymeric distribution patterns
assigned to samples of (A). In the case of sample (B), a similar pattern is shown in
Fig. A.4B, but the signals for the polymeric series are greatly reduced by the
presence of some unknown single charge contaminants.
In both spectra, most of the expected compounds (Fig. A.1) were identified. In
addition to the monoester components, various diester polymeric compounds were
also identified in both samples. Interestingly, PEG stearate
(C18H36O2․[OCH2CH2]n), which is proposed as a constituent by the manufacturer,
Gattefose, was not identified in either sample. Monoglycerides, diglycerides, and
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triglycerides were also found in both samples between 400 – 800 m/z. The mass
error for each peak assigned to these classes of molecules was less than 0.630 ppm.
Around 36 glycerides peaks were found in both Gelucire® samples. They are usually
formed by different combinations of fatty acids and glycerol. No mono caprylic acid
(C8) glyceride was found in the spectra, which is normally detected in negative ion
mode, 24 but mono stearic acid (C18) glyceride was found. Moreover, a small
fraction of Polypropylene glycol [H(OCH2CH2CH2)nOH] was also found in both
samples. In the spectra, there is a low intensity charge state distribution series in the
500-600 m/z region. Using internal calibration and matching the exact masses to
possible elemental compositions and isotopic distributions, the chemical composition
for these series was calculated to be [C74H147O33Na4]3+ with an average mass error of
(0.119±0.092) ppm. This series corresponded to PEG monolaurate ester
[C12H23O2․(OCH2CH2)nNa] (see Fig. A.5). The components in the samples are
similar to the structures proposed by previous literature1 and the producer.
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TABLE A.1. List of most common polymeric compounds found in the two batches
of Gelucire® 44/14
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FIGURE A.4: A) Spectrum of polymeric distribution patterns in Gelucire® 44/14 (A). B) Spectrum
of polymeric distribution patterns in Gelucire® 44/14 (B). Inserts 1A-1B, 2A-2B and 3A-3B show the
differences between the two spectra.
FIGURE A.5: Proposed chemical structure for [C74H147O33Na4]3+ with neutralization on –OH group.
The mass spectra of both batches are very similar. However, using the high
resolution of FT-ICR-MS, three major polymeric differences can be identified. The
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first difference is the presence of PEG [H(OCH2CH2)nOH] (mass error of 0.067 ppm)
in (A), but not in (B) (Fig. A.4, insert 1A-1B). This series is next to the series of
(C12H23O2․[OCH2CH2]nNa3)3+ and (C22H42O3․[OCH2CH2]nNa3)3+ with 0.02 Da
difference between the neighboring peak distributions.
The other two differences are the two polyethylene polymeric series, with a repeat
unit of CH2CH2, being inferred from the recorded mass difference of m/z 28.0313
(±0.0002). These series are only present in sample (A). The polyethylene polymeric
series, produces its most intense peak at m/z 963.7839 (1+). (Figure A.4, inset 2A-
2B). The proposed chemical formula corresponding to this peak is [C56H108O10Na]+,
with mass error of -0.065ppm. Polyethylene polymeric series 2 (Figure A.4, inset
3A-3B), produces its most intense peak at m/z 1089.8884 (1+). The proposed
chemical formula in this peak is [C64H122O11Na]+, with mass error -0.083ppm. From
the mass spectrum, only the information of the polymeric chemical composition is
obtained leaving some structural ambiguity. Thus, it is challenging to elucidate the
molecular structure of these compounds; which underlines the importance of using
MS/MS as well as complementary techniques in the analysis of highly complex
mixtures. Although in this particular case the use of MS/MS were relatively
uninformative, showing only one fragment corresponding to [M+H-Na]+. (See Fig.
A.6).
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FIGURE A.6: CAD spectrum of 765.41942+ from Polysorbate 80.
A.3.3. Comparison between batches of Polysorbate 80 from Acros (A) and
Fisher (B)
Analysis indicates that both the Acros (A) and Fisher (B) samples are composed of
sorbitan polyethoxylates, isosorbide polyethoxylates, and free PEG (Tables A.2).
Based on previous publications, and the chemistry involved, these compounds are
expected to be present in polysorbate 80.12, 25 The average mass errors of all charge
states in the spectra reported herein was below 0.12 ppm. Fig. A.7 shows a singly
charged compound located between the singly charged isosorbide polyethoxylate
peaks. This compound corresponds to sorbitan polyethoxylate (n = 25; m/z
1287.7138) with a molecular formula [C52H103O26Na2]+ and a mass error of 0.2 ppm.
The two possible chemical structures of this compound are shown in Fig. A.8.
Polypropylene glycol [H(OCH2CH2CH2)nOH] was also found in both samples. PEG
monolinoleate ester was only found in the Fisher sample. All of the compounds
indicated above are products of the reaction to produce Polysorbate 80.
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TABLE A.2: List of most common polymeric compounds found in the two batches
of Polysorbate 80
A closer look of the spectrum shows four main differences in the polymeric series
between the two samples (See inserts in Fig. A.7). The specific mass errors for
every peak are reported in section A.6 of this chapter. When comparing all the series
across the spectrum, there is only 0.1 Da difference between them. In the particular
case of the peak at m/z 917.5813, there are two possible chemical structures that have
the same molecular weight with different repeat units. For example, isosorbide
polyethoxylate monolinoleate ester repeat unit is 11; while PEG monolinolenate ester
repeat unit is 14, but they both have the same mass. Compared with Acros sample
(A), Fisher sample (B) components are a closer match with the expected products in
Polysorbate 80 with some fatty acid reacted with sorbitan, isosorbide polyethoxylate,
and free PEG. However, no stearic acid was detected.
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FIGURE A.7: A) Spectrum of polymeric distribution patterns in Acros sample (A). B) Spectrum of
polymeric distribution patterns in Fisher sample (B). Inserts 1A-1B, 2A-2B, 3A-3B, and 4A-4B show
the differences between the two spectra.
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FIGURE A.8: Proposed structure for sorbitan polyethoxylate [C52H103O26Na2]+;
[HO(CH2CH2O)nCH2COOH] with a Na replacement.
A.4. CONCLUSION
The use of high resolution mass spectrometry revealed the presence of polymeric
differences between two batch samples of Gelucire® 44/14 (A & B) and two batch
samples of Polysorbate 80. The additional presence of free PEG
[HO(OCH2CH2)nOH], polyethylene polymeric series [C56H108O10Na]+ and
[C64H122O11Na]+ was determined in Gelucire® 44/14 (sample A). The analysis of
these commercial Polysorbate formulations exposes the presence of PEG
monolinoelate ester, isosorbide polyethoxylate or PEG monolinoleate ester, and
Polysorbate monoleate. The results agreed with previous work on the Polysorbate
species distribution of Polysorbate 80 using different techniques.8, 12 However, the
use of FT-ICR-MS provided enough resolution to overcome the complexities in the
spectra.
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